var title_f24_17_24848="Antiphospholipid antibody syndrome purpura";
var content_f24_17_24848=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F65890&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F65890&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Purpura in antiphospholipid antibody syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 351px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Noninflammatory, retiform purpura are present on the buttocks and thighs.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_17_24848=[""].join("\n");
var outline_f24_17_24848=null;
var title_f24_17_24849="Beta globin bands Hb H disease";
var content_f24_17_24849=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F63845&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F63845&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 479px\">",
"   <div class=\"ttl\">",
"    Beta globin attached to the red cell cytoskeleton in hemoglobin H disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 459px; height: 359px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Red blood cell ghosts and cytoskeletons from patients with hemoglobin H (Hb H) disease analyzed by Triton acid urea gel electrophoresis are shown here; the reference standard is normal (Hb A) hemolysate (lane 4). Alpha and beta globin bands are not found on normal red cell ghosts (lane 1) or their cytoskeletons (lane 5). Although both beta and alpha globin bands are attached to the Hb H ghosts (lanes 2 and 3), only beta globin bands are attached to the cytoskeleton (lanes 6 and 7).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Advani, S, Sorenson, E, Shinar, W, et al. Characterization and comparison of the red blood cell membrane damage in severe human alpha and beta-thalassemia. Blood 1992; 79:1058. Copyright &copy; 1992 American Society of Hematology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_17_24849=[""].join("\n");
var outline_f24_17_24849=null;
var title_f24_17_24850="Patient information: Bone problems caused by kidney disease (The Basics)";
var content_f24_17_24850=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"15\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/86001\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/28/27072\">",
"         Anatomy of the urinary tract",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/43/15024\">",
"          Thyroid and parathyroid glands",
"         </a>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?27/35/28212\">",
"         Patient information: Chronic kidney disease (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?18/2/18467\">",
"         Patient information: Dialysis and diet (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?8/62/9188\">",
"         Patient information: Medicines for chronic kidney disease (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?13/5/13398\">",
"         Patient information: Chronic kidney disease (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Bone problems caused by kidney disease (The Basics)",
"    </div>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H1817871898\">",
"      <span class=\"h1\">",
"       What is kidney disease?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Kidney disease is when the kidneys don&rsquo;t work well. Normally, the kidneys filter the blood and remove waste and excess salt and water (",
"      <a class=\"graphic graphic_figure graphicRef79864 \" href=\"UTD.htm?26/28/27072\">",
"       figure 1",
"      </a>",
"      ).",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1817871930\">",
"      <span class=\"h1\">",
"       What bone problems can be caused by kidney disease?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Kidney disease can cause different types of bone problems. These problems usually start early on in kidney disease. If they are not treated, they will get worse as the kidney disease worsens.",
"     </p>",
"     <p>",
"      Terms that doctors might use for the bone problems caused by kidney disease are &ldquo;renal osteodystrophy&rdquo; or &ldquo;chronic kidney disease bone mineral disorder.&rdquo;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1817871945\">",
"      <span class=\"h1\">",
"       How does kidney disease cause bone problems?",
"      </span>",
"      &nbsp;&mdash;&nbsp;When the kidneys don&rsquo;t work normally, the levels of certain substances in the body can get too high or too low.",
"     </p>",
"     <p>",
"      Kidney disease commonly causes:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        High levels of phosphate (also called phosphorus) &ndash; Phosphate is a mineral found in many foods. Foods with high levels of phosphate include milk, other dairy foods, nuts, meat, eggs, beans, liver, and chocolate.",
"       </li>",
"       <li>",
"        Low levels of vitamin D",
"       </li>",
"       <li>",
"        Low levels of calcium",
"       </li>",
"       <li>",
"        High levels of parathyroid hormone &ndash; Parathyroid hormone (also called &ldquo;PTH&rdquo;) is a hormone made by a gland in the neck called the parathyroid (",
"        <a class=\"graphic graphic_figure graphicRef66834 \" href=\"UTD.htm?14/43/15024\">",
"         figure 2",
"        </a>",
"        ).",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Phosphate, vitamin D, calcium, and parathyroid hormone all have effects on each other. Bone problems happen when the levels of these substances get abnormal and out of balance.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1817871983\">",
"      <span class=\"h1\">",
"       What are the symptoms of bone problems caused by kidney disease?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Early on, people usually have no symptoms from their bone disease. But they do have an increased chance of breaking a bone. Later on, people who get a treatment for kidney disease called dialysis might have symptoms from their bone disease such as:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Bone, joint, or muscle pain",
"       </li>",
"       <li>",
"        Weakness",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1817871998\">",
"      <span class=\"h1\">",
"       Will I need tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Your doctor will order blood tests to measure the levels of phosphate, calcium, vitamin D, and parathyroid hormone in your blood. People usually need to have these blood tests repeated on a regular basis.",
"     </p>",
"     <p>",
"      Other tests that people might have include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        An X-ray",
"       </li>",
"       <li>",
"        A bone density test &ndash; Bone density testing is a way to measure how strong your bones are. It involves a special kind of X-ray.",
"       </li>",
"       <li>",
"        A bone biopsy &ndash; For this test, a doctor takes a small sample of your bone (usually from your hip). Then another doctor looks at it under a microscope. This is the only test that can tell for sure if you have bone problems caused by kidney disease.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1817872013\">",
"      <span class=\"h1\">",
"       How are bone problems caused by kidney disease treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Your treatment will depend on different factors, such as:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        How severe your kidney disease is",
"       </li>",
"       <li>",
"        Your age",
"       </li>",
"       <li>",
"        Whether you get dialysis treatment for your kidney disease",
"       </li>",
"       <li>",
"        Your levels of phosphate, calcium, vitamin D, and parathyroid hormone",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      In general, treatment for bone disease involves different parts.",
"     </p>",
"     <p>",
"      The first part of treatment usually involves lowering your phosphate level. This can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Diet changes &ndash; You should avoid eating foods that are high in phosphorus. But your doctor might recommend that you keep eating meat and eggs. Even though these foods are high in phosphorus, they are a good source of protein. To help you plan your meals, you will probably work with a dietitian (food expert).",
"       </li>",
"       <li>",
"        Medicines &ndash; Medicines called &ldquo;phosphate binders&rdquo; can help lower phosphate levels in the blood. There are different types of phosphate binders. Some contain calcium. Examples of these include",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?13/17/13589?source=see_link\">",
"         calcium carbonate",
"        </a>",
"        and",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?7/38/7780?source=see_link\">",
"         calcium acetate",
"        </a>",
"        . Others do not contain calcium. Examples of these include",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?22/1/22548?source=see_link\">",
"         sevelamer",
"        </a>",
"        (brand names: Renagel&reg;, Renvela&reg;) and lanthanum. Phosphate binders should be taken with food.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Other treatments for bone problems caused by kidney disease can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Vitamin D medicines, to treat or prevent low levels of vitamin D",
"       </li>",
"       <li>",
"        A &ldquo;calcimimetic&rdquo; medicine &ndash; This is a type of medicine that works like calcium in the body.",
"       </li>",
"       <li>",
"        Extra calcium, to treat low levels of calcium",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      These treatments will usually help lower the level of parathyroid hormone in your body. But if they don&rsquo;t, your doctor will talk with you about other treatment. This might involve surgery to remove your parathyroid glands.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1817872028\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/35/28212?source=see_link\">",
"       Patient information: Chronic kidney disease (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?8/62/9188?source=see_link\">",
"       Patient information: Medicines for chronic kidney disease (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?18/2/18467?source=see_link\">",
"       Patient information: Dialysis and diet (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?13/5/13398?source=see_link\">",
"       Patient information: Chronic kidney disease (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?24/17/24850?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 86001 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-124.240.187.80-4AC29DC90F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_17_24850=[""].join("\n");
var outline_f24_17_24850=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1817871898\">",
"      What is kidney disease?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1817871930\">",
"      What bone problems can be caused by kidney disease?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1817871945\">",
"      How does kidney disease cause bone problems?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1817871983\">",
"      What are the symptoms of bone problems caused by kidney disease?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1817871998\">",
"      Will I need tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1817872013\">",
"      How are bone problems caused by kidney disease treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1817872028\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/86001\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/28/27072\">",
"      Anatomy of the urinary tract",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/43/15024\">",
"       Thyroid and parathyroid glands",
"      </a>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/5/13398?source=related_link\">",
"      Patient information: Chronic kidney disease (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/35/28212?source=related_link\">",
"      Patient information: Chronic kidney disease (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/2/18467?source=related_link\">",
"      Patient information: Dialysis and diet (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?8/62/9188?source=related_link\">",
"      Patient information: Medicines for chronic kidney disease (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_17_24851="MRI hamstring avulsion fracture ischial tuberosity";
var content_f24_17_24851=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F87259&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F87259&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 618px\">",
"   <div class=\"ttl\">",
"    MRI hamstring avulsion fracture ischial tuberosity",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 598px; height: 292px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Left hip MRI demonstrates a focal cortical defect of the left ischial tuberosity with margins of the defect demonstrating low signal&nbsp;on T1-weighted coronal (arrow A), and T2-weighted coronal sequence (B).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Joseph Farnam, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_17_24851=[""].join("\n");
var outline_f24_17_24851=null;
var title_f24_17_24852="Risk stratification of metastatic testicular germ cell tumors";
var content_f24_17_24852=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Risk stratification of metastatic testicular germ cell tumors",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/17/24852/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/17/24852/contributors\">",
"     Timothy D Gilligan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/17/24852/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/17/24852/contributors\">",
"     William K Oh, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/17/24852/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/17/24852/contributors\">",
"     Don S Dizon, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/17/24852/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 11, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Testicular cancers are the most curable solid neoplasms because of remarkable treatment advances dating back to the mid 1970s. The majority of testicular cancers are germ cell tumors (GCTs). The development of effective chemotherapy is the primary factor responsible for this improved prognosis. Cisplatin-based combination chemotherapy can often cure GCTs, but there is a delicate balance between too little and too much therapy in men with GCTs. Inadequate therapy can lead to a missed opportunity for cure and an unnecessary patient death. Missed or reduced doses of chemotherapy or a failure to resect residual masses following chemotherapy for nonseminomas fall into this category. On the other hand, the cure rates are so high with intensive therapy that there is a risk of overtreatment, with its associated acute and delayed toxicities. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/7/13432?source=see_link\">",
"     \"Overview of the treatment of testicular germ cell tumors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/63/24568?source=see_link\">",
"     \"Initial risk-stratified treatment for advanced testicular germ cell tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The development of effective chemotherapy regimens led to of the development of a risk-based stratification system for patients with metastatic disease. The risk-based system in use was developed by the International Germ Cell Cancer Collaborative Group (IGCCCG). This staging system will be reviewed here. The integration of various treatment modalities in the treatment of testicular tumors, the applications of chemotherapy for the initial management of advanced testicular GCTs, and the management of extragonadal germ cell tumors are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/7/13432?source=see_link\">",
"     \"Overview of the treatment of testicular germ cell tumors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/63/24568?source=see_link\">",
"     \"Initial risk-stratified treatment for advanced testicular germ cell tumors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/52/10058?source=see_link\">",
"     \"Extragonadal germ cell tumors involving the mediastinum and retroperitoneum\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     IGCCCG STAGING SYSTEM",
"    </span>",
"    &nbsp;&mdash;&nbsp;While several different prognostic systems for patients with testicular GCT were available initially, these were replaced by a uniform validated prognostic model developed by International Germ Cell Cancer Collaborative Group (IGCCCG) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24852/abstract/1-8\">",
"     1-8",
"    </a>",
"    ]. In 1997, consensus was reached, which permitted the development of a new joint staging system for the American Joint Committee on Cancer (AJCC) and the International Union Against Cancer (IUCC) (",
"    <a class=\"graphic graphic_table graphicRef82117 \" href=\"UTD.htm?35/13/36061\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef56341 \" href=\"UTD.htm?20/34/21037\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef61906 \" href=\"UTD.htm?41/46/42732\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24852/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In this prognostic model, the number and size of metastases were not significant on multivariate analysis. Rather, prognosis was best predicted by the presence versus absence of metastases to organs other than the lungs and for nonseminomatous GCTs only, by the site of the primary tumor (testicular or retroperitoneal versus mediastinal), and the degree of elevation of the serum tumor markers.",
"   </p>",
"   <p>",
"    In the IGCCCG staging system, patients are divided into good-, intermediate-, and poor-risk groups, based upon these variables. As noted above, criteria differ for seminomas and nonseminomatous GCTs within each risk group (",
"    <a class=\"graphic graphic_table graphicRef61906 \" href=\"UTD.htm?41/46/42732\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24852/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When using serum tumor marker levels to risk stratify patients, it is essential to use marker levels drawn at the start of the first cycle of chemotherapy (ideally on day 1 of the first cycle prior to the infusion of chemotherapy).",
"   </p>",
"   <p>",
"    The criteria for both seminoma and nonseminomatous GCT are reviewed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Seminomas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Metastatic seminomas are classified as either good- or intermediate-risk, based upon whether or not extrapulmonary metastases are present. Serum levels of beta-human chorionic gonadotropin (beta-hCG) and lactate dehydrogenase (LDH) are not used in assigning risk status to patients with seminoma.",
"   </p>",
"   <p>",
"    A beta-hCG &gt;1000",
"    <span class=\"nowrap\">",
"     U/L",
"    </span>",
"    or any elevation of alpha-fetoprotein (AFP) is a highly unusual result for men with seminoma. In such cases, patients should be considered as having a NSGCT, even if pathologic evaluation of the testicle fails to identify these elements. This has implications for the risk stratification, chemotherapy treatment plan, and management of residual masses following chemotherapy.",
"   </p>",
"   <p>",
"    Very mild elevations of AFP (ie, AFP &lt;30",
"    <span class=\"nowrap\">",
"     ng/mL)",
"    </span>",
"    should be interpreted with caution because some individuals have chronic mild elevations of AFP unrelated to any identifiable disease process. In these cases, a very mildly elevated serum AFP that does not rise over time (nor decline following the initiation of chemotherapy) is unlikely to be due to a germ cell tumor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H181144799\">",
"    <span class=\"h3\">",
"     Good risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;Men with metastatic seminomas are classified as good risk if they meet all of the following criteria:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Any primary site",
"     </li>",
"     <li>",
"      No metastases to organs other than the lungs",
"     </li>",
"     <li>",
"      Normal serum AFP",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Intermediate risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with intermediate risk seminomas if all of the following are present:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Any primary site",
"     </li>",
"     <li>",
"      Metastases to organs other than the lungs are present (eg, liver or brain metastases)",
"     </li>",
"     <li>",
"      Normal serum AFP",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Nonseminomatous GCTs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with metastatic nonseminomatous GCTs are divided into good-, intermediate-, and poor-risk categories, based upon the primary site of the tumor, the extent and location of metastatic disease, and the degree of elevation of serum tumor markers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Good risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with metastatic nonseminomatous GCTs are categorized as good risk if they meet all of the following conditions:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Testicular or retroperitoneal primary tumor",
"     </li>",
"     <li>",
"      No metastases to organs other than the lungs",
"     </li>",
"     <li>",
"      Tumor markers:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Serum AFP &lt;1000",
"      <span class=\"nowrap\">",
"       ng/mL",
"      </span>",
"     </li>",
"     <li>",
"      beta-hCG &lt;5000 international",
"      <span class=\"nowrap\">",
"       units/L",
"      </span>",
"     </li>",
"     <li>",
"      Lactate dehydrogenase (LDH) &lt;1.5 times upper limit of normal",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Intermediate risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intermediate-risk patients with nonseminomatous GCTs if all of the following criteria are present:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Testicular or retroperitoneal primary tumor",
"     </li>",
"     <li>",
"      No metastases to organs other than the lungs",
"     </li>",
"     <li>",
"      Tumor markers:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Serum AFP 1000 to 10,000",
"      <span class=\"nowrap\">",
"       ng/mL",
"      </span>",
"     </li>",
"     <li>",
"      beta-hCG 5000 to 50,000 international",
"      <span class=\"nowrap\">",
"       units/L,",
"      </span>",
"      or",
"     </li>",
"     <li>",
"      LDH 1.5 to 10 times upper limit of normal.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Poor risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with nonseminomatous GCTs are considered poor risk if",
"    <strong>",
"     any",
"    </strong>",
"    of the following are present:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mediastinal primary site with or without metastases",
"     </li>",
"     <li>",
"      Metastases to organs other than the lungs (eg, liver or brain metastases)",
"     </li>",
"     <li>",
"      Tumor markers:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Serum AFP &gt;10,000",
"      <span class=\"nowrap\">",
"       ng/mL",
"      </span>",
"     </li>",
"     <li>",
"      beta-hCG &gt;50,000 international",
"      <span class=\"nowrap\">",
"       units/L",
"      </span>",
"      or",
"     </li>",
"     <li>",
"      LDH &gt;10 times the upper limit of normal",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The development of effective chemotherapy for testicular GCTs has resulted in an improved prognosis and an overall five-year survival rate of over 96 percent for all stages combined and over 70 percent for men with distant metastases.",
"   </p>",
"   <p>",
"    The prognostic value of the International Germ Cell Consensus Classification Collaborative Group (IGCCCG) was illustrated in a 1997 study involving patients with germ cell tumors (GCT, 5202 patients with nonseminomatous germ cell tumors and 660 with seminomas) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24852/abstract/8\">",
"     8",
"    </a>",
"    ]. The overall survival rate at five years stratified by risk group was:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Seminomas",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Good risk (90 percent of seminomas): 86 percent",
"     </li>",
"     <li>",
"      Intermediate risk (10 percent): 72 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nonseminomatous GCT",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Good risk (56 percent of nonseminomas): 92 percent",
"     </li>",
"     <li>",
"      Intermediate risk (28 percent): 80 percent",
"     </li>",
"     <li>",
"      Poor risk (16 percent): 48 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because the patients in this study were treated between 1975 and 1990 there was concern that the prognosis in patients with poor-risk nonseminomatous GCT was inaccurate because the time period under study did not reflect current treatment strategies. Therefore, a 2006 meta-analysis re-evaluated the risk-based prognosis in of 1775 patients with nonseminomas [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24852/abstract/10\">",
"     10",
"    </a>",
"    ]. Compared to the 1997 report, the five-year survival rate for the good- and intermediate-risk subsets was similar to those seen in the 1997 study (94 and 83 percent, respectively). However, there was a much higher five-year overall survival rate for poor-risk patients (71 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Testicular cancers are the most curable solid neoplasms because of the development of effective cisplatin-based combination chemotherapy that can often cure germ cell tumors. However, there is a delicate balance between too little and too much therapy in men with GCTs. Whenever possible, men with advanced testicular germ cell tumors should be referred to centers with expertise in the management of such tumors. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prognosis is determined by the International Germ Cell Cancer Collaborative Group (IGCCCG) Staging System. In this system, prognosis was best predicted by the presence versus absence of nonpulmonary visceral metastases and for nonseminomatous GCTs only, by the site of the primary tumor (testicular or retroperitoneal versus mediastinal) and the degree of elevation of the serum tumor markers. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'IGCCCG staging system'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All patients with advanced GCTs should be classified prior to treatment as good, intermediate, or poor risk to maximize the probability of cure with initial chemotherapy and minimize toxicity (",
"      <a class=\"graphic graphic_table graphicRef82117 \" href=\"UTD.htm?35/13/36061\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef56341 \" href=\"UTD.htm?20/34/21037\">",
"       table 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef61906 \" href=\"UTD.htm?41/46/42732\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'IGCCCG staging system'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/63/24568?source=see_link\">",
"       \"Initial risk-stratified treatment for advanced testicular germ cell tumors\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      When using serum tumor marker levels to risk stratify patients, it is essential to use marker levels drawn at the start of the first cycle of chemotherapy (ideally on day 1 of the first cycle prior to administering chemotherapy). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'IGCCCG staging system'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Metastatic seminomas are classified as either good or intermediate risk, based upon whether or not metastases to organs other than the lungs",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      lymph nodes are present. Serum levels of beta-human chorionic gonadotropin (beta-hCG) and lactate dehydrogenase (LDH) are not typically used in assigning risk status to patients with seminoma.",
"     </li>",
"     <li>",
"      Any elevation of alpha-fetoprotein (AFP) is inconsistent with the diagnosis of seminoma. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Seminomas'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with metastatic nonseminomatous GCTs are divided into good-, intermediate-, and poor-risk categories, based upon the primary site of the tumor, the extent and location of metastatic disease, and the degree of elevation of serum tumor markers. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Nonseminomatous GCTs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The development of effective chemotherapy for testicular GCTs has resulted in an improved prognosis and an overall five-year survival rate of over 96 percent for all stages combined and over 70 percent for men with distant metastases. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24852/abstract/1\">",
"      Birch R, Williams S, Cone A, et al. Prognostic factors for favorable outcome in disseminated germ cell tumors. J Clin Oncol 1986; 4:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24852/abstract/2\">",
"      Bosl GJ, Geller NL, Cirrincione C, et al. Multivariate analysis of prognostic variables in patients with metastatic testicular cancer. Cancer Res 1983; 43:3403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24852/abstract/3\">",
"      Droz JP, Kramar A, Ghosn M, et al. Prognostic factors in advanced nonseminomatous testicular cancer. A multivariate logistic regression analysis. Cancer 1988; 62:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24852/abstract/4\">",
"      Habuchi T, Kamoto T, Hara I, et al. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers. Cancer 2003; 98:1635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24852/abstract/5\">",
"      Levi JA, Thomson D, Sandeman T, et al. A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up. J Clin Oncol 1988; 6:1154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24852/abstract/6\">",
"      Prognostic factors in advanced non-seminomatous germ-cell testicular tumours: results of a multicentre study. Report from the Medical Research Council Working Party on Testicular Tumours. Lancet 1985; 1:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24852/abstract/7\">",
"      Stoter G, Sylvester R, Sleijfer DT, et al. Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer: results from a European Organization for Research on Treatment of Cancer Multiinstitutional Phase III Study. Cancer Res 1987; 47:2714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24852/abstract/8\">",
"      International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 1997; 15:594.",
"     </a>",
"    </li>",
"    <li>",
"     Testis. In: AJCC Cancer Staging Handbook, 6th, Green FL, Page DL, Fleming ID, et al (Eds), Springer Verlag, New York 2002. p.347.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24852/abstract/10\">",
"      van Dijk MR, Steyerberg EW, Habbema JD. Survival of non-seminomatous germ cell cancer patients according to the IGCC classification: An update based on meta-analysis. Eur J Cancer 2006; 42:820.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2988 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-222.190.118.195-58B3102C39-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_17_24852=[""].join("\n");
var outline_f24_17_24852=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      IGCCCG STAGING SYSTEM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Seminomas",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H181144799\">",
"      - Good risk",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Intermediate risk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Nonseminomatous GCTs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Good risk",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Intermediate risk",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Poor risk",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/2988\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2988|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/13/36061\" title=\"table 1\">",
"      TNM staging testicular CA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/34/21037\" title=\"table 2\">",
"      Stage group testicular CA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/46/42732\" title=\"table 3\">",
"      Risk strat system advancted TGCTs",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/52/10058?source=related_link\">",
"      Extragonadal germ cell tumors involving the mediastinum and retroperitoneum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/63/24568?source=related_link\">",
"      Initial risk-stratified treatment for advanced testicular germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/7/13432?source=related_link\">",
"      Overview of the treatment of testicular germ cell tumors",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_17_24853="Alagille facies";
var content_f24_17_24853=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F53349&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F53349&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 534px\">",
"   <div class=\"ttl\">",
"    Typical facies in Alagille syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 514px; height: 350px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The typical facial features of Alagille syndrome are triangular, with a prominent forehead, deep-set eyes, a pointed chin, and a straight nose with a bulbous tip. The facial features change over time, with a more triangular shape during childhood and prominence of the jaw as patients reach adulthood.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Kamath BM, Loomes KM, Piccoli DA. Medical Management of Alagille Syndrome. J Pediatr Gastroenterol Nutr 2010; 50:580. Copyright &copy; 2010 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_17_24853=[""].join("\n");
var outline_f24_17_24853=null;
var title_f24_17_24854="Fibromyalgia";
var content_f24_17_24854=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Fibromyalgia (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?24/17/24854/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/17/24854/contributors\" id=\"au4387\">",
"       Don L Goldenberg, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?24/17/24854/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/17/24854/contributors\" id=\"se5724\">",
"       Peter H Schur, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?24/17/24854/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/17/24854/contributors\" id=\"de4792\">",
"       Jerry M Greene, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?24/17/24854?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      FIBROMYALGIA OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Fibromyalgia is one of a group of chronic pain disorders that affect connective tissues, including the muscles, ligaments (the tough bands of tissue that bind together the ends of bones), and tendons (which attach muscles to bones). It is a chronic condition that causes widespread muscle pain, &ldquo;myalgia,&rdquo; and excessive tenderness in many areas of the body. Many patients also experience fatigue, sleep disturbances, headaches, and mood disturbances, such as depression and anxiety. Despite ongoing research, the cause, diagnosis, and optimal treatment of fibromyalgia are not clear.",
"    </p>",
"    <p>",
"     In the United States, fibromyalgia affects about 2 percent of people by age 20, which increases to approximately 8 percent of people by age 70; it is the most common cause of generalized musculoskeletal pain in women between 20 and 55 years. It is more common in women than men. Most people initially develop symptoms between the ages of 30 and 55.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      FIBROMYALGIA CAUSES",
"     </span>",
"    </p>",
"    <p>",
"     The cause of fibromyalgia is unknown. Various physical or emotional factors may play a role in triggering symptoms. Although the pain is felt in muscles and soft-tissues, there are no visible abnormalities at these sites. The muscles and tendons are excessively irritated by various painful stimuli. This is thought to be the result of a change in pain perception, a phenomenon termed &ldquo;central sensitization.&rdquo; Other conditions may also develop as a result of central sensitization, including irritable bowel syndrome, chronic fatigue syndrome, chronic headaches, and chronic jaw and facial pain.",
"    </p>",
"    <p>",
"     As research studies continue, the factors that lead to chronic pain in fibromyalgia will be better understood, hopefully allowing for the development of better treatments.",
"    </p>",
"    <p>",
"     Despite the large number of symptoms, there is no generally agreed upon explanation for how or why central sensitization develops. The most plausible theory suggests that some people have a genetic predisposition to fibromyalgia because of a heightened sense of pain. In other people, various stressors, including infection, physical or emotional trauma, sleep disturbances, or other medical conditions allow for the development of fibromyalgia [",
"     <a class=\"abstract\" href=\"UTD.htm?24/17/24854/abstract/1\">",
"      1",
"     </a>",
"     ].",
"    </p>",
"    <p>",
"     The chance of developing fibromyalgia is increased eightfold in family members of a person with fibromyalgia compared with people in the general population. Similar genetic factors are noted in people with irritable bowel syndrome, depression, and migraines.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      FIBROMYALGIA SYMPTOMS",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Pain",
"     </span>",
"     &nbsp;&mdash;&nbsp;The primary symptom of fibromyalgia is widespread (diffuse), chronic, and persistent pain. The pain may be described as a deep muscular aching, soreness, stiffness, burning, or throbbing. Patients may also feel numbness, tingling, or unusual &ldquo;crawling&rdquo; sensations in the arms and legs. Although some degree of muscle pain is always present, it varies in intensity and is aggravated by certain conditions, such as anxiety or stress, poor sleep, exertion, or exposure to cold or dampness. Muscle stiffness is typically present upon awakening and tends to improve as the day progresses. However, in some cases, muscle stiffness can remain throughout the day. A common description is, &ldquo;It feels as if I always have the flu.&rdquo;",
"    </p>",
"    <p>",
"     The pain may be confined to specific areas, often the neck or shoulders, early in the course of the disease. Multiple muscle groups may eventually become involved, with most patients experiencing pain in the neck, middle and lower back, arms and legs, and chest wall. These areas feel painful with even slight pressure and are called tender points (",
"     <a class=\"graphic graphic_figure graphicRef53200 \" href=\"UTD.htm?39/57/40862\">",
"      figure 1",
"     </a>",
"     ). Many patients with fibromyalgia feel that their joints are swollen, although there is no visible inflammation of the joints (arthritis).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Other pain symptoms",
"     </span>",
"     &nbsp;&mdash;&nbsp;Patients with fibromyalgia are often affected by other pain symptoms.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       A majority of people with fibromyalgia experience repeated migraines or muscular headaches. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?15/51/16179?source=see_link\">",
"        \"Patient information: Headache causes and diagnosis in adults (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       Symptoms of irritable bowel syndrome (IBS), including frequent abdominal pain and episodes of diarrhea, constipation, or both, are common in fibromyalgia. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?3/53/3926?source=see_link\">",
"        \"Patient information: Irritable bowel syndrome (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       Interstitial cystitis or painful bladder syndrome causes bladder pain, urinary urgency, and frequency and is common in many people with fibromyalgia. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?30/48/31490?source=see_link\">",
"        \"Patient information: Diagnosis of interstitial cystitis/bladder pain syndrome (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       Some people with fibromyalgia have facial and jaw pain or tenderness caused by temporomandibular joint (TMJ) syndrome. People with TMJ syndrome may have limited jaw movement; clicking, snapping, or popping sounds while opening or closing the mouth; pain within facial or jaw muscles in or around the ear; or headaches.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Fatigue and sleep disturbances",
"     </span>",
"     &nbsp;&mdash;&nbsp;Persistent fatigue occurs in more than 90 percent of people with fibromyalgia. Most people complain of unusually light, unrefreshing, or nonrestorative sleep. Difficulties falling asleep, awakening repeatedly during the night, and feeling exhausted upon awakening are also common problems.",
"    </p>",
"    <p>",
"     People with fibromyalgia may also have sleep apnea (when the person stops breathing for a few moments while sleeping) or restless leg syndrome (when there is an uncontrollable urge to move the legs). If one or both of these problems are present, formal testing is recommended to confirm the diagnosis. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?25/25/26003?source=see_link\">",
"      \"Patient information: Sleep apnea in adults (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     There appears to be a close relationship between fibromyalgia and chronic fatigue syndrome (CFS), which is primarily characterized by chronic, debilitating fatigue. Most patients with CFS meet the &ldquo;tender point&rdquo; criteria for fibromyalgia, and up to 70 percent of those with fibromyalgia fulfill the criteria for CFS (",
"     <a class=\"graphic graphic_table graphicRef62764 \" href=\"UTD.htm?9/60/10187\">",
"      table 1",
"     </a>",
"     ). (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?41/11/42161?source=see_link\">",
"      \"Patient information: Chronic fatigue syndrome (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Depression and anxiety",
"     </span>",
"     &nbsp;&mdash;&nbsp;Approximately 30 percent of people with fibromyalgia have major depression at the time of their diagnosis; the incidence of depression or anxiety in people with fibromyalgia is as high as 74 and 60 percent, respectively, over a lifetime. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/41/20116?source=see_link\">",
"      \"Patient information: Depression in adults (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Infectious diseases",
"     </span>",
"     &nbsp;&mdash;&nbsp;Chronic pain and tenderness may be triggered by some infections, such as Lyme disease. Continued symptoms of fibromyalgia are not due to &ldquo;chronic&rdquo; Lyme disease. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?31/17/32022?source=see_link\">",
"      \"Patient information: Lyme disease symptoms and diagnosis (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H9\">",
"     <span class=\"h1\">",
"      FIBROMYALGIA TESTS",
"     </span>",
"    </p>",
"    <p>",
"     There are no specific laboratory or imaging tests used to diagnose fibromyalgia. Thus, the diagnosis is typically based upon a thorough patient history, a complete physical examination, and blood tests, which are used to exclude conditions with similar symptoms.",
"    </p>",
"    <p>",
"     The American College of Rheumatology (ACR) developed classification criteria for fibromyalgia in 1990 that have often been used to help make the diagnosis. According to the ACR, people can be classified as having fibromyalgia if they have the following symptoms and findings:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Widespread musculoskeletal pain",
"      </li>",
"      <li>",
"       Excess tenderness in at least 11 of 18 specific sites known as &ldquo;tender points&rdquo; (",
"       <a class=\"graphic graphic_figure graphicRef53200 \" href=\"UTD.htm?39/57/40862\">",
"        figure 1",
"       </a>",
"       )",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     An alternative approach to diagnosis uses the 2010 ACR preliminary diagnostic criteria for fibromyalgia, which do not require a tender point examination. These criteria allow for the diagnosis to be made based upon combined numerical scores for the extent of widespread pain and for the severity and extent of symptoms.",
"    </p>",
"    <p>",
"     The healthcare provider will perform a physical examination to rule out arthritis, other connective tissue disorders, and neurologic conditions. Routine laboratory tests may be recommended to help exclude other conditions, such as inflammatory arthritis, thyroid disease, and disorders of the muscles. Results of these tests are normal in most people with fibromyalgia.",
"    </p>",
"    <p>",
"     People with fibromyalgia frequently have additional symptoms, including persistent fatigue, headache, additional pain symptoms, and sleep and mood disturbances. Thus, the evaluation may also include the following:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Informal or formal evaluation of mood problems such as depression or anxiety. The person may be referred to a mental health specialist for further evaluation or treatment.",
"      </li>",
"      <li>",
"       A thorough sleep history. If this suggests a sleep disturbance such as restless legs syndrome or sleep apnea, the person will be referred to a sleep specialist for additional evaluation and treatment. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?25/25/26003?source=see_link\">",
"        \"Patient information: Sleep apnea in adults (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Fibromyalgia or another illness?",
"     </span>",
"     &nbsp;&mdash;&nbsp;The process of determining whether a person's signs and symptoms are related to fibromyalgia or to another condition can be lengthy and complex in some cases. Many illnesses can cause generalized muscle aches, fatigue, and other common symptoms of fibromyalgia. The following is a sample of disorders that may be considered in the diagnostic process:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Rheumatoid arthritis and systemic lupus erythematosus (SLE) &mdash; Rheumatoid arthritis is a chronic disease that causes inflammation of joints, resulting in pain, swelling, and potential deformity of the affected joints. SLE is also a chronic, inflammatory disorder of connective tissue. Patients may be affected by abnormalities involving multiple organ systems.",
"       <br/>",
"       <br/>",
"       Although both disorders share many symptoms with fibromyalgia, they have other features that are not usually seen in people with fibromyalgia, including inflammation of the synovial membranes (connective tissue that lines the spaces between bones and joints). (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?28/35/29238?source=see_link\">",
"        \"Patient information: Systemic lupus erythematosus (SLE) (Beyond the Basics)\"",
"       </a>",
"       and",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?20/61/21463?source=see_link\">",
"        \"Patient information: Rheumatoid arthritis symptoms and diagnosis (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       Osteoarthritis &mdash; Osteoarthritis causes stiffness, tenderness, pain, and potential deformity of affected joints, and it most commonly occurs in older individuals. It is differentiated from fibromyalgia based upon a patient's history, clinical examination, and degenerative joint changes seen on x-ray in people with osteoarthritis. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?15/46/16098?source=see_link\">",
"        \"Patient information: Osteoarthritis symptoms and diagnosis (Beyond the Basics)\"",
"       </a>",
"       .)",
"       <br/>",
"       <br/>",
"       It is important to note that fibromyalgia can occur in people with rheumatoid arthritis, SLE, or osteoarthritis. Thus, it may be difficult to determine whether symptoms of chronic pain and fatigue are caused by fibromyalgia or another condition.",
"      </li>",
"      <li>",
"       Ankylosing spondylitis (AS) &mdash; AS is a chronic, progressive, inflammatory disease involving joints of the spine. This condition leads to stiffness, pain, and decreased movement of the spine. AS also causes characteristic findings that can be seen on x-ray, which are absent in people with fibromyalgia. In contrast, spinal motion and x-rays are usually normal in people with fibromyalgia. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?18/38/19045?source=see_link\">",
"        \"Patient information: Ankylosing spondylitis and spondyloarthritis (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       Polymyalgia rheumatica (PMR) &mdash; PMR is an episodic, chronic, inflammatory condition that causes stiffness and pain in the shoulders, hips, or other regions. The disorder, which primarily affects individuals over age 50, is frequently associated with inflammation of certain large arteries. PMR is differentiated from fibromyalgia based upon a person's medical history, physical examination, and blood tests. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?41/54/42852?source=see_link\">",
"        \"Patient information: Polymyalgia rheumatica and giant cell (temporal) arteritis (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       Hypothyroidism and other endocrine disorders &mdash; Decreased activity of the thyroid gland, known as hypothyroidism, can cause fatigue, sleep disturbances, and generalized aches, similar to those in fibromyalgia. Thyroid function tests are routinely conducted to help exclude hypothyroidism. Other endocrine disorders, including increased activity of the parathyroid glands (hyperparathyroidism), can cause symptoms similar to fibromyalgia. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?14/54/15203?source=see_link\">",
"        \"Patient information: Hypothyroidism (underactive thyroid) (Beyond the Basics)\"",
"       </a>",
"       and",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?28/52/29507?source=see_link\">",
"        \"Patient information: Primary hyperparathyroidism (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       Muscle inflammation (myositis) or muscle disease due to metabolic abnormalities (metabolic myopathy) &mdash; These conditions cause muscle fatigue and weakness, compared to the widespread pain seen in fibromyalgia. In addition, patients with myositis typically have abnormal levels of muscle enzymes. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?26/11/26804?source=see_link\">",
"        \"Patient information: Myositis (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       Neurologic disorders &mdash; These may include disorders of the brain and spinal cord (central nervous system or CNS) or of nerves outside the CNS (peripheral nervous system). A thorough neurologic examination can assist in differentiating fibromyalgia from other neurologic disease.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H11\">",
"     <span class=\"h1\">",
"      FIBROMYALGIA TREATMENT TIPS",
"     </span>",
"    </p>",
"    <p>",
"     Optimal treatment of fibromyalgia should include the patient, clinician, physical therapist, mental health professional, and other healthcare professionals.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Fibromyalgia is not a degenerative or deforming condition, nor does it result in life-threatening complications. However, treatment of chronic pain and fatigue is challenging, and there are no &ldquo;quick cures.&rdquo;",
"      </li>",
"      <li>",
"       Treatments are available. Medications may be helpful in alleviating pain, in improving the quality of sleep, and in improving the mood. Exercise, stretching programs, and other activities are also important in helping to manage symptoms. Symptoms of fibromyalgia are not related to any destructive process, and being active will not cause harm.",
"      </li>",
"      <li>",
"       Understanding fibromyalgia may help to improve response to treatment. As an example, some patients believe that their illness is due to an undiagnosed infection, although there is no evidence that fibromyalgia is related to persistent infection.",
"      </li>",
"      <li>",
"       It is important to have realistic expectations concerning the ability to function and manage the condition over the long term. Symptoms often wax and wane over time, yet some degree of muscle pain and fatigue generally persist. Nevertheless, most people with fibromyalgia improve, and most patients lead full, active lives.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H12\">",
"     <span class=\"h1\">",
"      FIBROMYALGIA MEDICATIONS",
"     </span>",
"    </p>",
"    <p>",
"     As of 2011, three medications had been approved by the FDA for the treatment of fibromyalgia [",
"     <a class=\"abstract\" href=\"UTD.htm?24/17/24854/abstract/2-8\">",
"      2-8",
"     </a>",
"     ]. These included pregabalin, an alpha-2-ligand inhibitor, as well as duloxetine and milnacipran, which are selective norepinephrine and serotonin reuptake inhibitors.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H30590436\">",
"     <span class=\"h2\">",
"      Anticonvulsants",
"     </span>",
"     &nbsp;&mdash;&nbsp;Anticonvulsants (drugs used primarily for treating epilepsy) may help to relieve pain and improve sleep. Pregabalin was the first drug approved in the United States for the treatment of fibromyalgia in 2007 [",
"     <a class=\"abstract\" href=\"UTD.htm?24/17/24854/abstract/3,5,6\">",
"      3,5,6",
"     </a>",
"     ]. It works as an alpha-2-ligand inhibitor, and its pain relief is probably related to blocking certain chemicals that increase pain transmission.",
"    </p>",
"    <p>",
"     One of the older anticonvulsants, gabapentin, also significantly improved symptoms in people with fibromyalgia [",
"     <a class=\"abstract\" href=\"UTD.htm?24/17/24854/abstract/9\">",
"      9",
"     </a>",
"     ]. Some healthcare providers use these medications in combination with other analgesics or antidepressants, although such combined therapies have not been studied in a scientific fashion.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H30590456\">",
"     <span class=\"h3\">",
"      Side effects",
"     </span>",
"     &nbsp;&mdash;&nbsp;The most common side effects of these drugs include feeling sedated or dizzy, gaining weight, or developing swelling in the lower legs; however, most people tolerate these medications well.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H30590463\">",
"     <span class=\"h2\">",
"      Dual-reuptake inhibitors",
"     </span>",
"     &nbsp;&mdash;&nbsp;Duloxetine and milnacipran, both inhibitors of norepinephrine and serotonin reuptake by nerve cells, have helped pain, fatigue, and well-being in people with fibromyalgia, regardless of whether or not the person was depressed [",
"     <a class=\"abstract\" href=\"UTD.htm?24/17/24854/abstract/2,7,8\">",
"      2,7,8",
"     </a>",
"     ]. The most common side effects of these dual reuptake inhibitors are nausea and dizziness, but these are generally less problematic if the dose is started at a low level and is increased very slowly.",
"    </p>",
"    <p>",
"     A variety of other medications have been used to manage the symptoms associated with fibromyalgia. The medications that have been most effective in relieving symptoms of fibromyalgia in clinical trials are drugs that target chemicals in the brain and spinal cord that are important in processing pain. In contrast, medications and techniques that work to decrease symptoms of pain locally, such as antiinflammatory drugs and analgesics, are less effective.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h3\">",
"      Tricyclic antidepressants (TCAs)",
"     </span>",
"     &nbsp;&mdash;&nbsp;Taking tricyclic antidepressants before bedtime may promote deeper sleep and may alleviate muscle pain. Examples of TCAs include amitriptyline or cyclobenzaprine.",
"    </p>",
"    <p>",
"     In addition, this treatment may improve depression. Although cyclobenzaprine is considered to be a muscle relaxant, its chemical structure and mode of action are very similar to those of amitriptyline. Studies have shown that treatment with these tricyclic antidepressants results in significant improvement in about 25 to 45 percent of patients with fibromyalgia, although the effectiveness may lessen over time [",
"     <a class=\"abstract\" href=\"UTD.htm?24/17/24854/abstract/1,10\">",
"      1,10",
"     </a>",
"     ]. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/24/21894?source=see_link\">",
"      \"Patient information: Depression treatment options for adults (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     TCAs are typically started at a very low dose and are slowly increased to the most effective and tolerable dose. However, even at low doses, side effects are common and may include dry mouth, fluid retention, weight gain, constipation, or difficulty concentrating.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h3\">",
"      Selective serotonin reuptake inhibitors (SSRIs)",
"     </span>",
"     &nbsp;&mdash;&nbsp;Selective serotonin-reuptake inhibitors (SSRIs) such as fluoxetine and paroxetine may also be effective in fibromyalgia. SSRIs are a group of antidepressant drugs that work to increase the concentration of serotonin in the brain. Serotonin is a naturally produced chemical that regulates the delivery of messages between nerve cells. More information about SSRIs is available in a separate topic review. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/24/21894?source=see_link\">",
"      \"Patient information: Depression treatment options for adults (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Some reports suggest that combining various drugs, such as fluoxetine in the morning and amitriptyline before bedtime, may be more effective than any single medication [",
"     <a class=\"abstract\" href=\"UTD.htm?24/17/24854/abstract/11,12\">",
"      11,12",
"     </a>",
"     ].",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H19\">",
"     <span class=\"h2\">",
"      Antiinflammatory drugs",
"     </span>",
"     &nbsp;&mdash;&nbsp;Fibromyalgia does not cause tissue inflammation. Neither nonsteroidal antiinflammatory drugs (NSAIDs) used alone nor glucocorticoids (steroids) help people with fibromyalgia. However, when used in combination with other medications, nonsteroidal antiinflammatory drugs (NSAIDs) such as ibuprofen or naproxen may have some benefit. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/13/2262?source=see_link\">",
"      \"Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H20\">",
"     <span class=\"h2\">",
"      Analgesics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Analgesics are pain medications; some are available over-the-counter while others require a prescription. The prescription analgesic tramadol, either alone or combined with acetaminophen, was found to be helpful in alleviating the pain associated with fibromyalgia in clinical trials. Tramadol may cause dizziness, diarrhea, or sleep disturbances in some people. Use of tramadol is less likely to result in addiction compared with other, more potent, narcotic pain relievers.",
"    </p>",
"    <p>",
"     Narcotic or opioid pain medications have not been studied for the treatment of fibromyalgia. Most healthcare providers do not recommend using narcotic pain medications for the long term, although they may be appropriate in selected people for short-term relief of symptoms that do not improve with all other treatments.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H22\">",
"     <span class=\"h1\">",
"      COMPLEMENTARY AND ALTERNATIVE TREATMENTS OF FIBROMYALGIA",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H23\">",
"     <span class=\"h2\">",
"      Exercise",
"     </span>",
"     &nbsp;&mdash;&nbsp;Regular cardiovascular exercises, such as walking, swimming, or biking, are helpful in reducing muscle pain and in improving muscle strength and fitness in fibromyalgia [",
"     <a class=\"abstract\" href=\"UTD.htm?24/17/24854/abstract/9\">",
"      9",
"     </a>",
"     ]. Muscle pain and fatigue often seem to worsen when a patient begins to exercise. However, engaging in aerobic exercise typically improves symptoms.",
"    </p>",
"    <p>",
"     Muscle strengthening programs also appear to improve pain, to decrease the number of tender points, and to improve muscle strength in people with fibromyalgia.",
"    </p>",
"    <p>",
"     People with fibromyalgia should consider working with a physical therapist to develop an appropriate, individualized exercise program that provides the greatest benefit. Eventually, a person should exercise for a minimum of 30 minutes three times weekly. A separate topic review is available that discusses exercise and arthritis. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/62/28645?source=see_link\">",
"      \"Patient information: Arthritis and exercise (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H24\">",
"     <span class=\"h2\">",
"      Relaxation therapies",
"     </span>",
"     &nbsp;&mdash;&nbsp;In selected people with fibromyalgia, participating in stress-reduction programs, learning relaxation techniques, or participating in hypnotherapy (hypnosis), biofeedback, or cognitive behavioral therapy may help to alleviate certain symptoms.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Hypnosis induces a trance-like state (similar to daydreaming) of altered awareness and perception, during which there may be heightened responsiveness to suggestions.",
"      </li>",
"      <li>",
"       During biofeedback, patients use information about typically unconscious bodily functions, such as muscle tension or blood pressure, to help gain conscious control over such functions.",
"      </li>",
"      <li>",
"       Cognitive behavioral therapy (CBT) is based on the concept that people&rsquo;s perceptions of themselves and of their surroundings affect their emotions and behavior. The goal of CBT is to change the way a person thinks about pain and to deal with illness more positively.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H25\">",
"     <span class=\"h2\">",
"      Acupuncture",
"     </span>",
"     &nbsp;&mdash;&nbsp;Acupuncture involves inserting hair-thin, metal needles into the skin at specific points on the body. It causes little to no pain. In some cases, a mild electric current is applied to the needle. In clinical studies, traditional Chinese acupuncture has not been more effective than sham (fake) acupuncture treatments in relieving symptoms of fibromyalgia. However, some people have benefitted from acupuncture. In general, the quality of studies examining acupuncture is poor, and it difficult to know for certain what, if any, benefits that acupuncture could provide.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3822118\">",
"     <span class=\"h2\">",
"      Tai chi",
"     </span>",
"     &nbsp;&mdash;&nbsp;Some people with fibromyalgia benefit from a traditional Chinese exercise called tai chi, which combines mind-body practice with gentle, flowing movement exercises.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H26\">",
"     <span class=\"h1\">",
"      LIFE WITH FIBROMYALGIA",
"     </span>",
"    </p>",
"    <p>",
"     Most people with fibromyalgia continue to have chronic pain and fatigue. After an average follow-up of 14 years, one study found that there is usually little change in the patient's symptoms. However, two-thirds of patients reported that they were working full-time and that fibromyalgia interfered only modestly with their lives [",
"     <a class=\"abstract\" href=\"UTD.htm?24/17/24854/abstract/13\">",
"      13",
"     </a>",
"     ]. These studies are from specialists; there is evidence that people with fibromyalgia in the general population often get better with little or no treatment.",
"    </p>",
"    <p>",
"     Many people with fibromyalgia worry that their symptoms represent the &ldquo;early stages&rdquo; of a more serious condition, such as lupus. Long-term studies of people with fibromyalgia do not indicate that there is an increased risk of other rheumatic diseases or neurologic conditions. Fibromyalgia is not life-threatening, although it can affect the quality of day-to-day life. The severity of this impact depends upon a number of factors, including the patients&rsquo; medical, family, and social supports; their financial status; and their past experiences.",
"    </p>",
"    <p>",
"     One of the most important factors in a person's long-term prognosis is the person's ability to take charge, to avoid &ldquo;catastrophizing,&rdquo; and to learn to cope well with symptoms while remaining as active as possible.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H27\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1804368369\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11737368\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/20/43329?source=see_link\">",
"      Patient information: Fibromyalgia (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?4/47/4850?source=see_link\">",
"      Patient information: Chronic fatigue syndrome (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?9/17/9490?source=see_link\">",
"      Patient information: Complex regional pain syndrome (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?0/34/547?source=see_link\">",
"      Patient information: Sj&ouml;gren&rsquo;s syndrome (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11737394\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?15/51/16179?source=see_link\">",
"      Patient information: Headache causes and diagnosis in adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?3/53/3926?source=see_link\">",
"      Patient information: Irritable bowel syndrome (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/48/31490?source=see_link\">",
"      Patient information: Diagnosis of interstitial cystitis/bladder pain syndrome (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?25/25/26003?source=see_link\">",
"      Patient information: Sleep apnea in adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?41/11/42161?source=see_link\">",
"      Patient information: Chronic fatigue syndrome (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/41/20116?source=see_link\">",
"      Patient information: Depression in adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?31/17/32022?source=see_link\">",
"      Patient information: Lyme disease symptoms and diagnosis (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/35/29238?source=see_link\">",
"      Patient information: Systemic lupus erythematosus (SLE) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?20/61/21463?source=see_link\">",
"      Patient information: Rheumatoid arthritis symptoms and diagnosis (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?15/46/16098?source=see_link\">",
"      Patient information: Osteoarthritis symptoms and diagnosis (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?18/38/19045?source=see_link\">",
"      Patient information: Ankylosing spondylitis and spondyloarthritis (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?41/54/42852?source=see_link\">",
"      Patient information: Polymyalgia rheumatica and giant cell (temporal) arteritis (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?14/54/15203?source=see_link\">",
"      Patient information: Hypothyroidism (underactive thyroid) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/52/29507?source=see_link\">",
"      Patient information: Primary hyperparathyroidism (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?26/11/26804?source=see_link\">",
"      Patient information: Myositis (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/24/21894?source=see_link\">",
"      Patient information: Depression treatment options for adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/13/2262?source=see_link\">",
"      Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/62/28645?source=see_link\">",
"      Patient information: Arthritis and exercise (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H28\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/55/8056?source=see_link\">",
"      Clinical manifestations and diagnosis of fibromyalgia in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/49/35608?source=see_link\">",
"      Differential diagnosis of fibromyalgia",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/19/31031?source=see_link\">",
"      Pathogenesis of fibromyalgia",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/15/14586?source=see_link\">",
"      Initial treatment of fibromyalgia in adults",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"        www.nlm.nih.gov/medlineplus/healthtopics.html",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       National Institute of Arthritis, Musculoskeletal, and Skin Diseases",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.niams.nih.gov/\">",
"        www.niams.nih.gov/",
"       </a>",
"       , search for \"fibromyalgia\")",
"      </li>",
"      <li>",
"       National Fibromyalgia Research Association",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.nfra.net/\">",
"        www.nfra.net",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       National Fibromyalgia Association",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.fmaware.org/\">",
"        www.fmaware.org",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       The Arthritis Foundation",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.arthritis.org/\">",
"        www.arthritis.org",
"       </a>",
"       )",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H29\">",
"     <span class=\"h2\">",
"      Patient support",
"     </span>",
"     &nbsp;&mdash;&nbsp;There are a number of online forums where patients can find information and support from other people with similar conditions.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       <a class=\"external\" href=\"file://about.com/\">",
"        About.com",
"       </a>",
"       Fibromyalgia and Chronic Fatigue Syndrome Forum",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://chronicfatigue.about.com/forum\">",
"        file://chronicfatigue.about.com/forum",
"       </a>",
"       )",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?24/17/24854/abstract/1-3,9-13\">",
"      1-3,9-13",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 6, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?24/17/24854?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24854/abstract/1\">",
"      Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA 2004; 292:2388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24854/abstract/2\">",
"      Arnold LM, Lu Y, Crofford LJ, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 2004; 50:2974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24854/abstract/3\">",
"      Crofford LJ, Rowbotham MC, Mease PJ, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005; 52:1264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24854/abstract/4\">",
"      Arnold LM, Goldenberg DL, Stanford SB, et al. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum 2007; 56:1336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24854/abstract/5\">",
"      Mease PJ, Russell IJ, Arnold LM, et al. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol 2008; 35:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24854/abstract/6\">",
"      Straube S, Derry S, Moore RA, McQuay HJ. Pregabalin in fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reports. Rheumatology (Oxford) 2010; 49:706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24854/abstract/7\">",
"      Arnold LM, Clauw DJ, Wohlreich MM, et al. Efficacy of duloxetine in patients with fibromyalgia: pooled analysis of 4 placebo-controlled clinical trials. Prim Care Companion J Clin Psychiatry 2009; 11:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24854/abstract/8\">",
"      Arnold LM, Gendreau RM, Palmer RH, et al. Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2010; 62:2745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24854/abstract/9\">",
"      Gowans SE, deHueck A, Voss S, et al. Effect of a randomized, controlled trial of exercise on mood and physical function in individuals with fibromyalgia. Arthritis Rheum 2001; 45:519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24854/abstract/10\">",
"      Arnold LM, Keck PE Jr, Welge JA. Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics 2000; 41:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24854/abstract/11\">",
"      Goldenberg D, Mayskiy M, Mossey C, et al. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 1996; 39:1852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24854/abstract/12\">",
"      Arnold LM, Hess EV, Hudson JI, et al. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med 2002; 112:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24854/abstract/13\">",
"      Wolfe F, Anderson J, Harkness D, et al. Health status and disease severity in fibromyalgia: results of a six-center longitudinal study. Arthritis Rheum 1997; 40:1571.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f24_17_24854=[""].join("\n");
var outline_f24_17_24854=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           FIBROMYALGIA OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           FIBROMYALGIA CAUSES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           FIBROMYALGIA SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H9\">",
"           FIBROMYALGIA TESTS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H11\">",
"           FIBROMYALGIA TREATMENT TIPS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H12\">",
"           FIBROMYALGIA MEDICATIONS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H22\">",
"           COMPLEMENTARY AND ALTERNATIVE TREATMENTS OF FIBROMYALGIA",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H26\">",
"           LIFE WITH FIBROMYALGIA",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H27\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/57/40862\" title=\"figure 1\">",
"           Tender points fibro PI",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          TABLES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_table\" href=\"UTD.htm?9/60/10187\" title=\"table 1\">",
"           Fibromyalgia CFS PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f24_17_24855="Proximal humeral fractures in children";
var content_f24_17_24855=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Proximal humeral fractures in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/17/24855/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/17/24855/contributors\">",
"     Leticia Manning Ryan, MD, MPH, FAAP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/17/24855/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/17/24855/contributors\">",
"     Richard G Bachur, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/17/24855/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/17/24855/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/17/24855/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Proximal humeral fractures represent fewer than 5 percent of all pediatric fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. These fractures may occur either through the physis (growth plate) or in the metaphysis. One of the most important features of humeral fractures is their ability to remodel. The majority of these fractures can be treated with a sling and swathe or with a shoulder immobilizer.",
"   </p>",
"   <p>",
"    This review addresses proximal fractures of the humerus in children. Fractures of the midshaft and distal humerus, including supracondylar fractures, are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/22/25961?source=see_link\">",
"     \"Evaluation and management of supracondylar fractures in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/8/22663?source=see_link\">",
"     \"Epicondylar and transphyseal elbow fractures in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/46/19175?source=see_link\">",
"     \"Evaluation and management of condylar elbow fractures in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/13/30934?source=see_link\">",
"     \"Midshaft humeral fractures in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PERTINENT ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The humerus is the largest bone in the upper extremity. The proximal humerus articulates with the glenoid of the scapula to form the glenohumeral (shoulder) joint. The muscles and tendons of the rotator cuff, the acromion, and ligamentous attachments such as those between the coracoid process of the scapula and the acromion, serve to both stabilize the glenohumeral articulation and provide for a wide range of shoulder joint motion.",
"   </p>",
"   <p>",
"    The pediatric humerus has distinctive structural features that influence fracture risk, fracture pattern, and the potential for healing [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Periosteum",
"      </strong>",
"      &ndash; In the humerus bone, a thick periosteal sleeve is present along the shaft which limits fracture displacement and promotes healing in proximal humeral fractures [",
"      <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/5\">",
"       5",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20104?source=see_link&amp;anchor=H4#H4\">",
"       \"General principles of fracture management: Fracture patterns and description in children\", section on 'Fracture patterns in children'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Growth plate (physis)",
"      </strong>",
"      &ndash; The proximal humeral growth plate accounts for about 80 percent of the growth of the entire bone (",
"      <a class=\"graphic graphic_figure graphicRef67781 \" href=\"UTD.htm?12/8/12416\">",
"       figure 1",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/5\">",
"       5",
"      </a>",
"      ]. It closes between 16 and 19 years of age [",
"      <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/5\">",
"       5",
"      </a>",
"      ]. For these reasons, the remodeling potential in the proximal humerus is extraordinary, allowing even the most displaced fractures to be treated conservatively. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20104?source=see_link&amp;anchor=H8#H8\">",
"       \"General principles of fracture management: Fracture patterns and description in children\", section on 'Physeal (growth plate)'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Physeal fractures of the proximal humerus may occur at any age, but they are more common in the adolescent population. Rapid growth during adolescence makes the physeal region relatively weak and susceptible to fracture. Before adolescence, most proximal humeral fractures occur at the metaphysis, although Salter-Harris type I injuries are seen occasionally (",
"      <a class=\"graphic graphic_figure graphicRef54582 \" href=\"UTD.htm?20/55/21361\">",
"       figure 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef71443 \" href=\"UTD.htm?6/9/6289\">",
"       figure 3",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Nerve anatomy",
"      </strong>",
"      &ndash; Following a displaced proximal humeral fracture, the axillary nerve is at potential risk for injury. However, nerve injuries after proximal humeral fractures are exceedingly rare. When seen, the majority are neurapraxias, ie, temporary loss of nerve function (especially motor function) without anatomical nerve disruption.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MECHANISM OF INJURY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Neonates",
"    </span>",
"    &nbsp;&mdash;&nbsp;Humeral fractures are the second most common birth injury after clavicle fractures. Neonatal humeral fractures result from rotation or hyperextension of the upper extremity during passage through the birth canal (",
"    <a class=\"graphic graphic_figure graphicRef50851 \" href=\"UTD.htm?18/39/19056\">",
"     figure 4",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Children and adolescents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fractures of the proximal humerus commonly occur due to a fall on an outstretched hand (FOOSH) or from a direct blow to the lateral aspect of the shoulder (",
"    <a class=\"graphic graphic_figure graphicRef58495 \" href=\"UTD.htm?19/21/19793\">",
"     figure 5",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/3,6\">",
"     3,6",
"    </a>",
"    ]. Stress fractures of the proximal humeral physis may also occur due to repetitive internal rotation of an abducted externally rotated shoulder while throwing a baseball [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/5,7\">",
"     5,7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Pathologic fracture",
"    </span>",
"    &nbsp;&mdash;&nbsp;The humerus is a common location of bone cysts and other benign lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/3,6-9\">",
"     3,6-9",
"    </a>",
"    ]. A proximal humeral fracture that occurs with a history of minimal trauma may suggest a pathologic fracture through such a lesion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Child abuse",
"    </span>",
"    &nbsp;&mdash;&nbsp;A mechanism inconsistent with the injury or a fracture in an otherwise healthy child under three years of age with normal bone by radiograph should raise concern for child abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/6\">",
"     6",
"    </a>",
"    ]. Metaphyseal corner fractures, also known as bucket handle fractures, at the proximal humeral physis may occur when the extremity is pulled or twisted forcibly, or the child is shaken (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef79186 \" href=\"UTD.htm?8/12/8399\">",
"     image 1",
"    </a>",
"    ). These fractures are highly correlated with child abuse. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/30/13802?source=see_link&amp;anchor=H17#H17\">",
"     \"Orthopedic aspects of child abuse\", section on 'Humeral fractures'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     PHYSICAL FINDINGS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Proximal humerus fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;The child with a proximal humeral fracture typically presents with a history of trauma, severe shoulder pain, and marked pain on arm movement. For nondisplaced proximal humeral fractures, the physical findings may be limited to tenderness and mild swelling [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/6,10\">",
"     6,10",
"    </a>",
"    ]. For displaced fractures, significant anterior swelling and altered shoulder appearance relative to the unaffected side is often present, and the arm is usually shortened and held in extension [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Detailed neurovascular assessment is important to identify axillary nerve deficit. This injury presents with decreased sensation over the lateral shoulder and loss of deltoid muscle function (shoulder abduction).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Neonatal fracture",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to arm swelling or deformity, the neonate with a proximal humeral fracture may present with irritability when held and may refuse to move the upper extremity (\"pseudoparalysis\") [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Associated findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;After major trauma, proximal humeral fractures may be associated with shoulder dislocation or life-threatening injuries of the neck, head, and thorax. If present, these injuries should take priority over management of the humeral fracture during stabilization of the patient. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/16/29962?source=see_link\">",
"     \"Trauma management: Approach to the unstable child\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     RADIOGRAPHIC FINDINGS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Proximal humeral fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine AP and axillary lateral views of the humerus are generally sufficient to diagnose a proximal humeral fracture. If the injured child is tender at the physis, the treating physician should suspect a Salter-Harris I fracture, even in the presence of normal radiographs [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20104?source=see_link&amp;anchor=H15#H15\">",
"     \"General principles of fracture management: Fracture patterns and description in children\", section on 'Physeal fracture description'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If clinical concern for a shoulder injury is present, a complete three view shoulder series should also be obtained. This series includes an anterior-posterior view of the glenohumeral joint, an axillary view, and a scapular Y view. The last two views are necessary to assess the glenohumeral relationship and to exclude any dislocation or subluxation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Comparison views of the unaffected humerus may be helpful to determine if widening of the physis is present. Variations in the epiphyseal line of the proximal humerus are normal findings and should not be confused with a fracture [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Neonatal fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is challenging to evaluate a young infant's shoulder and proximal humerus radiographically because the humeral head is primarily cartilaginous and, thus, not seen on plain films until approximately six months of age [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/3\">",
"     3",
"    </a>",
"    ]. Plain films alone may be inadequate to distinguish between a physeal fracture and a dislocation. In this circumstance, ultrasonography or MRI imaging is often needed to diagnose and fully characterize the fracture [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/3,6\">",
"     3,6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Proximal humeral fracture description",
"    </span>",
"    &nbsp;&mdash;&nbsp;Proximal humeral fractures involving the physis are classified using the Salter-Harris classification system (",
"    <a class=\"graphic graphic_figure graphicRef71443 \" href=\"UTD.htm?6/9/6289\">",
"     figure 3",
"    </a>",
"    ). Physeal fractures of the proximal humerus are most commonly seen in adolescents, in whom rapid growth leads to relative weakness of the physis (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef78155 \" href=\"UTD.htm?8/6/8288\">",
"     image 2",
"    </a>",
"    ). Salter-Harris II fractures are the most common pattern in this age group. Younger children most commonly suffer metaphyseal fractures (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef78062 \" href=\"UTD.htm?20/19/20784\">",
"     image 3",
"    </a>",
"    ), although Salter-Harris I fractures may occasionally occur. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20104?source=see_link&amp;anchor=H15#H15\">",
"     \"General principles of fracture management: Fracture patterns and description in children\", section on 'Physeal fracture description'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Metaphyseal proximal humeral fractures are classified in a descriptive manner by their anatomic location, fracture pattern, displacement, and angulation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/6,8\">",
"     6,8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     INITIAL TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;For children with proximal humeral fractures, initial treatment consists of pain management, immobilization, and radiographic evaluation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Analgesia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Parenteral analgesia (eg, intravenous",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32233?source=see_link\">",
"     morphine",
"    </a>",
"    0.1 to 0.15",
"    <span class=\"nowrap\">",
"     mg/kg,",
"    </span>",
"    maximum single dose: 10 mg) is most appropriate for initial pain control in patients with moderate to severe pain and should be given prior to radiographic evaluation. Oral analgesia (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/48/7946?source=see_link\">",
"     ibuprofen",
"    </a>",
"    10",
"    <span class=\"nowrap\">",
"     mg/kg)",
"    </span>",
"    may suffice for patients who have suffered a nondisplaced proximal humeral fracture. We suggest that the clinician avoid the oral route for patients likely to require sedation or general anesthesia for fracture reduction or repair. In most circumstances, pain relief will result in an improved ability to assess and obtain necessary radiographs in the apprehensive child.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Immobilization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immobilization in a sling and swathe (",
"    <a class=\"graphic graphic_figure graphicRef78370 \" href=\"UTD.htm?26/7/26736\">",
"     figure 6",
"    </a>",
"    ) or shoulder immobilizer, depending on the child's age, enhances patient comfort and prevents further fracture displacement. Neurovascular status should be checked before and after immobilization. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Definitive care'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Orthopedic consultation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prompt orthopedic consultation should be obtained in the following circumstances:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Proximal humeral fracture associated with shoulder dislocation",
"     </li>",
"     <li>",
"      Intraarticular (Salter-Harris IV) fracture",
"     </li>",
"     <li>",
"      Completely displaced fracture in children over 12 years of age (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef68755 \" href=\"UTD.htm?3/8/3202\">",
"       image 4",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Fracture with neurovascular compromise (eg, axillary nerve injury)",
"     </li>",
"     <li>",
"      Open fracture (rare in the proximal humerus)",
"     </li>",
"     <li>",
"      Fracture with evidence of compartment syndrome (rare in the proximal humerus)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Child protection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnosis of a humeral fracture in a child with no plausible mechanism of injury should prompt involvement of an experienced child protection team (eg, social worker, nurse, physician with more extensive experience in the management of child abuse), if available. In many parts of the world (including the US, UK, and Australia), a mandatory report to appropriate governmental authorities is also required. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Child abuse'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/5/35927?source=see_link&amp;anchor=H3#H3\">",
"     \"Child abuse: Social and medicolegal issues\", section on 'Reporting suspected abuse'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, the medical care team should ensure that funduscopic examination to assess for retinal hemorrhages and skeletal survey occur once the patient's clinical status is stabilized. The safety of other children in the home must be ensured by local Child Protective Services. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/19/24890?source=see_link\">",
"     \"Physical abuse in children: Diagnostic evaluation and management\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/7/20602?source=see_link\">",
"     \"Child abuse: Eye findings in children with abusive head trauma (AHT)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     DEFINITIVE CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of proximal humeral fractures varies by patient age.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Infants",
"    </span>",
"    &nbsp;&mdash;&nbsp;For infants, a sling and swathe (with the arm wrapped to the torso by an Ace&reg; wrap) is sufficient immobilization for a proximal humeral fracture. Because of the early healing potential and the palpable callous mass that is typically formed, immobilization may be limited to four weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/6\">",
"     6",
"    </a>",
"    ]. Follow-up examinations should be done to exclude a brachial plexus injury [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/3,11\">",
"     3,11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Children and adolescents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Either sling immobilization or a shoulder immobilizer should be used for minimally displaced proximal humeral fractures in older children and adolescents. Gentle pendulum exercises may be started between two and four weeks post-injury, and an active range of motion may be started between four and six weeks. Most patients can resume overhead activities after four to six weeks and often have normal or near-normal function two months from the date of injury [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/3,6,7\">",
"     3,6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Individual variation in duration of immobilization and progress in return to normal activity may reflect the patient's healing capacity and injury severity. Orthopedic follow-up is recommended during the course of the injury to confirm appropriate management and clinical progress.",
"   </p>",
"   <p>",
"    In most cases, even markedly displaced proximal humeral fractures in children &le;12 years of age should be treated with a U-slab, sling, and swathe (",
"    <a class=\"graphic graphic_figure graphicRef63053 \" href=\"UTD.htm?22/14/22754\">",
"     figure 7",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/6\">",
"     6",
"    </a>",
"    ]. In this young patient population, the significant remodeling potential of the proximal humerus allows a markedly displaced fracture to heal and remodel to a normal appearing, fully functional shoulder [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/6,12,13\">",
"     6,12,13",
"    </a>",
"    ]. Acceptable displacements and angulation have been described with an age-based algorithm [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/14\">",
"     14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       &lt;5 years of age",
"      </strong>",
"      &ndash; Up to 70 degrees angulation, 100 percent displacement",
"     </li>",
"     <li>",
"      <strong>",
"       5 to 12 years of age",
"      </strong>",
"      &ndash; 40 to 70 degrees angulation (displacement not specified by the algorithm)",
"     </li>",
"     <li>",
"      <strong>",
"       Over 12 years of age",
"      </strong>",
"      &ndash; Up to 40 degrees angulation, 50 percent displacement",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For comfort, improvement in length, and cosmesis, the child may receive a hanging arm cast, which fatigues the muscles spanning the fracture and often improves the deformity. Children frequently prefer to sleep upright in a recliner for the first 7 to 10 days.",
"   </p>",
"   <p>",
"    Recommendations are variable regarding the degree of deformity acceptable in adolescents with displaced proximal humeral fractures; 20 to 50 degrees of angulation and 50 percent apposition are generally tolerable. The results of some published reports suggest that operative treatment should be considered in older children (&ge;12 years of age) with marked displacement [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/15,16\">",
"     15,16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The indications for closed reduction or operative treatment are controversial. The literature contains no generally accepted guidelines for acceptable angulation and displacement [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/6\">",
"     6",
"    </a>",
"    ]. It is reasonable to attempt closed reduction in children who have significantly displaced fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/13\">",
"     13",
"    </a>",
"    ]. The technique of closed reduction involves traction, abduction, forward flexion, and external rotation of the arm. If the fracture is unstable, percutaneous fixation may be required [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/11\">",
"     11",
"    </a>",
"    ]. Patients treated with a successful closed reduction are immobilized for four to six weeks, followed by an active range of motion. If pins are used, they are routinely removed at three to four weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/6\">",
"     6",
"    </a>",
"    ]. Some pediatric orthopedic surgeons favor nonoperative management unless the patient is within one year of skeletal maturity, the dominant arm is affected, or the patient is an athlete or worker.",
"   </p>",
"   <p>",
"    Open treatment is reserved for those patients who have displaced intraarticular fractures or those with neurovascular compromise, which is extremely rare in the pediatric patient population [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     FOLLOW-UP CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with proximal humeral fractures should be discharged with instructions to follow up with an orthopedic surgeon in seven to ten days. Infants are maintained in a sling and swathe for three to four weeks. Either sling immobilization or a shoulder immobilizer should be used for proximal humeral fractures in older children and adolescents who do not undergo surgical repair.",
"   </p>",
"   <p>",
"    Children who have received operative care (closed reduction with percutaneous pinning or open reduction with internal fixation or fragment removal) should be admitted for 24 to 48 hour observation of neurovascular status and soft tissue compartments. Once discharged, these patients are followed closely and may require weekly orthopedic evaluation with radiographs to determine the optimal timing for subsequent hardware removal.",
"   </p>",
"   <p>",
"    Most nerve deficits associated with humeral fractures are neurapraxic injuries that resolve with observation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications of proximal humeral fractures are rare in children. The most common complication is a mild shortening of the humerus, secondary to physeal damage and growth retardation, which may occur more frequently in older children [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/3,17\">",
"     3,17",
"    </a>",
"    ]. This limb length discrepancy is not usually associated with functional disability and often is not clinically apparent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Radiographic malunion of the fracture is also a reported complication, but is rarely associated with functional limitation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In neonates, a brachial plexus palsy may occur as an additional complication of birth trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/19\">",
"     19",
"    </a>",
"    ]. Infants with a proximal humeral fracture should be followed closely with serial neurologic examinations to identify this potentially significant injury. In general, neurovascular injury resulting from proximal humeral fractures is otherwise rare in the pediatric population.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications of proximal humeral fractures are uncommon in the pediatric population. The prognosis for healing and remodeling is excellent, especially in young patients [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24855/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?10/51/11058?source=see_link\">",
"       \"Patient information: Cast and splint care (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?25/21/25937?source=see_link\">",
"       \"Patient information: Cast and splint care (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fractures of the proximal humerus are uncommon childhood injuries that typically occur from a fall on an outstretched hand or a direct blow. A growth plate (physis) is present in the proximal humerus which closes between 16 and 19 years of age (",
"      <a class=\"graphic graphic_figure graphicRef67781 \" href=\"UTD.htm?12/8/12416\">",
"       figure 1",
"      </a>",
"      ). Growth plates are susceptible to fracture and these physeal injuries are more common during times of rapid growth, such as adolescence (",
"      <a class=\"graphic graphic_figure graphicRef71443 \" href=\"UTD.htm?6/9/6289\">",
"       figure 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pertinent anatomy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'Mechanism of injury'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A humeral fracture which occurs with a history of minimal trauma may suggest a pathological fracture or an intentional injury (child abuse). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Pathologic fracture'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Child abuse'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H20\">",
"       'Child protection'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Physical findings",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The child with a proximal humeral fracture typically presents with a history of trauma, severe shoulder pain, and marked pain on arm movement. For nondisplaced proximal humeral fractures, the physical findings may be limited to tenderness and mild swelling. For displaced fractures, significant anterior swelling and altered shoulder appearance relative to the unaffected side is typically present, and the arm is often shortened and held in extension. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Physical findings'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Detailed neurovascular assessment is important to identify axillary nerve deficit manifest by decreased sensation over the lateral shoulder and loss of deltoid muscle function (shoulder abduction). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Physical findings'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If the injured child is tender at the physis, the treating physician should suspect a fracture and not a sprain, even in the presence of normal radiographs. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Proximal humerus fractures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Proximal humeral fractures involving the physis are classified using the Salter-Harris classification system (",
"      <a class=\"graphic graphic_figure graphicRef71443 \" href=\"UTD.htm?6/9/6289\">",
"       figure 3",
"      </a>",
"      ). Physeal fractures of the proximal humerus are most commonly seen in adolescents, in whom rapid growth leads to relative weakness of the physis (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef78155 \" href=\"UTD.htm?8/6/8288\">",
"       image 2",
"      </a>",
"      ). Salter-Harris II fractures are the most common pattern seen in this age group. Younger children most commonly suffer metaphyseal fractures (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef78062 \" href=\"UTD.htm?20/19/20784\">",
"       image 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Proximal humeral fracture description'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H12\">",
"       'Radiographic findings'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20104?source=see_link&amp;anchor=H8#H8\">",
"       \"General principles of fracture management: Fracture patterns and description in children\", section on 'Physeal (growth plate)'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Definitive care",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Proximal humeral fractures in infants are treated with simple immobilization in a sling and swathe (",
"      <a class=\"graphic graphic_figure graphicRef78370 \" href=\"UTD.htm?26/7/26736\">",
"       figure 6",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Infants'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children with minimally displaced fractures may be immobilized with a sling and swathe (",
"      <a class=\"graphic graphic_figure graphicRef78370 \" href=\"UTD.htm?26/7/26736\">",
"       figure 6",
"      </a>",
"      ) or shoulder immobilizer. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Children and adolescents'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Displaced proximal humeral fractures typically are treated initially with a U slab splint, sling, and swathe in children and adolescents (",
"      <a class=\"graphic graphic_figure graphicRef63053 \" href=\"UTD.htm?22/14/22754\">",
"       figure 7",
"      </a>",
"      ), depending on the child's age, degree of angulation, and displacement. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Children and adolescents'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The emergency clinician should obtain prompt orthopedic consultation in selected circumstances. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Orthopedic consultation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The prognosis for full recovery without functional limitation after a proximal humeral fracture is excellent, especially in young patients. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Outcomes'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H25\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24855/abstract/1\">",
"      Mizuta T, Benson WM, Foster BK, et al. Statistical analysis of the incidence of physeal injuries. J Pediatr Orthop 1987; 7:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24855/abstract/2\">",
"      Landin LA. Epidemiology of children's fractures. J Pediatr Orthop B 1997; 6:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24855/abstract/3\">",
"      Carson S, Woolridge DP, Colletti J, Kilgore K. Pediatric upper extremity injuries. Pediatr Clin North Am 2006; 53:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24855/abstract/4\">",
"      Della-Giustina K, Della-Giustina DA. Emergency department evaluation and treatment of pediatric orthopedic injuries. Emerg Med Clin North Am 1999; 17:895.",
"     </a>",
"    </li>",
"    <li>",
"     Bachman D, Santora S. Orthopedic trauma. In: Textbook of Pediatric Emergency Medicine, Fleisher GR, Ludwig S.  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.1537.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24855/abstract/6\">",
"      Shrader MW. Proximal humerus and humeral shaft fractures in children. Hand Clin 2007; 23:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24855/abstract/7\">",
"      Benjamin, HJ, Hang, BT. Common acute upper extremity injuries in sports. Clin Pediatr Emerg Med 2007; 8:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24855/abstract/8\">",
"      Caviglia H, Garrido CP, Palazzi FF, Meana NV. Pediatric fractures of the humerus. Clin Orthop Relat Res 2005; :49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24855/abstract/9\">",
"      Shaw BA, Murphy KM, Shaw A, et al. Humerus shaft fractures in young children: accident or abuse? J Pediatr Orthop 1997; 17:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24855/abstract/10\">",
"      Kohler R, Trillaud JM. Fracture and fracture separation of the proximal humerus in children: report of 136 cases. J Pediatr Orthop 1983; 3:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24855/abstract/11\">",
"      SHULMAN BH, TERHUNE CB. Epiphyseal injuries in breech delivery. Pediatrics 1951; 8:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24855/abstract/12\">",
"      Dameron TB Jr, Reibel DB. Fractures involving the proximal humeral epiphyseal plate. J Bone Joint Surg Am 1969; 51:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24855/abstract/13\">",
"      Beringer DC, Weiner DS, Noble JS, Bell RH. Severely displaced proximal humeral epiphyseal fractures: a follow-up study. J Pediatr Orthop 1998; 18:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24855/abstract/14\">",
"      Beaty JH. Fractures of the proximal humerus and shaft in children. Instr Course Lect 1992; 41:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24855/abstract/15\">",
"      Markel DC, Donley BG, Blasier RB. Percutaneous intramedullary pinning of proximal humeral fractures. Orthop Rev 1994; 23:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24855/abstract/16\">",
"      Bishop JY, Flatow EL. Pediatric shoulder trauma. Clin Orthop Relat Res 2005; :41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24855/abstract/17\">",
"      Neer CS 2nd, Horwitz BS. Fractures of the proximal humeral epiphysial plate. Clin Orthop Relat Res 1965; 41:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24855/abstract/18\">",
"      Ellefsen BK, Frierson MA, Raney EM, Ogden JA. Humerus varus: a complication of neonatal, infantile, and childhood injury and infection. J Pediatr Orthop 1994; 14:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24855/abstract/19\">",
"      Drew SJ, Giddins GE, Birch R. A slowly evolving brachial plexus injury following a proximal humeral fracture in a child. J Hand Surg Br 1995; 20:24.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6540 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-213.131.41.98-0FBBA5EC0B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_17_24855=[""].join("\n");
var outline_f24_17_24855=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H27\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PERTINENT ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MECHANISM OF INJURY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Neonates",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Pathologic fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Child abuse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      PHYSICAL FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Proximal humerus fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Neonatal fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Associated findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      RADIOGRAPHIC FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Proximal humeral fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Neonatal fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Proximal humeral fracture description",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      INITIAL TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Analgesia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Immobilization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Orthopedic consultation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Child protection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      DEFINITIVE CARE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Infants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      FOLLOW-UP CARE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Physical findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Definitive care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6540\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6540|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?8/12/8399\" title=\"diagnostic image 1\">",
"      Metaphyseal corner fx",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?8/6/8288\" title=\"diagnostic image 2\">",
"      Salter-Harris I fracture proximal humerus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?20/19/20784\" title=\"diagnostic image 3\">",
"      Metaphyseal fracture of the proximal humerus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?3/8/3202\" title=\"diagnostic image 4\">",
"      Displaced proximal humeral fracture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6540|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?12/8/12416\" title=\"figure 1\">",
"      Proximal humeral physis anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?20/55/21361\" title=\"figure 2\">",
"      Salter-Harris classification system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/9/6289\" title=\"figure 3\">",
"      Physeal fractures of the proximal humerus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/39/19056\" title=\"figure 4\">",
"      Mechanism for neonatal humeral fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?19/21/19793\" title=\"figure 5\">",
"      Sports mechanism for proximal humeral fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/7/26736\" title=\"figure 6\">",
"      Sling and swathe splint",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?22/14/22754\" title=\"figure 7\">",
"      Sling and swathe",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/7/20602?source=related_link\">",
"      Child abuse: Eye findings in children with abusive head trauma (AHT)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/5/35927?source=related_link\">",
"      Child abuse: Social and medicolegal issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/8/22663?source=related_link\">",
"      Epicondylar and transphyseal elbow fractures in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/46/19175?source=related_link\">",
"      Evaluation and management of condylar elbow fractures in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/22/25961?source=related_link\">",
"      Evaluation and management of supracondylar fractures in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20104?source=related_link\">",
"      General principles of fracture management: Fracture patterns and description in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/13/30934?source=related_link\">",
"      Midshaft humeral fractures in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/30/13802?source=related_link\">",
"      Orthopedic aspects of child abuse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?25/21/25937?source=related_link\">",
"      Patient information: Cast and splint care (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?10/51/11058?source=related_link\">",
"      Patient information: Cast and splint care (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/19/24890?source=related_link\">",
"      Physical abuse in children: Diagnostic evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/16/29962?source=related_link\">",
"      Trauma management: Approach to the unstable child",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_17_24856="Acne keloidalis";
var content_f24_17_24856=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F58129&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F58129&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acne keloidalis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 296px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hypertrophic scarring and flesh-colored papules are seen in this patient.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP, MD. Goodheart's Photoguide of Common Skin Disorders, 2nd ed. Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy;2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_17_24856=[""].join("\n");
var outline_f24_17_24856=null;
var title_f24_17_24857="Diagnostic approach to and initial treatment of cervical lymphadenitis in children";
var content_f24_17_24857=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diagnostic approach to and initial treatment of cervical lymphadenitis in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/17/24857/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/17/24857/contributors\">",
"     C Mary Healy, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/17/24857/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/17/24857/contributors\">",
"     Jan E Drutz, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/17/24857/contributors\">",
"     Glenn C Isaacson, MD, FAAP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/17/24857/contributors\">",
"     Morven S Edwards, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/17/24857/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/17/24857/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/17/24857/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 4, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cervical lymphadenitis is common in childhood. The incidence is difficult to ascertain because it is usually caused by a viral upper respiratory illness and is self-limited.",
"   </p>",
"   <p>",
"    The evaluation and treatment of cervical lymphadenitis in children will be reviewed here. The pathogenesis, etiology, and clinical manifestations are discussed separately, as is peripheral lymphadenopathy in children. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/27/8632?source=see_link\">",
"     \"Etiology and clinical manifestations of cervical lymphadenitis in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/1/30744?source=see_link\">",
"     \"Causes of peripheral lymphadenopathy in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/22/33128?source=see_link\">",
"     \"Approach to the child with peripheral lymphadenopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cervical lymphadenitis is defined as enlarged, inflamed, and tender lymph node(s) of the neck. Cervical lymphadenopathy refers simply to enlarged lymph node(s) of the neck. However, the two terms often are used interchangeably. Acute lymphadenitis develops over a few days, whereas",
"    <span class=\"nowrap\">",
"     subacute/chronic",
"    </span>",
"    lymphadenitis develops over weeks to months.",
"   </p>",
"   <p>",
"    Generalized lymphadenopathy is the enlargement of two or more noncontiguous lymph node regions (ie, cervical and axillary) and is the result of systemic disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/1/30744?source=see_link&amp;anchor=H12#H12\">",
"     \"Causes of peripheral lymphadenopathy in children\", section on 'Generalized lymphadenopathy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC APPROACH",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are numerous infectious and noninfectious causes of cervical lymphadenitis in children (",
"    <a class=\"graphic graphic_table graphicRef56712 \" href=\"UTD.htm?6/55/7037\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef77911 \" href=\"UTD.htm?11/21/11612\">",
"     table 2",
"    </a>",
"    ). The diagnostic approach may vary from observation and reassurance to comprehensive diagnostic testing and aggressive medical and surgical therapy, depending upon the findings from the history and physical examination. It is not necessary to try to identify the etiology of every case of cervical lymphadenitis since most cases, particularly those that are acute and bilateral, are benign and self-limited. In difficult cases, consultation with a specialist in pediatric infectious diseases can help to direct the evaluation and management.",
"   </p>",
"   <p>",
"    A thorough history and physical examination should be performed in all children. The most common infectious causes of cervical lymphadenitis in children vary depending upon whether the adenitis is acute or",
"    <span class=\"nowrap\">",
"     subacute/chronic,",
"    </span>",
"    and bilateral or unilateral (",
"    <a class=\"graphic graphic_table graphicRef56712 \" href=\"UTD.htm?6/55/7037\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    We use this categorization in conjunction with the findings from the history and examination to guide the initial laboratory evaluation. Subsequent testing depends upon the results of the initial evaluation and the clinical course, including the response to antimicrobial therapy if it is initiated. The pace of the diagnostic evaluation is dictated by how ill the patient appears.",
"   </p>",
"   <p>",
"    Early excisional biopsy is indicated in children with clinical features suggestive of malignancy or nontuberculous mycobacterial (NTM) infection. (See",
"    <a class=\"local\" href=\"#H25\">",
"     'Additional testing'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;A thorough medical history is imperative for an accurate diagnosis and should include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Duration and laterality of adenopathy and change in size over time",
"     </li>",
"     <li>",
"      Associated symptoms (weight loss, fever, arthralgias, sore throat, conjunctivitis, rash)",
"     </li>",
"     <li>",
"      Ill contacts (viral respiratory infections, cytomegalovirus [CMV], Epstein-Barr virus [EBV],",
"      <em>",
"       Streptococcus pyogenes",
"      </em>",
"      [group A streptococcus, GAS], tuberculosis [TB])",
"     </li>",
"     <li>",
"      Ingestion of unpasteurized animal milk (brucellosis,",
"      <em>",
"       Mycobacterium bovis",
"      </em>",
"      ) or undercooked meats (toxoplasmosis)",
"     </li>",
"     <li>",
"      Dental problems or mouth sores (anaerobes, actinomycosis, enteroviral herpangina, herpes simplex gingivostomatitis)",
"     </li>",
"     <li>",
"      Skin lesions or trauma (",
"      <em>",
"       Staphylococcus aureus",
"      </em>",
"      , GAS, herpes simplex virus [HSV], cat scratch disease, tularemia, plague)",
"     </li>",
"     <li>",
"      Animal exposures (cat scratch disease, toxoplasmosis [cats], brucellosis [especially goats], tularemia [especially rabbits], bubonic plague [especially prairie dogs])",
"     </li>",
"     <li>",
"      Flea or tick bites (bubonic plague, tularemia)",
"     </li>",
"     <li>",
"      Immunization status (diphtheria, measles, mumps)",
"     </li>",
"     <li>",
"      Medications (eg,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/19/33082?source=see_link\">",
"       phenytoin",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/36/5706?source=see_link\">",
"       carbamazepine",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Geographic location and travel (tularemia, bubonic plague, TB)",
"     </li>",
"     <li>",
"      Recurrent adenopathy with other associated features (fever, pharyngitis, aphthous stomatitis) may suggest periodic fever with aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/11/8377?source=see_link\">",
"       \"Periodic fever with aphthous stomatitis, pharyngitis and adenitis (PFAPA syndrome)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;A comprehensive physical examination is important, with special attention given to the lymphatic system, the oral cavity, conjunctivae, and skin.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lymphatic system &ndash; Examination of the lymphatic system, including assessment of the liver, spleen, cervical lymph nodes, and noncervical lymph nodes, should be performed. Hepatosplenomegaly with generalized adenitis indicates a possible infection with EBV, CMV, human immunodeficiency virus (HIV), histoplasmosis, TB, or syphilis. These findings also may be signs of neoplastic disease, collagen vascular disease, or other noninfectious etiology (",
"      <a class=\"graphic graphic_table graphicRef77911 \" href=\"UTD.htm?11/21/11612\">",
"       table 2",
"      </a>",
"      ). (See appropriate topic reviews).",
"      <br/>",
"      <br/>",
"      The lymph node number, location (",
"      <a class=\"graphic graphic_figure graphicRef69528 \" href=\"UTD.htm?18/53/19285\">",
"       figure 1",
"      </a>",
"      ), size, shape, consistency, tenderness, mobility, and color should be recorded.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      \"Reactive\" lymph nodes are usually discrete, mobile, feel rubbery, are minimally tender, and are often referred to as \"shotty\".",
"     </li>",
"     <li>",
"      Infected lymph nodes are usually isolated, asymmetric, tender, warm, and erythematous; they may be fluctuant; they are less mobile and discrete than reactive lymph nodes.",
"     </li>",
"     <li>",
"      Malignant lymph nodes often are hard, fixed or matted to the underlying structures; they are usually nontender.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Oral cavity &ndash; The oral cavity should be examined for evidence of periodontal disease, herpangina, HSV gingivostomatitis, or pharyngitis.",
"     </li>",
"     <li>",
"      Eyes &ndash; Conjunctival injection may indicate Parinaud oculoglandular syndrome (associated with cat scratch disease) or Kawasaki disease (",
"      <a class=\"graphic graphic_picture graphicRef78898 \" href=\"UTD.htm?15/1/15376\">",
"       picture 1",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/47/23289?source=see_link\">",
"       \"Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12248?source=see_link\">",
"       \"Kawasaki disease: Clinical features and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Skin &ndash; A generalized rash may suggest a viral illness, whereas a localized skin lesion may indicate a more specific etiology (eg, cat scratch disease (",
"      <a class=\"graphic graphic_picture graphicRef78770 graphicRef59249 \" href=\"UTD.htm?2/2/2084\">",
"       picture 2A-B",
"      </a>",
"      ), tularemia (",
"      <a class=\"graphic graphic_picture graphicRef52036 \" href=\"UTD.htm?5/19/5439\">",
"       picture 3",
"      </a>",
"      ),",
"      <em>",
"       S. aureus",
"      </em>",
"      or GAS, HSV, etc). Less common infections in which a papular or pustular lesion is suggestive of an inoculation site include [",
"      <a class=\"abstract\" href=\"UTD.htm?24/17/24857/abstract/1\">",
"       1",
"      </a>",
"      ]:",
"     </li>",
"     <li>",
"      Nocardia (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/6/16489?source=see_link\">",
"       \"Clinical manifestations and diagnosis of nocardiosis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Actinomycosis (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/3/21559?source=see_link\">",
"       \"Cervicofacial actinomycosis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Sporotrichosis (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/11/12469?source=see_link\">",
"       \"Clinical features and diagnosis of sporotrichosis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Plague (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/15/11512?source=see_link\">",
"       \"Clinical manifestations, diagnosis, and treatment of plague (Yersinia pestis infection)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Cutaneous diphtheria (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/38/29287?source=see_link\">",
"       \"Epidemiology, pathophysiology and clinical manifestations of diphtheria\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     INITIAL EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial evaluation depends upon the duration and laterality of the adenopathy, the clinical status of the child, and the course of lymphadenitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Acute bilateral disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with acute bilateral lymphadenitis usually are managed conservatively because the most common etiology is a viral upper respiratory infection. The extent of the evaluation depends upon the child's clinical status and the course of lymphadenitis. Testing for group A streptococcus (GAS) pharyngitis is indicated in patients with an exudative pharyngitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/28/41417?source=see_link&amp;anchor=H4#H4\">",
"     \"Approach to diagnosis of acute infectious pharyngitis in children and adolescents\", section on 'Group A streptococcus'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Mild illness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children who appear mildly ill and have slightly enlarged, minimally tender, mobile, bilateral cervical adenopathy can have the lymph nodes measured with a ruler; the size should be recorded. The lymph nodes should be followed with serial examinations every few weeks until they regress. If new or worsening symptoms occur, the child should be seen back sooner for reevaluation, as described below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Severe, progressive, or persistent adenopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;For children with acute bilateral cervical lymphadenitis who are ill-appearing, febrile, or have progressive or persistent symptoms (ie, for longer than six to eight weeks without diminishing in size), we suggest the following evaluation:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Complete blood count (CBC) with differential",
"     </li>",
"     <li>",
"      Erythrocyte sedimentation rate (ESR)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      C-reactive protein (CRP)",
"     </li>",
"     <li>",
"      Hepatic profile (looking for evidence of systemic involvement, but not necessarily for a specific pathogen)",
"     </li>",
"     <li>",
"      Blood culture",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/35/15924?source=see_link\">",
"       Tuberculin skin test",
"      </a>",
"     </li>",
"     <li>",
"      Epstein-Barr virus (EBV), cytomegalovirus (CMV), human immunodeficiency virus (HIV) serology",
"     </li>",
"     <li>",
"      Other serologic testing (eg,",
"      <em>",
"       T. gondii",
"      </em>",
"      , syphilis, or brucellosis) as indicated by the history and examination",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The CBC, ESR",
"    <span class=\"nowrap\">",
"     (and/or",
"    </span>",
"    CRP), and hepatic profile are nonspecific tests that may provide information about the presence of inflammation, bone marrow suppression or infiltration, and liver function. Abnormal results may prompt additional evaluation (eg, bone marrow biopsy in children with peripheral cytopenias or blasts). The remainder of the tests may help to establish an etiology and the need for specific therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Acute unilateral disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute unilateral cervical lymphadenitis in children is usually caused by",
"    <em>",
"     S. aureus",
"    </em>",
"    or GAS. Other causes include group B streptococcal infection (in young infants), anaerobes, tularemia, and",
"    <em>",
"     Yersinia pestis",
"    </em>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/27/8632?source=see_link&amp;anchor=H12#H12\">",
"     \"Etiology and clinical manifestations of cervical lymphadenitis in children\", section on 'Acute unilateral'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The extent of the evaluation depends upon the child's clinical status and course of lymphadenitis, as described below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Minimal symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the child appears well and has only a slightly enlarged and minimally tender lymph node, we suggest recording the size of the lymph node and monitoring for changes. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Mild illness'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Moderate symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;In children who have acute unilateral cervical lymphadenitis and moderate symptoms (eg, fever, warm",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    tender adenitis without evidence of fluctuance), needle aspiration for Gram stain and culture (aerobic and anaerobic) may help to guide antimicrobial therapy. Although mycobacteria more typically present as subacute or chronic infections, acid fast bacilli (AFB) stain and culture should also be obtained if an adequate specimen is available. An infectious etiology is identified in 60 to 80 percent of patients subjected to needle aspiration for bacterial and mycobacterial culture [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24857/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. Blood cultures are indicated if the child is febrile and ill-appearing.",
"   </p>",
"   <p>",
"    In addition, cultures of draining skin lesions and exudative tonsils should be performed. However, isolation of GAS from the throat or skin in a patient with lymphadenitis does not necessarily confirm GAS as the cause of lymph node inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24857/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The results of the Gram stain can guide empiric antimicrobial therapy, whereas cultures and susceptibility testing determine definitive therapy. Anaerobes are fastidious organisms that require proper bacteriologic techniques for isolation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24857/abstract/5\">",
"     5",
"    </a>",
"    ]. Thus, negative cultures do not absolutely exclude anaerobic infection, particularly in older children with poor dental hygiene or periodontal disease. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Initial treatment'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Severe symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;In children who have acute unilateral cervical lymphadenitis and severe symptoms (eg, ill-appearing, fever, fluctuant nodes, concomitant cellulitis), we suggest blood cultures be performed. Fluctuant lymph nodes should be incised and drained. Although needle aspiration may at times be therapeutic, incision and drainage is the preferred procedure to reduce the likelihood of reaccumulation of pus. Such children often require hospitalization and parenteral antimicrobial therapy for several days. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Parenteral therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Ultrasound evaluation of the lymph node can be a useful means to detect the presence and extent of an abscess if lymph node fluctuance is not obvious by manual examination. Some surgeons may request computed tomography (CT) with contrast before performing incision and drainage to detect unappreciated deep loculations.",
"   </p>",
"   <p>",
"    Abscess fluid should be sent for Gram stain and bacterial culture (aerobic and anaerobic). Abscess material also should be sent for mycobacterial and fungal stains and cultures, although these organisms more typically cause chronic lymphadenitis. Finally, lymph node tissue should be sent for histopathologic",
"    <span class=\"nowrap\">",
"     examination.",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Subacute/chronic disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Subacute/chronic",
"    cervical lymphadenitis has a number of infectious and noninfectious causes (",
"    <a class=\"graphic graphic_table graphicRef56712 \" href=\"UTD.htm?6/55/7037\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef77911 \" href=\"UTD.htm?11/21/11612\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    During the initial evaluation of children with",
"    <span class=\"nowrap\">",
"     subacute/chronic",
"    </span>",
"    cervical lymphadenitis, we suggest the following tests:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      CBC with differential and ESR.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/35/15924?source=see_link\">",
"       Tuberculin skin test",
"      </a>",
"      (TST) with intermediate (5 tuberculin unit) purified protein derivative (PPD) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/17/24857/abstract/6\">",
"       6",
"      </a>",
"      ]. Children who respond with 5 to 15 mm of induration at 48 hours may have nontuberculous mycobacterial infection (NTM) or tuberculosis (TB) (depending upon their risk for TB), whereas those with &ge;15 mm induration usually have TB; however, reactions of 10 to 20 mm may occur with nontuberculous mycobacteria [",
"      <a class=\"abstract\" href=\"UTD.htm?24/17/24857/abstract/1,6-9\">",
"       1,6-9",
"      </a>",
"      ]. Intermediate gamma release assay (IGRA) tests may be useful in differentiating TB from NTM. IGRA tests usually are positive with TB but negative with NTM unless the infecting organism is",
"      <em>",
"       M. kansasii",
"      </em>",
"      ,",
"      <em>",
"       M. marinum",
"      </em>",
"      , or",
"      <em>",
"       M. szulgai",
"      </em>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?24/17/24857/abstract/10\">",
"       10",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/42/13994?source=see_link&amp;anchor=H2272513031#H2272513031\">",
"       \"Overview of nontuberculous mycobacterial lymphadenitis in children\", section on 'M. tuberculosis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/7/27768?source=see_link&amp;anchor=H5#H5\">",
"       \"Tuberculous lymphadenitis\", section on 'Cervical lymphadenopathy'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/53/13143?source=see_link&amp;anchor=H8#H8\">",
"       \"Latent tuberculosis infection in children\", section on 'Interferon-gamma release assays'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/4/23625?source=see_link&amp;anchor=H12#H12\">",
"       \"Tuberculosis disease in children\", section on 'Interferon gamma release assays'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      The clinical appearance of NTM adenitis, especially when the overlying skin becomes violaceous and thin, is so characteristic that the diagnosis can frequently be made based upon the history and physical examination (",
"      <a class=\"graphic graphic_picture graphicRef69475 \" href=\"UTD.htm?40/60/41934\">",
"       picture 4",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/17/24857/abstract/11\">",
"       11",
"      </a>",
"      ]. Excisional biopsy of the involved lymph node can provide a definitive diagnosis of NTM adenitis and is the preferred treatment. Curettage is an alternative when excisional biopsy cannot be performed. Incision and drainage are contraindicated, due to the risk of developing a chronically draining fistula. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/42/13994?source=see_link&amp;anchor=H2272512951#H2272512951\">",
"       \"Overview of nontuberculous mycobacterial lymphadenitis in children\", section on 'Diagnosis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/42/13994?source=see_link&amp;anchor=H2272513047#H2272513047\">",
"       \"Overview of nontuberculous mycobacterial lymphadenitis in children\", section on 'Management'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Serologic testing. Serologic testing for HIV, EBV, and CMV should be performed in children with bilateral",
"      <span class=\"nowrap\">",
"       subacute/chronic",
"      </span>",
"      cervical adenitis. Serologic testing for",
"      <em>",
"       Bartonella henselae",
"      </em>",
"      can be performed if there is a clinical suspicion of cat scratch disease. Serology for tularemia, toxoplasmosis, or plague also may be helpful in selected cases. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/47/23289?source=see_link&amp;anchor=H19#H19\">",
"       \"Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease\", section on 'Diagnosis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/10/30888?source=see_link\">",
"       \"Clinical manifestations, diagnosis, and treatment of tularemia\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/38/16999?source=see_link\">",
"       \"Toxoplasmosis in immunocompetent hosts\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/15/11512?source=see_link\">",
"       \"Clinical manifestations, diagnosis, and treatment of plague (Yersinia pestis infection)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If no etiology is identified with the above tests, excisional biopsy for histopathology, bacterial, mycobacterial, and fungal stains and cultures is usually indicated. (See",
"    <a class=\"local\" href=\"#H25\">",
"     'Additional testing'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     INITIAL TREATMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Acute bilateral LN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment is not usually necessary for acute bilateral lymphadenitis (LN), which most frequently is related to a self-limited viral illness. The treatment of those with severe, progressive, or persistent cervical lymphadenitis depends upon the etiology.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Acute unilateral LN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute unilateral cervical LN is usually caused by",
"    <em>",
"     S. aureus",
"    </em>",
"    or group A streptococcus (GAS). The initial treatment depends upon the severity of symptoms.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In well-appearing children with a slightly enlarged and minimally tender cervical lymph node, we suggest measuring the lymph node and monitoring it over time.",
"     </li>",
"     <li>",
"      In children with moderate symptoms (eg, fever, warm",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      tender adenitis without evidence of fluctuance) we recommend a course of oral antimicrobial therapy. Needle aspiration of the inflamed node before initiation of oral therapy may help to guide antimicrobial coverage. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Oral therapy'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      In children with severe symptoms (eg, fever, fluctuant node, cellulitis), we recommend parenteral antimicrobial therapy after incision and drainage of the inflamed node. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Parenteral therapy'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Oral therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend empiric oral antimicrobial therapy against",
"    <em>",
"     S. aureus",
"    </em>",
"    and GAS in children with acute unilateral cervical lymphadenitis and moderate symptoms (eg, fever, warm",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    tender adenitis without evidence of fluctuance). Antimicrobial treatment should be adjusted according to the culture and susceptibility results once they are available. The total length of therapy is usually 10 to 14 days.",
"   </p>",
"   <p>",
"    Potential empiric regimens include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/56/34688?source=see_link\">",
"       Clindamycin",
"      </a>",
"      30",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day orally divided every six to eight hours (maximum dose 1.8",
"      <span class=\"nowrap\">",
"       g/day)",
"      </span>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?30/5/30804?source=see_link\">",
"       Cephalexin",
"      </a>",
"      25 to 100",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day orally divided every six to eight hours (maximum dose 4",
"      <span class=\"nowrap\">",
"       g/day)",
"      </span>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/32/32259?source=see_link\">",
"       Cefadroxil",
"      </a>",
"      30",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day orally divided every 12 hours (maximum dose 2",
"      <span class=\"nowrap\">",
"       g/day)",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The choice of empiric therapy is influenced by several factors. Community-associated methicillin-resistant",
"    <em>",
"     S. aureus",
"    </em>",
"    (CA-MRSA) infections in children are increasingly common [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24857/abstract/12-16\">",
"     12-16",
"    </a>",
"    ]. In contrast to hospital-acquired MRSA, community-associated isolates are more likely to be susceptible to",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/56/34688?source=see_link\">",
"     clindamycin",
"    </a>",
"    , which effectively penetrates lymph node tissue.",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/23/41336?source=see_link\">",
"     Trimethoprim-sulfamethoxazole",
"    </a>",
"    (TMP-SMX, 10",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day of the TMP component PO divided every 12 hours) is another option for the treatment of CA-MRSA soft tissue infections. However, TMP-SMX should not be used initially because it is not active against GAS [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24857/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/21/30042?source=see_link&amp;anchor=H10#H10\">",
"     \"Epidemiology and clinical spectrum of methicillin-resistant Staphylococcus aureus infections in children\", section on 'CA-MRSA strains'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Clinicians practicing in areas where CA-MRSA is prevalent may prefer to use empiric",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/56/34688?source=see_link\">",
"     clindamycin",
"    </a>",
"    therapy. The disadvantage of liquid oral therapy is that it is relatively expensive and it tastes bad, which may adversely affect adherence. Ten percent or more of methicillin-susceptible",
"    <em>",
"     S. aureus",
"    </em>",
"    and MRSA isolates in some geographic areas are clindamycin-resistant, so if clindamycin is chosen, follow-up to ensure clinical response is needed. Empiric treatment of the mild to moderately ill child with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?30/5/30804?source=see_link\">",
"     cephalexin",
"    </a>",
"    or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/32/32259?source=see_link\">",
"     cefadroxil",
"    </a>",
"    is a reasonable option, and if the patient fails to improve, a change of antimicrobial therapy to clindamycin or TMP-SMX may be indicated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/6/29802?source=see_link&amp;anchor=H11#H11\">",
"     \"Treatment of invasive methicillin-resistant Staphylococcus aureus infection in children\", section on 'Treatment approach'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33290?source=see_link&amp;anchor=H10#H10\">",
"     \"Evaluation and management of suspected methicillin-resistant Staphylococcus aureus skin and soft tissue infections in children\", section on 'Approach for children &gt;30 days of age'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If periodontal disease is present,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/56/34688?source=see_link\">",
"     clindamycin",
"    </a>",
"    or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/26/34214?source=see_link\">",
"     amoxicillin-clavulanate",
"    </a>",
"    is preferred, since these drugs are active against oral anaerobes, as well as",
"    <em>",
"     S. aureus",
"    </em>",
"    and GAS.",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/49/34583?source=see_link\">",
"     Amoxicillin",
"    </a>",
"    -clavulanate is dosed according to the amoxicillin component; the dose depends upon the formulation:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/26/34214?source=see_link\">",
"       Amoxicillin-clavulanate",
"      </a>",
"      40",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day of the",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/49/34583?source=see_link\">",
"       amoxicillin",
"      </a>",
"      component, divided every eight hours, if using the 125",
"      <span class=\"nowrap\">",
"       mg/5",
"      </span>",
"      mL or 250",
"      <span class=\"nowrap\">",
"       mg/5",
"      </span>",
"      mL suspensions or the 125 mg, 250 mg, or 250 mg tablets",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/26/34214?source=see_link\">",
"       Amoxicillin-clavulanate",
"      </a>",
"      25 to 45",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day of the",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/49/34583?source=see_link\">",
"       amoxicillin",
"      </a>",
"      component divided every 12 hours, if using the 200",
"      <span class=\"nowrap\">",
"       mg/5",
"      </span>",
"      mL or 400",
"      <span class=\"nowrap\">",
"       mg/5",
"      </span>",
"      mL suspensions or the 200 mg or 400 mg chewable tablets",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Children who are receiving appropriate antimicrobial therapy should have a clinical response within 48 to 72 hours (eg, decreased inflammation and tenderness of the node and decreased maximum daily temperature) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24857/abstract/1\">",
"     1",
"    </a>",
"    ]. However, it may take four to six weeks for the lymph node to regress in size [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24857/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Failure to improve within 48 to 72 hours may indicate infection with a resistant organism. If not performed previously, needle aspiration for Gram stain, culture, and susceptibilities may be indicated.",
"   </p>",
"   <p>",
"    Occasionally, symptoms progress despite appropriate antimicrobial therapy and the patient requires an incision and drainage procedure. Antimicrobial therapy is usually continued for seven days after the time of drainage.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Parenteral therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend empiric parenteral antimicrobial therapy against",
"    <em>",
"     S. aureus",
"    </em>",
"    and GAS in children with acute unilateral cervical lymphadenitis and severe symptoms (eg, ill-appearing, fever, fluctuant node, concomitant cellulitis). Antimicrobial treatment should be adjusted according to the culture and susceptibility results once they are available.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/56/34688?source=see_link\">",
"     Clindamycin",
"    </a>",
"    40",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day intravenously (IV) divided every six to eight hours (maximum dose 4.8",
"    <span class=\"nowrap\">",
"     g/day)",
"    </span>",
"    is the preferred treatment option for hospitalized children with complicated skin and soft tissue infections if the clindamycin resistance rate is low (eg, &lt;10 percent) in the community. Clindamycin also provides good anaerobic coverage. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/6/29802?source=see_link&amp;anchor=H11#H11\">",
"     \"Treatment of invasive methicillin-resistant Staphylococcus aureus infection in children\", section on 'Treatment approach'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In communities where substantial",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/56/34688?source=see_link\">",
"     clindamycin",
"    </a>",
"    resistance is observed among methicillin-susceptible",
"    <em>",
"     S. aureus",
"    </em>",
"    (MSSA) or CA-MRSA isolates (&ge;10 percent),",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"     vancomycin",
"    </a>",
"    45 to 60",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day IV divided every six to eight hours (maximum dose 2 to 4",
"    <span class=\"nowrap\">",
"     g/day)",
"    </span>",
"    is recommended. The higher dose is recommended for children with serious infections.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/52/22345?source=see_link\">",
"     Linezolid",
"    </a>",
"    600 mg IV twice daily for children 12 years of age or older and 30",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day divided every eight hours for children &lt;12 years of age (maximum daily dose 1200 mg) is an alternative to",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"     vancomycin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24857/abstract/17\">",
"     17",
"    </a>",
"    ]. Linezolid can be administered intravenously or orally.",
"   </p>",
"   <p>",
"    If MSSA is isolated, potential treatment regimens include continuation of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/56/34688?source=see_link\">",
"     clindamycin",
"    </a>",
"    (if susceptible) or:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?9/36/9797?source=see_link\">",
"       Cefazolin",
"      </a>",
"      50 to 100",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day IV divided every eight hours (maximum dose 6",
"      <span class=\"nowrap\">",
"       g/day),",
"      </span>",
"      or",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/57/26519?source=see_link\">",
"       Nafcillin",
"      </a>",
"      or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/59/950?source=see_link\">",
"       oxacillin",
"      </a>",
"      150",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day IV divided every four to six hours (maximum dose 12",
"      <span class=\"nowrap\">",
"       g/day).",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    After a few days of intravenous therapy, a switch usually can be made to oral therapy, guided by the results of culture, to complete a total of 10 to 14 days of therapy. Transition to oral therapy depends upon:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The clinical course (resolution of fever, decreased pain, decreased swelling and redness)",
"     </li>",
"     <li>",
"      Improvement in erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) if previously measured",
"     </li>",
"     <li>",
"      Availability of an equivalent oral therapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Treatment failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the child fails to respond to empiric therapy, the differential diagnosis needs to be expanded to include uncommon causes of acute unilateral cervical adenitis, including noninfectious causes. The history needs to be re-reviewed. Surgical excision, drainage, or biopsy may be",
"    <span class=\"nowrap\">",
"     necessary.",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Subacute/chronic LN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Subacute/chronic",
"    cervical lymphadenitis is usually caused by cat scratch disease or nontuberculous mycobacterial (NTM) infection. However, the possibility of leukemia or lymphoma must be considered, particularly in adolescents. Information from the history, physical examination, and initial evaluation (eg, tuberculin skin testing, serology) help to distinguish among these possibilities. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/27/8632?source=see_link&amp;anchor=H20#H20\">",
"     \"Etiology and clinical manifestations of cervical lymphadenitis in children\", section on 'Subacute/chronic unilateral'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/27/8632?source=see_link&amp;anchor=H27#H27\">",
"     \"Etiology and clinical manifestations of cervical lymphadenitis in children\", section on 'Neoplasm'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Cat scratch disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some experts suggest treatment of typical cat scratch disease (CSD) in immunocompetent patients with mild to moderate illness is not necessary [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24857/abstract/18\">",
"     18",
"    </a>",
"    ]. When CSD is suspected but not confirmed, empiric therapy for",
"    <em>",
"     S. aureus",
"    </em>",
"    and GAS should be provided, and empiric therapy for CSD is optional. Empiric therapy for",
"    <em>",
"     S. aureus",
"    </em>",
"    and GAS cervical lymphadenitis is discussed above; agents that may be used in CSD include",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/15/35056?source=see_link\">",
"     azithromycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/52/17225?source=see_link\">",
"     rifampin",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/23/41336?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    , or parenteral",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/48/37632?source=see_link\">",
"     gentamicin",
"    </a>",
"    . Rifampin has an advantage of providing additive therapy to other antimicrobials against",
"    <em>",
"     S. aureus",
"    </em>",
"    and GAS. The treatment of CSD is discussed separately. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Acute unilateral LN'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/2/37925?source=see_link\">",
"     \"Treatment of cat scratch disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Surgical excision is not usually necessary for cat scratch lymphadenitis. However, painful, suppurative nodes can be treated with needle aspiration(s) for symptomatic relief.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Nontuberculous mycobacteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;When nontuberculous mycobacterial (NTM) infection is suspected, excisional biopsy and culture of the involved lymph node can provide a definitive diagnosis and is the preferred treatment when it can be performed safely because of excellent cure rates, healing, and cosmetic results. If excision is not possible, incision and complete curettage of the lesion is an alternative to prevent local fistula formation. The clinical features, diagnosis and management of NTM lymphadenitis in children is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/42/13994?source=see_link\">",
"     \"Overview of nontuberculous mycobacterial lymphadenitis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H137115380\">",
"    <span class=\"h3\">",
"     Suspected malignancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Excisional biopsy should occur as early in the course as possible if malignancy is suspected (eg, unilateral, nontender, hard, progressive cervical lymphadenopathy or associated constitutional symptoms). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/27/8632?source=see_link&amp;anchor=H27#H27\">",
"     \"Etiology and clinical manifestations of cervical lymphadenitis in children\", section on 'Neoplasm'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     ADDITIONAL TESTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;If after the initial evaluation the etiology of the adenitis remains uncertain, or the adenitis has persisted for six to eight weeks with no response to antimicrobial therapy, additional testing may be indicated [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24857/abstract/1\">",
"     1",
"    </a>",
"    ]. This may include (depending upon which studies were performed as part of the initial evaluation and identified risk factors):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Repeat complete blood count (CBC) with differential",
"     </li>",
"     <li>",
"      Rapid plasma reagin (RPR) or venereal disease research laboratory test (VDRL) for syphilis",
"     </li>",
"     <li>",
"      Serology for Epstein-Barr virus (EBV), cytomegalovirus (CMV), human herpesvirus-6, human immunodeficiency virus (HIV), histoplasmosis, coccidiomycosis, toxoplasmosis, tularemia,",
"      <em>",
"       B. henselae",
"      </em>",
"      , and brucella",
"     </li>",
"     <li>",
"      Chest radiograph",
"     </li>",
"     <li>",
"      Excisional biopsy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Excisional biopsy should occur as early in the course as possible if malignancy or nontuberculous mycobacterial infection is suspected. Biopsy specimens should be submitted for bacterial, mycobacterial, and fungal stains and cultures and histopathologic examination. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/42/13994?source=see_link&amp;anchor=H2272512951#H2272512951\">",
"     \"Overview of nontuberculous mycobacterial lymphadenitis in children\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The biopsy should be performed at a medical center specializing in the care of children, and the pathologist should know in advance there will be a lymph node biopsy. This will ensure the proper smears, stains, and cultures are performed. Parts of the sample should not be fixed at the time of excision to allow for sensitive marker studies, such as immunophenotyping, cytogenetics and molecular studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cervical lymphadenitis spontaneously regresses in most children over the course of several weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24857/abstract/1,19-21\">",
"     1,19-21",
"    </a>",
"    ]. Reactivation of inflammation may occur in children who have conditions that predispose to infection (eg, dermatitis, infestation, foreign body) or if there is an occult source of infection that was not adequately treated (eg, dental abscess) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24857/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Delayed diagnosis and initiation of appropriate therapy may result in a prolonged clinical course or complications [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24857/abstract/1\">",
"     1",
"    </a>",
"    ]. Persistent and recurrent lymphadenitis is the most frequent complication [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24857/abstract/22\">",
"     22",
"    </a>",
"    ]. Other complications vary depending upon the underlying etiology and include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Development of a sinus tract and or disseminated disease (",
"      <em>",
"       Mycobacteria",
"      </em>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/17/24857/abstract/23-25\">",
"       23-25",
"      </a>",
"      ] (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/42/13994?source=see_link&amp;anchor=H2272512912#H2272512912\">",
"       \"Overview of nontuberculous mycobacterial lymphadenitis in children\", section on 'Clinical features'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/24/37257?source=see_link\">",
"       \"Overview of disseminated nontuberculous mycobacterial (NTM) infections and NTM bacteremia in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Abscess formation, cellulitis, bacteremia (",
"      <em>",
"       S. aureus",
"      </em>",
"      and group A streptococcus [GAS]) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/17/24857/abstract/2,26,27\">",
"       2,26,27",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Acute glomerulonephritis (GAS) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/17/24857/abstract/3\">",
"       3",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?42/59/43955?source=see_link\">",
"       \"Patient information: Swollen neck nodes in children (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Evaluation",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There are numerous infectious and noninfectious causes of cervical lymphadenitis (",
"      <a class=\"graphic graphic_table graphicRef56712 \" href=\"UTD.htm?6/55/7037\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef77911 \" href=\"UTD.htm?11/21/11612\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Important aspects of the history include constitutional symptoms, exposures (eg, ill contacts, animals, drugs, travel), dental problems, and medications. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'History'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Important aspects of the examination include the lymphatic system, oral cavity, conjunctivae, and skin. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acute bilateral lymphadenitis is usually caused by a self-limited viral upper respiratory infection and requires only monitoring unless it is accompanied by severe symptoms, progresses, or persists. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Acute bilateral disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acute unilateral lymphadenitis is usually caused by",
"      <em>",
"       Staphylococcus aureus",
"      </em>",
"      or group A streptococcus (GAS). The extent of the evaluation depends upon the child's clinical status and course of lymphadenitis. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Acute unilateral disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that children who are well-appearing and have slightly enlarged nodes with minimal tenderness can be followed clinically. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Minimal symptoms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For children who have moderate symptoms (eg, fever, warm",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      tender adenitis without evidence of fluctuance), needle aspiration for Gram stain and culture (aerobic and anaerobic) may be indicated. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Moderate symptoms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For children who have severe symptoms (ill-appearing, fever, fluctuant nodes, concomitant cellulitis), we suggest blood cultures, and incision and drainage if the lymph node is fluctuant or liquefied. Abscess fluid should be sent for bacterial, fungal, and mycobacterial stains and cultures and for histopathology. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Severe symptoms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For the initial evaluation of children with",
"      <span class=\"nowrap\">",
"       subacute/chronic",
"      </span>",
"      cervical lymphadenitis, we suggest complete blood count (CBC) with differential, erythrocyte sedimentation rate (ESR), tuberculin skin testing (TST), and serology for Epstein-Barr virus (EBV), cytomegalovirus (CMV), and human immunodeficiency virus (HIV). Serologic testing for",
"      <em>",
"       Bartonella henselae",
"      </em>",
"      , tularemia, toxoplasmosis, or plague may be helpful in select cases. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Subacute/chronic disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Indications for excisional biopsy include suspicion of malignancy, tuberculosis, or nontuberculous mycobacterial lymphadenitis, and persistent (more than six to eight weeks) or enlarging adenopathy with uncertain diagnosis. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Additional testing'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute bilateral cervical lymphadenitis usually does not require treatment. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Acute bilateral LN'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that children with cervical lymphadenitis and moderate to severe symptoms (eg, fever; warm, tender, or fluctuant nodes; or concomitant cellulitis) be treated with antimicrobial therapy (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Initial empiric therapy should provide coverage for",
"      <em>",
"       S. aureus",
"      </em>",
"      and GAS; coverage for anaerobes should be included in patients with periodontal disease or poor oral hygiene. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Acute unilateral LN'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children with acute unilateral lymphadenitis who are receiving appropriate antimicrobial therapy usually manifest decreased inflammation and tenderness of the node and decreased maximum daily temperature within 48 to 72 hours. Failure to improve within 48 to 72 hours may indicate infection with a resistant organism, particularly methicillin-resistant",
"      <em>",
"       S. aureus",
"      </em>",
"      . (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Oral therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When cat scratch disease is suspected but not confirmed, empiric therapy should provide coverage for",
"      <em>",
"       S. aureus",
"      </em>",
"      and GAS, as well as for cat scratch disease. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Cat scratch disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The management of suspected nontuberculous mycobacterial lymphadenitis is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/42/13994?source=see_link&amp;anchor=H2272513047#H2272513047\">",
"       \"Overview of nontuberculous mycobacterial lymphadenitis in children\", section on 'Management'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23671351\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editorial staff at UpToDate, Inc. would like to acknowledge Dr. Douglas Swanson, who contributed to an earlier version of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Healy CM, Baker CJ. Cervical lymphadenitis. In: Textbook of Pediatric Infectious Diseases, 6th ed, Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (Eds), Saunders, Philadelphia 2009. p.185.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24857/abstract/2\">",
"      Barton LL, Feigin RD. Childhood cervical lymphadenitis: a reappraisal. J Pediatr 1974; 84:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24857/abstract/3\">",
"      DAJANI AS, GARCIA RE, WOLINSKY E. Etiology of cervical lymphadenitis in children. N Engl J Med 1963; 268:1329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24857/abstract/4\">",
"      Scobie WG. Acute suppurative adenitis in children: a review of 964 cases. Scott Med J 1969; 14:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24857/abstract/5\">",
"      Brook I. Aerobic and anaerobic bacteriology of cervical adenitis in children. Clin Pediatr (Phila) 1980; 19:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24857/abstract/6\">",
"      Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24857/abstract/7\">",
"      Margileth AM. The use of purified protein derivative mycobacterial skin test antigens in children and adolescents: purified protein derivative skin test results correlated with mycobacterial isolates. Pediatr Infect Dis 1983; 2:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24857/abstract/8\">",
"      Perlman DC, D'Amico R, Salomon N. Mycobacterial Infections of the Head and Neck. Curr Infect Dis Rep 2001; 3:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24857/abstract/9\">",
"      Lindeboom JA, Kuijper EJ, Prins JM, et al. Tuberculin skin testing is useful in the screening for nontuberculous mycobacterial cervicofacial lymphadenitis in children. Clin Infect Dis 2006; 43:1547.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Diseases caused by nontuberculous mycobacteria: (atypical mycobacteria, mycobacteria other than Mycobacterium tuberculosis. In: Red Book: 2012 Report of the Committee on Infectious Diseases, 29th, Pickering LK.  (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2012. p.759.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24857/abstract/11\">",
"      Fraser L, Moore P, Kubba H. Atypical mycobacterial infection of the head and neck in children: a 5-year retrospective review. Otolaryngol Head Neck Surg 2008; 138:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24857/abstract/12\">",
"      Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998; 279:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24857/abstract/13\">",
"      Gerber JS, Coffin SE, Smathers SA, Zaoutis TE. Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children's hospitals in the United States. Clin Infect Dis 2009; 49:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24857/abstract/14\">",
"      Como-Sabetti K, Harriman KH, Buck JM, et al. Community-associated methicillin-resistant Staphylococcus aureus: trends in case and isolate characteristics from six years of prospective surveillance. Public Health Rep 2009; 124:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24857/abstract/15\">",
"      Tillotson GS, Draghi DC, Sahm DF, et al. Susceptibility of Staphylococcus aureus isolated from skin and wound infections in the United States 2005-07: laboratory-based surveillance study. J Antimicrob Chemother 2008; 62:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24857/abstract/16\">",
"      Duggal P, Naseri I, Sobol SE. The increased risk of community-acquired methicillin-resistant Staphylococcus aureus neck abscesses in young children. Laryngoscope 2011; 121:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24857/abstract/17\">",
"      Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52:e18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24857/abstract/18\">",
"      Rolain JM, Brouqui P, Koehler JE, et al. Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother 2004; 48:1921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24857/abstract/19\">",
"      Schaad UB, Votteler TP, McCracken GH Jr, Nelson JD. Management of atypical mycobacterial lymphadenitis in childhood: a review based on 380 cases. J Pediatr 1979; 95:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24857/abstract/20\">",
"      Flint D, Mahadevan M, Barber C, et al. Cervical lymphadenitis due to non-tuberculous mycobacteria: surgical treatment and review. Int J Pediatr Otorhinolaryngol 2000; 53:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24857/abstract/21\">",
"      Maltezou HC, Spyridis P, Kafetzis DA. Nontuberculous mycobacterial lymphadenitis in children. Pediatr Infect Dis J 1999; 18:968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24857/abstract/22\">",
"      Wolinsky E. Mycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases with long-term follow-up. Clin Infect Dis 1995; 20:954.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24857/abstract/23\">",
"      BLACK BG, CHAPMAN JS. CERVICAL ADENITIS IN CHILDREN DUE TO HUMAN AND UNCLASSIFIED MYCOBACTERIA. Pediatrics 1964; 33:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24857/abstract/24\">",
"      Ord RJ, Matz GJ. Tuberculous cervical lymphadenitis. Arch Otolaryngol 1974; 99:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24857/abstract/25\">",
"      Kent DC. Tuberculous lymphadenitis: not a localized disease process. Am J Med Sci 1967; 254:866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24857/abstract/26\">",
"      Brook AH, Winter GB. Cervico-facial suppurative lymphadenitis due to staphylococcal infection in childhood. Br J Oral Surg 1971; 8:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24857/abstract/27\">",
"      CHAPMAN JS, GUY LR. Scrofula caused by atypical Mycobacteria. Pediatrics 1959; 23:323.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6061 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-190.111.122.2-6B4A64F196-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_17_24857=[""].join("\n");
var outline_f24_17_24857=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H28\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DIAGNOSTIC APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      INITIAL EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Acute bilateral disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Mild illness",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Severe, progressive, or persistent adenopathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Acute unilateral disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Minimal symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Moderate symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Severe symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Subacute/chronic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      INITIAL TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Acute bilateral LN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Acute unilateral LN",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Oral therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Parenteral therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Treatment failure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Subacute/chronic LN",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Cat scratch disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Nontuberculous mycobacteria",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H137115380\">",
"      - Suspected malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      ADDITIONAL TESTING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23671351\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6061\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6061|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/53/19285\" title=\"figure 1\">",
"      Lymph nodes head and neck",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6061|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?15/1/15376\" title=\"picture 1\">",
"      Conjunctivitis in Kawasaki",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?7/60/8128\" title=\"picture 2A\">",
"      Cat scratch disease typical papular lesion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/3/25663\" title=\"picture 2B\">",
"      Cat scratch disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/19/5439\" title=\"picture 3\">",
"      Tularemia adenitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?40/60/41934\" title=\"picture 4\">",
"      Mycobacterium avium adenitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6061|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/55/7037\" title=\"table 1\">",
"      Infectious causes of cervical nodes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/21/11612\" title=\"table 2\">",
"      Noninfectious causes of cervical nodes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/28/41417?source=related_link\">",
"      Approach to diagnosis of acute infectious pharyngitis in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/22/33128?source=related_link\">",
"      Approach to the child with peripheral lymphadenopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/1/30744?source=related_link\">",
"      Causes of peripheral lymphadenopathy in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/3/21559?source=related_link\">",
"      Cervicofacial actinomycosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/11/12469?source=related_link\">",
"      Clinical features and diagnosis of sporotrichosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/6/16489?source=related_link\">",
"      Clinical manifestations and diagnosis of nocardiosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/15/11512?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of plague (Yersinia pestis infection)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/10/30888?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of tularemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/21/30042?source=related_link\">",
"      Epidemiology and clinical spectrum of methicillin-resistant Staphylococcus aureus infections in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/38/29287?source=related_link\">",
"      Epidemiology, pathophysiology and clinical manifestations of diphtheria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/27/8632?source=related_link\">",
"      Etiology and clinical manifestations of cervical lymphadenitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33290?source=related_link\">",
"      Evaluation and management of suspected methicillin-resistant Staphylococcus aureus skin and soft tissue infections in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12248?source=related_link\">",
"      Kawasaki disease: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/53/13143?source=related_link\">",
"      Latent tuberculosis infection in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/47/23289?source=related_link\">",
"      Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/24/37257?source=related_link\">",
"      Overview of disseminated nontuberculous mycobacterial (NTM) infections and NTM bacteremia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/42/13994?source=related_link\">",
"      Overview of nontuberculous mycobacterial lymphadenitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/59/43955?source=related_link\">",
"      Patient information: Swollen neck nodes in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/11/8377?source=related_link\">",
"      Periodic fever with aphthous stomatitis, pharyngitis and adenitis (PFAPA syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/38/16999?source=related_link\">",
"      Toxoplasmosis in immunocompetent hosts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/2/37925?source=related_link\">",
"      Treatment of cat scratch disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/6/29802?source=related_link\">",
"      Treatment of invasive methicillin-resistant Staphylococcus aureus infection in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/4/23625?source=related_link\">",
"      Tuberculosis disease in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/7/27768?source=related_link\">",
"      Tuberculous lymphadenitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_17_24858="Rectovaginal or bowel endometriosis";
var content_f24_17_24858=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Rectovaginal or bowel endometriosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/17/24858/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/17/24858/contributors\">",
"     Nicola Berlanda, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/17/24858/contributors\">",
"     Paolo Vercellini, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/17/24858/contributors\">",
"     Luigi Fedele, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/17/24858/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/17/24858/contributors\">",
"     Tommaso Falcone, MD, FRCSC, FACOG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/17/24858/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/17/24858/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/17/24858/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H4930774\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endometriosis is the presence of endometrial glands and stroma at extrauterine sites. These ectopic endometrial implants are usually located in the pelvis but can occur nearly anywhere in the body. Endometriosis appears to be the most frequent cause of chronic pelvic pain in women of reproductive age and may cause prolonged suffering and disability that negatively affect health-related quality of life [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Rectovaginal or bowel involvement is estimated to be present in 5 to 12 percent of women with endometriosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/2\">",
"     2",
"    </a>",
"    ]. The rectosigmoid colon is the most common site of bowel endometriosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/2-5\">",
"     2-5",
"    </a>",
"    ]. Bowel involvement typically coexists with disease at other sites. Thus, evaluation and management of colorectal disease must take into account full distribution of endometriotic lesions.",
"   </p>",
"   <p>",
"    Bowel endometriosis can be thought of as two different entities, depending upon anatomic location: (1) rectovaginal endometriosis and (2) involvement of the bowel wall proximal to the rectosigmoid colon. Presenting symptoms, evaluation, and management differ somewhat for these two general locations.",
"   </p>",
"   <p>",
"    Diagnosis and management of rectovaginal or bowel endometriosis are reviewed here. General principles of the treatment of endometriosis, as well as endometriosis of the urinary tract and thorax, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14810?source=see_link\">",
"     \"Overview of the treatment of endometriosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/60/1993?source=see_link\">",
"     \"Urinary tract endometriosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/42/25254?source=see_link\">",
"     \"Thoracic endometriosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29778980\">",
"    <span class=\"h1\">",
"     OVERVIEW OF DISEASE CHARACTERISTICS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5266609\">",
"    <span class=\"h2\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The three theories for the pathogenesis of endometriosis include: (1) spread of endometrial cells from retrograde menstruation; (2) lymphatic or hematogenous dissemination; and (3) coelomic metaplasia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/48/19210?source=see_link&amp;anchor=H3#H3\">",
"     \"Pathogenesis, clinical features, and diagnosis of endometriosis\", section on 'Pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    According to the theory of retrograde menstruation, rectovaginal endometriosis develops when cells that efflux from the fallopian tubes then implant in the most dependent area of the pelvis, the posterior cul-de-sac (also referred to as the pouch of Douglas). The rectosigmoid colon acts as an anatomic shelter, covering endometrial cells and preventing them from being cleared by the usual processes within the peritoneal cavity. Endometrial implants elicit an inflammatory response, and eventually a fibrotic nodule is originated and buried under the peritoneum. Findings of disease more distal from the pelvis may be due to the spread of cells throughout the peritoneal cavity.",
"   </p>",
"   <p>",
"    Alternatively, some experts have suggested that rectovaginal endometriosis represents adenomyotic nodules of the rectovaginal septum, originated from m&uuml;llerian rests by a process of metaplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/6\">",
"     6",
"    </a>",
"    ]. In general, adenomyosis (ie, the presence of endometrial cells in the myometrium) is limited to the uterine wall. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/35/27191?source=see_link\">",
"     \"Uterine adenomyosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5266309\">",
"    <span class=\"h2\">",
"     Distribution of disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bowel endometriosis is most commonly found on the rectosigmoid colon. In case series of 100 or more women who underwent surgical treatment of endometriosis of the bowel, the distribution of both peritoneal or deep bowel lesions sites was as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/2-5\">",
"     2-5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Rectum (13 to 53 percent)",
"     </li>",
"     <li>",
"      Sigmoid colon (18 to 47 to percent)",
"     </li>",
"     <li>",
"      Ileum or other small bowel (2 to 5 percent)",
"     </li>",
"     <li>",
"      Appendix (3 to 18 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Endometriosis may also occur in other gastrointestinal tract locations; there are isolated reports of lesions of the descending colon, transverse colon, or stomach [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/2,5,7-10\">",
"     2,5,7-10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Many patients have multiple lesions in close proximity",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    involvement of more than one bowel segment [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. In addition, rectovaginal or bowel endometriosis commonly coexists with endometriosis at other sites (eg, ovary, peritoneal surface). As an example, one study found that deep infiltrating endometriosis, which includes both bowel and urinary tract endometriosis, occurred without disease at other sites in only 6.5 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29779101\">",
"    <span class=\"h2\">",
"     Anatomy of rectovaginal disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;In normal female pelvic anatomy, the anterior rectum is apposed the posterior vagina; this is referred to as the rectovaginal septum. In the majority of women, the rectovaginal septum extends to the level of the middle one-third of the vagina (",
"    <a class=\"graphic graphic_figure graphicRef50155 \" href=\"UTD.htm?19/14/19683\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Superior to the rectovaginal septum, the vagina and rectum separate and create a peritoneum-lined space called the posterior cul-de-sac. The anatomic boundaries of the posterior cul-de-sac are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Inferiorly, the rectovaginal septum",
"     </li>",
"     <li>",
"      Laterally, the uterosacral ligaments",
"     </li>",
"     <li>",
"      Anteriorly and superiorly, the posterior vagina, cervix, and uterus",
"     </li>",
"     <li>",
"      Posteriorly, the rectum",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Endometriosis of the bowel is most commonly found on the rectosigmoid colon, as noted above. (See",
"    <a class=\"local\" href=\"#H5266309\">",
"     'Distribution of disease'",
"    </a>",
"    above.) In women with rectal disease, a nodule of the pouch of Douglas is likely the initial lesion. The nodule and surrounding fibrosis may then infiltrate the rectal or vaginal walls. The pelvic posterior cul-de-sac may be obliterated by dense adhesions, and the uterosacral ligaments may develop endometriotic nodules [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/16\">",
"     16",
"    </a>",
"    ]. When the nodule extends laterally, the ureter and the parametrium may be involved.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1460574\">",
"    <span class=\"h2\">",
"     Depth of infiltration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deep endometriosis is defined as a solid endometriotic mass situated more than 5 mm deep to the peritoneum [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/17\">",
"     17",
"    </a>",
"    ]. According to some experts, endometriotic foci located on the bowel serosa that do not meet these criteria are defined as peritoneal endometriosis rather than bowel endometriosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/12,18\">",
"     12,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Only a minority of bowel lesions infiltrate to the level of the bowel mucosa. In a systematic review of women who underwent bowel resection for colorectal endometriosis, 15 studies reported the microscopic extent of bowel invasion [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/11\">",
"     11",
"    </a>",
"    ]. Most women had involvement of the serosa (95 percent) and muscularis propria (95 percent), and fewer had lesions that penetrated to the submucosa (38 percent) or mucosa (6 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23891569\">",
"    <span class=\"h1\">",
"     PREVALENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of endometriosis in the general population is unknown. The best clinical estimate is 1 to 7 percent of women, based upon data from gross examination of the pelvis in women who have undergone gynecologic surgery for indications other than the typical symptoms of endometriosis (pelvic pain, infertility) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/19-21\">",
"     19-21",
"    </a>",
"    ]. Among women with endometriosis, the reported prevalence of rectovaginal or bowel involvement ranges widely, from 5 to 25 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/2,3,22\">",
"     2,3,22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/48/19210?source=see_link&amp;anchor=H2#H2\">",
"     \"Pathogenesis, clinical features, and diagnosis of endometriosis\", section on 'Epidemiology and risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23891848\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with rectovaginal or bowel endometriosis may present with the classic symptoms of endometriosis (dysmenorrhea, dyspareunia, and infertility)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    with gastrointestinal symptoms. Women may also be asymptomatic [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/48/19210?source=see_link&amp;anchor=H11#H11\">",
"     \"Pathogenesis, clinical features, and diagnosis of endometriosis\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rectovaginal endometriosis may present with dyspareunia, dysmenorrhea, or dyschezia. Chronic non-menstrual pelvic pain may also be present. Dyspareunia is typically localized to the posterior vaginal wall or experienced during deep vaginal thrusting. For women with dyschezia, painful defecation may ultimately result in constipation. Rarely, women present with rectal bleeding. When bleeding is present and consistently coincides with menstrual bleeding, it is highly suggestive of rectovaginal endometriosis with infiltration into the rectal wall.",
"   </p>",
"   <p>",
"    There are two likely mechanisms of rectovaginal pain during intercourse or defecation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/24-26\">",
"     24-26",
"    </a>",
"    ] (see",
"    <a class=\"local\" href=\"#H29779101\">",
"     'Anatomy of rectovaginal disease'",
"    </a>",
"    above):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      During vaginal intercourse, from direct pressure on the posterior vaginal fornix",
"     </li>",
"     <li>",
"      During defecation, from stretching of the rectovaginal tissue against the posterior vaginal fornix due to the passage of hard stools",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Endometriosis of the bowel wall proximal to the rectosigmoid colon may be associated with nonspecific gastrointestinal symptoms. These include diarrhea, constipation, bloating, and abdominal pain [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. In rare cases, bowel obstruction occurs [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/29,30\">",
"     29,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Endometriosis is commonly associated with infertility, but the impact of bowel lesions on fertility is uncertain. It has been hypothesized that the dense posterior cul-de-sac adhesions that are often associated with rectovaginal disease may, in fact, occlude the endometriotic lesions and limit detrimental effects on the remainder of the pelvis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/24,25,31\">",
"     24,25,31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/15/38136?source=see_link&amp;anchor=H2#H2\">",
"     \"Pathogenesis and treatment of infertility in women with endometriosis\", section on 'Pathogenesis of infertility'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3390061\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms of rectovaginal or bowel endometriosis are often nonspecific. Treatment may involve surgery, potentially with extensive pelvic dissection or bowel resection; therefore, it is imperative to exclude other etiologies of the presenting symptoms prior to treatment.",
"   </p>",
"   <p>",
"    Women with pelvic pain symptoms (dysmenorrhea, dyspareunia, non-menstrual pelvic pain) should be evaluated for endometriosis. A combination of pelvic pain and infertility increases the likelihood of this diagnosis. These symptoms may be due to endometriosis at any site, not just rectovaginal or bowel disease. Identifying the distribution of endometriosis requires further evaluation. In addition, other etiologies of pelvic pain and infertility should be excluded. (See",
"    <a class=\"local\" href=\"#H23891856\">",
"     'Diagnosis and evaluation'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/60/39879?source=see_link\">",
"     \"Primary dysmenorrhea in adult women: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/1/43032?source=see_link\">",
"     \"Approach to the woman with sexual pain\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/26/41384?source=see_link\">",
"     \"Causes of chronic pelvic pain in women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/18/3367?source=see_link\">",
"     \"Causes of female infertility\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The gastrointestinal symptoms associated with rectovaginal or bowel endometriosis are mostly nonspecific. Since rectovaginal or bowel endometriosis is a fairly uncommon condition, other etiologies should be considered first. In general, rectovaginal or bowel endometriosis is suspected in women with gastrointestinal symptoms",
"    <strong>",
"     only",
"    </strong>",
"    if at least one of the classic endometriosis symptoms (dysmenorrhea, dyspareunia, infertility) is also present.",
"   </p>",
"   <p>",
"    Even in women with classic endometriosis symptoms, other etiologies of gastrointestinal symptoms should be excluded. Women with dyschezia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    rectal bleeding should be evaluated for a bowel neoplasm, inflammatory bowel disease, and other etiologies (eg, constipation, hemorrhoids, perirectal abscess). Symptoms that consistently coincide with menstrual bleeding are highly suggestive of rectovaginal endometriosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/6/7272?source=see_link\">",
"     \"Etiology of lower gastrointestinal bleeding in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/40/26246?source=see_link\">",
"     \"Perianal abscess: Clinical manifestations, diagnosis, treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Diarrhea, constipation, abdominal pain, or bloating may be associated with a variety of gastrointestinal conditions (eg, inflammatory bowel disease, irritable bowel syndrome, diverticulitis) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/28\">",
"     28",
"    </a>",
"    ]. Patients with bowel obstruction require evaluation for neoplastic or adhesive disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/55/43897?source=see_link\">",
"     \"Approach to the adult with chronic diarrhea in developed countries\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/22/13673?source=see_link\">",
"     \"Etiology and evaluation of chronic constipation in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/30/16874?source=see_link\">",
"     \"Differential diagnosis of abdominal pain in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/18/24872?source=see_link\">",
"     \"Intestinal gas and bloating\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/46/14058?source=see_link\">",
"     \"Small bowel obstruction: Causes and management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Alternatively, an evaluation for rectovaginal or bowel endometriosis is reasonable if gastrointestinal symptoms are present",
"    <strong>",
"     and",
"    </strong>",
"    physical examination or imaging findings suggest rectovaginal or bowel endometriosis. (See",
"    <a class=\"local\" href=\"#H23891848\">",
"     'Clinical manifestations'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H1461149\">",
"     'Physical examination'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H1461141\">",
"     'Imaging'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23891856\">",
"    <span class=\"h1\">",
"     DIAGNOSIS AND EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of rectovaginal or bowel endometriosis is typically suggested by a physical examination finding of a painful rectovaginal nodule or by findings on pelvic ultrasonography. Alternatively, rectovaginal or bowel endometriosis may be discovered during laparoscopy performed to evaluate pelvic pain or infertility.",
"   </p>",
"   <p>",
"    Confirmation of the diagnosis requires biopsy, which nearly always requires surgery. In some women, depending upon the type and severity of symptoms, it is often reasonable to avoid surgery and treat patients with medical therapy based upon an empiric diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/48/19210?source=see_link&amp;anchor=H15#H15\">",
"     \"Pathogenesis, clinical features, and diagnosis of endometriosis\", section on 'Diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14810?source=see_link&amp;anchor=H3#H3\">",
"     \"Overview of the treatment of endometriosis\", section on 'Treatment of pelvic pain'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rectovaginal or bowel endometriosis typically coexists with other sites of endometriosis. The diagnosis and evaluation are performed as part of the overall assessment of a patient who presents with pelvic pain",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    infertility. Aspects of this evaluation specific to rectovaginal or bowel disease are presented here. General principles of the evaluation and diagnosis of endometriosis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/48/19210?source=see_link&amp;anchor=H15#H15\">",
"     \"Pathogenesis, clinical features, and diagnosis of endometriosis\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The evaluation is guided by the patient's symptoms and may vary by the site of disease. Rectovaginal disease often presents with localized symptoms (deep dyspareunia, dyschezia). These symptoms are evaluated with a rectovaginal examination and rectosigmoid imaging. In contrast, endometriosis proximal to the rectosigmoid is likely to be associated with nonspecific symptoms (diarrhea, bloating, abdominal pain). Physical examination and imaging of endometriosis at proximal bowel sites is unlikely to be conclusive. Thus, disease at these sites may not be diagnosed until lesions are noted during diagnostic laparoscopy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1461059\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinician should elicit a history of general endometriosis symptoms (pelvic pain, infertility) and of those specifically associated with rectovaginal or bowel endometriosis (eg, dyschezia, constipation, bloating). The severity and frequency of symptoms and their relationship to the menstrual cycle should be assessed. It is often helpful to have the patient chart her symptoms over several months on a menstrual calendar. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/48/19210?source=see_link&amp;anchor=H12#H12\">",
"     \"Pathogenesis, clinical features, and diagnosis of endometriosis\", section on 'Symptoms'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H23891848\">",
"     'Clinical manifestations'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The medical history is unlikely to be diagnostic, but is important for other reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A thorough discussion of symptoms and past medical history helps to guide further evaluation for endometriosis or other conditions. (See",
"      <a class=\"local\" href=\"#H3390061\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Assessing the impact of symptoms on the patient's quality of life helps to guide decisions regarding invasive treatment (ie, are the symptoms bothersome enough to warrant a bowel resection?).",
"     </li>",
"     <li>",
"      Clinical suspicion of rectovaginal or bowel endometriosis contributes to counseling of patients who may require surgery regarding the possibility of bowel surgery.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1461149\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;A bimanual pelvic examination is an important part of the diagnostic process for rectovaginal endometriosis. The posterior fornix, retrocervical tissue and parametria should be thoroughly palpated. Findings that are highly suggestive of rectovaginal endometriosis include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      a tender nodule of rectovaginal septum or pelvic posterior cul-de-sac (",
"      <a class=\"graphic graphic_picture graphicRef80415 \" href=\"UTD.htm?34/56/35712\">",
"       picture 1",
"      </a>",
"      ) &nbsp;",
"     </li>",
"     <li>",
"      thick and fibrotic uterosacral ligaments",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, findings of a fixed and retroverted uterus and of pain with mobilization of the uterus are consistent with adhesions and endometriotic lesions in the posterior cul-de-sac.",
"   </p>",
"   <p>",
"    Rectovaginal examination is also performed. If a rectovaginal nodule is present, the depth of involvement of the anterior rectal wall should be assessed.",
"   </p>",
"   <p>",
"    On speculum examination, lateral displacement of the cervix to one side suggests scarring of the ipsilateral uterosacral ligament [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/32\">",
"     32",
"    </a>",
"    ]. Infrequently, there is a visible lesion in the vaginal epithelium, particularly in the posterior fornix.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H600841\">",
"    <span class=\"h2\">",
"     Biopsy of visible lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;A lesion consistent with endometriosis is occasionally visible in the vaginal mucosa of the posterior fornix (",
"    <a class=\"graphic graphic_picture graphicRef80415 \" href=\"UTD.htm?34/56/35712\">",
"     picture 1",
"    </a>",
"    ). These are typically cystic-appearing and pigmented due to the presence of hemosiderin. These can be biopsied in an office setting. Posterior vaginal wall nodules that are palpable but deep to the vaginal mucosa should not be biopsied in an office setting because they can be quite deep and may involve the rectal wall. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/27/5560?source=see_link&amp;anchor=H8#H8\">",
"     \"Vaginal intraepithelial neoplasia\", section on 'Biopsy technique'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1461141\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transvaginal ultrasound followed by rectal endoscopic ultrasound is the imaging sequence of choice for evaluation of women with suspected rectovaginal endometriosis.",
"   </p>",
"   <p>",
"    For bowel proximal to the rectosigmoid colon, standard abdominal imaging techniques can identify some bowel lesions, but cannot differentiate between endometriosis and other pathology. These lesions are more reliably detected and evaluated via laparoscopy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1220610\">",
"    <span class=\"h3\">",
"     Ultrasound",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1892424\">",
"    <span class=\"h4\">",
"     Transvaginal ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transvaginal sonography is the first-line imaging study when rectovaginal endometriosis is suspected [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/12\">",
"     12",
"    </a>",
"    ]. A systematic review of 10 prospective studies including 1106 women reported a sensitivity of 91 percent and specificity of 98 percent for the diagnosis of rectosigmoid endometriosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/33\">",
"     33",
"    </a>",
"    ]. All participants had suspected endometriosis, and all studies used surgical exploration as the reference standard.",
"   </p>",
"   <p>",
"    Transvaginal ultrasound is performed routinely in women with pelvic pain. If rectovaginal endometriosis is suspected, the radiologist should be informed so that the rectosigmoid colon may be evaluated.",
"   </p>",
"   <p>",
"    Limitations of transvaginal ultrasound include [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/12\">",
"     12",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Imaging field extends only to the rectosigmoid junction",
"     </li>",
"     <li>",
"      Cannot assess the depth of infiltration into the vaginal or rectal walls",
"     </li>",
"     <li>",
"      Cannot determine the distance from the nodule to the anal junction; this information is important to determine the extent of surgical resection",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Visualization of the rectovaginal septum with transvaginal ultrasonography is limited since the probe cannot be rotated perpendicular to the vaginal wall, but these lesions are typically identified on rectovaginal examination [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1892431\">",
"    <span class=\"h4\">",
"     Rectal endoscopic ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rectal endoscopic ultrasonography is not typically used as a first-line study for evaluating rectovaginal endometriosis. This is because the information it yields is similar to transvaginal ultrasound, but rectal ultrasound is more uncomfortable and requires sedation in some patients [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/34-36\">",
"     34-36",
"    </a>",
"    ]. If a rectovaginal lesion is found on transvaginal ultrasonography, rectal endoscopic ultrasonography is used as a follow-up study to determine the depth of infiltration and the distance from the anal junction [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/12\">",
"     12",
"    </a>",
"    ]. This information is important to assess the need for and the extent of rectal surgery.",
"   </p>",
"   <p>",
"    The diagnostic performance of rectal endoscopic sonography appears to be similar to transvaginal sonography [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/34-36\">",
"     34-36",
"    </a>",
"    ]. As an example, in the largest prospective study (n = 134), rectal endoscopic compared with transvaginal ultrasound had a similar sensitivity (96 and 91 percent) and specificity (100 and 97 percent) for the diagnosis of rectal wall endometriosis. Surgical exploration was used as the reference standard [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Similar to transvaginal sonography, the imaging field of rectal endoscopic ultrasonography extends only to the rectosigmoid junction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1892632\">",
"    <span class=\"h3\">",
"     Magnetic resonance imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Magnetic resonance imaging (MRI) does not appear to be superior to transvaginal or rectal endoscopic ultrasound for evaluating endometriosis of the rectal wall [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/37-39\">",
"     37-39",
"    </a>",
"    ]. This was illustrated in a retrospective study of 92 women that compared the three modalities and found a similar sensitivity (MRI: 87 percent; transvaginal ultrasound: 94 percent; and rectal endoscopic ultrasound: 89 percent) and specificity (93, 100, and 93 percent) for diagnosis of rectal endometriosis; surgical exploration was used as the reference standard [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/34\">",
"     34",
"    </a>",
"    ]. Another study using the same patient cohort reported that both MRI and rectal endoscopic ultrasound had a similar sensitivity for detection of infiltration of endometriosis into the rectal muscularis (MRI: 98 percent, and rectal endoscopic ultrasound: 90 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The only unique contribution of MRI is the evaluation of rectovaginal septum disease; however, imaging is not typically necessary for this since the rectovaginal septum can be evaluated with rectovaginal examination. Evaluation of the rectovaginal septum by MRI was reported by a retrospective study of 92 women with known or suspected endometriosis that compared MRI with other imaging modalities and with physical examination [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/34\">",
"     34",
"    </a>",
"    ]. MRI had the highest sensitivity for detecting rectovaginal septum disease (MRI: 55 percent; transvaginal ultrasound: 9 percent; rectal endoscopic ultrasound: 18 percent; and physical examination: 18 percent); the specificity of each method was 95 percent or higher. These results are in contrast with our clinical experience; we have generally found the rectovaginal examination to be more useful than imaging studies for detection of a nodule of the rectovaginal septum. Further comparative study is needed to validate these findings.",
"   </p>",
"   <p>",
"    Given these data, and taking into consideration the expense of MRI, we suggest that for women with suspected rectovaginal endometriosis, MRI be reserved for women in whom a rectovaginal disease is suspected but is not found after evaluation with both physical examination and transvaginal ultrasound.",
"   </p>",
"   <p>",
"    The utility of MRI for diagnosis of bowel endometriosis proximal to the rectosigmoid colon has not been well studied. Such lesions are most commonly diagnosed with diagnostic laparoscopy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1220625\">",
"    <span class=\"h3\">",
"     Other imaging studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Computed tomography with rectal enteroclysis has been reported for the evaluation of rectal endometriosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/40\">",
"     40",
"    </a>",
"    ]. The use of computed tomography to evaluate lesions proximal to the rectosigmoid colon has not been reported. We do not use computed tomography to evaluate patients with suspected rectovaginal or bowel endometriosis.",
"   </p>",
"   <p>",
"    Double contrast",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    enema is useful mainly if gastrointestinal symptoms suggestive of partial bowel obstruction are present. This study provides information about the presence of lesions that protrude into the bowel lumen. However, the results are not specific to endometriosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9832995\">",
"    <span class=\"h3\">",
"     Urinary tract imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with suspected bowel endometriosis may also have other sites of deep infiltrating endometriosis and should also be evaluated for obstructive uropathy or bladder lesions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/60/1993?source=see_link&amp;anchor=H17037264#H17037264\">",
"     \"Urinary tract endometriosis\", section on 'Diagnosis and evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H960154\">",
"    <span class=\"h2\">",
"     Bowel endoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sigmoidoscopy or colonoscopy is rarely useful to diagnose bowel endometriosis since lesions that penetrate the mucosa are unusual [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/12,41\">",
"     12,41",
"    </a>",
"    ]. It is, however, important to perform bowel endoscopy prior to surgery in the following clinical contexts:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      To exclude a malignancy if there are symptoms suggestive of a bowel neoplasm",
"     </li>",
"     <li>",
"      To assess for bowel stenosis in women with symptoms suggestive of partial bowel obstruction or who have abnormal findings at double contrast",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"       barium",
"      </a>",
"      enema",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1090993\">",
"    <span class=\"h2\">",
"     Diagnostic laparoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rectovaginal disease may not be visible at laparoscopy since it is often occluded by posterior cul-de-sac adhesions.",
"   </p>",
"   <p>",
"    Bowel endometriosis is often found incidentally at the time of diagnostic surgery for pelvic pain or infertility. Diagnosis of these lesions on laparoscopy is somewhat limited, however, and it is difficult to fully evaluate the hepatic and splenic flexures of the bowel laparoscopically. Thus, if bowel lesions are suspected preoperatively, a double",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    enema may be useful. (See",
"    <a class=\"local\" href=\"#H1220625\">",
"     'Other imaging studies'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The biopsy of lesions provides a definitive diagnosis of endometriosis, but many surgeons rely upon visual recognition to avoid the risks of bowel surgery, particularly if there has been no bowel preparation. (See",
"    <a class=\"local\" href=\"#H2750185\">",
"     'Management of incidental bowel lesions'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2750080\">",
"    <span class=\"h1\">",
"     APPROACH TO TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of rectovaginal or bowel endometriosis is guided by several factors, including the indication for treatment, anatomic location of disease, and patient preference. Women who are asymptomatic or who have mild symptoms that are not bothersome are managed expectantly.",
"   </p>",
"   <p>",
"    Rectovaginal or bowel endometriosis typically coexists with other sites of disease, and a treatment plan must take the full distribution of disease. Medical therapy treats all sites of disease simultaneously. For women who require surgical treatment and who do not have bowel symptoms, we treat other sites first and do not ablate or remove bowel disease as part of a primary procedure. This approach is usually successful at relieving general symptoms of endometriosis (pelvic pain, infertility). It also avoids the potentially morbid extensive pelvic dissection or bowel resection required for surgical treatment of rectovaginal or bowel endometriosis. If symptoms persist, surgical treatment of bowel disease may be performed as a follow-up procedure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14810?source=see_link&amp;anchor=H15#H15\">",
"     \"Overview of the treatment of endometriosis\", section on 'Conservative surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1090893\">",
"    <span class=\"h2\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of rectovaginal disease is indicated if characteristic symptoms are present (deep dyspareunia, dyschezia, cyclic rectal bleeding) and rectovaginal endometriosis is found upon evaluation.",
"   </p>",
"   <p>",
"    Treatment of bowel endometriosis is indicated for nonspecific gastrointestinal symptoms (eg, rectal bleeding, constipation, bloating)",
"    <strong>",
"     only",
"    </strong>",
"    if other etiologies of these symptoms have been excluded. (See",
"    <a class=\"local\" href=\"#H3390061\">",
"     'Differential diagnosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Urgent treatment is indicated in the rare instances in which a woman presents with bowel or ureteral obstruction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1091088\">",
"    <span class=\"h2\">",
"     Medical versus surgical treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical treatment has been considered the mainstay of therapy for rectovaginal or bowel endometriosis. However, in the absence of bowel or ureteral stenosis, we prefer medical treatment as primary therapy for most women. If symptoms persist or recur, we offer surgery.",
"   </p>",
"   <p>",
"    Medical treatment of rectovaginal or bowel endometriosis avoids the risks associated with surgery. These are potentially significant since extensive pelvic dissection or bowel resection may result in complications such as genital tract fistulae, bladder dysfunction, or bowel anastomotic leakage. (See",
"    <a class=\"local\" href=\"#H2499718\">",
"     'Complications'",
"    </a>",
"    below.) While it is generally accepted that women with a rectovaginal nodule are more likely to achieve complete relief of symptoms (deep dyspareunia, dyschezia) following surgical treatment than with medical therapy, in our opinion, this benefit is not outweighed by the high risk of major postoperative complications [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/11\">",
"     11",
"    </a>",
"    ]. In addition, many women with endometriosis undergo several surgeries, and the risk of surgical complications increases with repeat procedures due to multiple exposures to surgical risk and development of scar tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/42\">",
"     42",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H23176626\">",
"     'Medical treatment'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H602138\">",
"     'Surgical treatment'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    No studies have compared medical with surgical treatment for rectovaginal or bowel endometriosis. In observational studies, the overall rates of improvement in pain symptoms are 70 percent or higher for either medical or surgical treatment, but these do not give information about severity of disease, and most do not provide long-term data [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/17,43-47\">",
"     17,43-47",
"    </a>",
"    ]. Unfortunately, there are few data regarding the effectiveness of medical therapy in treating pelvic pain specifically in women with rectovaginal or bowel endometriosis, and there is only one study on relief of gastrointestinal symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/45\">",
"     45",
"    </a>",
"    ]. However, the effectiveness of medical therapy for endometriosis-related pain in general is well established. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14810?source=see_link&amp;anchor=H3#H3\">",
"     \"Overview of the treatment of endometriosis\", section on 'Treatment of pelvic pain'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Disadvantages of medical therapy are those typically associated with chronic pharmacologic therapy: symptoms recur when drug therapy is discontinued; adverse effects may occur; and patients may find chronic therapy burdensome [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/43,48\">",
"     43,48",
"    </a>",
"    ]. In women who are trying to conceive, hormonal medications must be discontinued since they interfere with ovulation and are potentially teratogenic. Pain may recur in women during this time, but this usually ceases to be an issue during pregnancy since in most women symptoms of endometriosis often regress at this time. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/48/19210?source=see_link&amp;anchor=H35875410#H35875410\">",
"     \"Pathogenesis, clinical features, and diagnosis of endometriosis\", section on 'Course in pregnancy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Regarding the biologic basis of medical compared with surgical treatment, some experts have postulated that medical therapy would be less effective because it treats the lesion but not the surrounding fibrosis. Such fibrosis almost always accompanies deep endometriosis and likely contributes to pain, and certainly to bowel obstruction [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/12\">",
"     12",
"    </a>",
"    ]. On the other hand, medical treatment likely results in reduced stimulation of pain fibers by decreasing intra- and perilesional inflammation and production of prostaglandins and cytokines.",
"   </p>",
"   <p>",
"    Neither surgical nor pharmacologic therapy for rectovaginal or bowel endometriosis is effective for the treatment of infertility. Infertility may be treated by surgical treatment of endometriosis at other anatomic sites or with assisted reproduction techniques. (See",
"    <a class=\"local\" href=\"#H4930802\">",
"     'Infertility'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/15/38136?source=see_link&amp;anchor=H3#H3\">",
"     \"Pathogenesis and treatment of infertility in women with endometriosis\", section on 'Approach to treatment'",
"    </a>",
"    .)",
"    <br/>",
"    <br/>",
"    Given these considerations, for most women with symptomatic rectovaginal or bowel endometriosis, we suggest medical rather than surgical treatment as first-line therapy. Surgery is a reasonable choice for women who are willing to accept the risks of surgery and who prefer to avoid chronic medical therapy. Urgent surgical treatment is required for women with bowel or ureteral stenosis. If medical treatment fails to adequately relieve symptoms, we suggest surgical therapy.",
"   </p>",
"   <p>",
"    This recommendation is consistent with the American Society for Reproductive Medicine Practice Committee statement: \"Endometriosis should be viewed as a chronic disease that requires a life-long management plan with the goal of maximizing the use of medical treatment and avoiding repeated surgical procedures\" [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H960221\">",
"    <span class=\"h2\">",
"     Counseling patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinicians should review all treatment options with patients. Women should be counseled about medical and surgical options for current symptoms, but they should also be made aware that endometriosis is a chronic disease that persists until menopause. One or more types of therapy may be necessary over the course of the disease. We pursue a shared decision-making process.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23176626\">",
"    <span class=\"h1\">",
"     MEDICAL TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medical therapy for rectovaginal or bowel endometriosis appears to be effective in many women, but it requires further evaluation. Results from the few available studies show a promising effect on pain symptoms, with 60 to 90 percent of patients reporting considerable improvement or complete relief [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/43-47\">",
"     43-47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The limitations of the studies to date are that they have been conducted almost exclusively in women with rectovaginal disease who have recurrent or persistent symptoms following conservative surgery (uterus and ovaries were not removed). In addition, more data are needed regarding lesions beyond the rectum and gastrointestinal, rather than pelvic, symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23176687\">",
"    <span class=\"h2\">",
"     Estrogens and progestins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pain symptoms associated with rectovaginal endometriosis appear to improve or resolve with the use of either a combination of estrogen and progestin or progestin alone [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/44,45,50-52\">",
"     44,45,50-52",
"    </a>",
"    ]. In our practice, we use progestin alone as first-line treatment (eg, oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/52/16199?source=see_link\">",
"     norethindrone acetate",
"    </a>",
"    2.5",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Estrogen progestin therapy was evaluated in a randomized trial that compared a combined estrogen and progestin regimen with progestin alone and found that both resulted in a similar relief of symptoms. In the trial, 90 women with pain symptoms following conservative surgery were treated daily either with an oral combination of ethinyl estradiol 0.01 mg and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/2/14374?source=see_link\">",
"     cyproterone",
"    </a>",
"    3 mg or with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/52/16199?source=see_link\">",
"     norethindrone",
"    </a>",
"    2.5 mg [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/44\">",
"     44",
"    </a>",
"    ]. At 12-month follow-up, there was no significant difference between groups in patient satisfaction (estrogen progestin: 62 percent and progestin-only: 73 percent) or in patient questionnaire scores for dysmenorrhea, dyspareunia, non-menstrual pelvic pain, and dyschezia.",
"   </p>",
"   <p>",
"    Both the combined estrogen and progestin and progestin-alone regimens were effective. Within each group, symptom scores were significantly reduced from baseline, and symptoms resolved completely in many women. As an example, in the estrogen-progestin group, dyschezia was present in 46 percent of women at baseline compared with 10 percent at 12-month follow-up. Following treatment, 6 to 11 percent of women continued to have moderate to severe symptoms. The therapies were well tolerated; few women withdrew from the study because of side effects (two in the estrogen-progestin group; three in the progestin-only group).",
"   </p>",
"   <p>",
"    The doses used in the trial varied from standard oral contraceptive doses (eg, Diane-35&reg;, a contraceptive pill available outside of the United States, is ethinyl estradiol 0.035 mg and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/2/14374?source=see_link\">",
"     cyproterone",
"    </a>",
"    2 mg and Micronor&reg;, a progestin-only contraceptive, is",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/52/16199?source=see_link\">",
"     norethindrone",
"    </a>",
"    0.35 mg). Studies of treatment of other sites of endometriosis have shown that effective therapies include either an estrogen-progestin oral contraceptive or progestin doses higher than for oral contraception (eg, norethindrone 5 mg or depot medroxyprogesterone). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14810?source=see_link&amp;anchor=H6#H6\">",
"     \"Overview of the treatment of endometriosis\", section on 'Estrogen-progestin oral contraceptives'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14810?source=see_link&amp;anchor=H9#H9\">",
"     \"Overview of the treatment of endometriosis\", section on 'Progestins'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There may be differences, however, across different preparations. A prospective study that included 59 women with rectovaginal endometriosis who were still symptomatic after conservative surgery compared treatment with the contraceptive vaginal ring (15 &micro;g ethinyl estradiol and 120 &micro;g",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/1/35863?source=see_link\">",
"     etonogestrel",
"    </a>",
"    per day) with the patch (20 &micro;g ethinyl estradiol and 150 &micro;g norelgestromin per day). The ring was associated with a significantly greater improvement in dysmenorrhea, while improvement in dyspareunia and chronic pelvic pain was similar for the two preparations [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/50\">",
"     50",
"    </a>",
"    ]. A small study (n = 11) reported that the use of the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    intrauterine device was associated with improvement in dysmenorrhea, pelvic pain, and dyschezia in women with rectovaginal endometriosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/46\">",
"     46",
"    </a>",
"    ]. Further study is needed to evaluate the use of non-oral contraceptives.",
"   </p>",
"   <p>",
"    Relief of gastrointestinal symptoms of bowel endometriosis with medical therapy has not been well studied. The only report of this outcome was a prospective study of 40 women with rectosigmoid endometriosis who were still symptomatic following surgery and were treated with norethisterone (2.5 mg per day) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/45\">",
"     45",
"    </a>",
"    ]. At 12-month follow-up, treatment was associated with significant improvements in diarrhea, intestinal cramping, passage of mucus with stool, and cyclic rectal bleeding. Constipation was improved only in women who had cyclic symptoms. No significant improvement was found in abdominal bloating or the feeling of incomplete evacuation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23176694\">",
"    <span class=\"h2\">",
"     Other medical therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of rectovaginal or bowel endometriosis with hormonal medications other than estrogen and progestins have been investigated in only a few studies. Gonadotropin releasing hormone agonists and aromatase inhibitors have each been evaluated in one study and found to improve symptoms in women with rectovaginal endometriosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/48,54\">",
"     48,54",
"    </a>",
"    ]. However, long-term use of these agents is generally avoided since these medications result in menopausal symptoms and a decrease in bone density. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14810?source=see_link&amp;anchor=H8#H8\">",
"     \"Overview of the treatment of endometriosis\", section on 'GnRH agonists'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14810?source=see_link&amp;anchor=H12#H12\">",
"     \"Overview of the treatment of endometriosis\", section on 'Aromatase inhibitors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The results for vaginal",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/0/26629?source=see_link\">",
"     danazol",
"    </a>",
"    may be more promising. Danazol is usually administered orally and is often not well tolerated because of androgenic side effects. However, a study of vaginal danazol (one 200 mg vaginal capsule per vaginam daily) for 12 months in 21 women with pain symptoms following surgery for rectovaginal endometriosis reported a significant reduction in symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/47\">",
"     47",
"    </a>",
"    ]. No major side effects were reported and metabolic and coagulative parameters did not vary significantly. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14810?source=see_link&amp;anchor=H11#H11\">",
"     \"Overview of the treatment of endometriosis\", section on 'Danazol'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Analgesics alone are usually of limited efficacy in treating pain associated with endometriosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14810?source=see_link&amp;anchor=H5#H5\">",
"     \"Overview of the treatment of endometriosis\", section on 'Analgesics'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23176701\">",
"    <span class=\"h2\">",
"     Following patients during treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with rectovaginal or bowel endometriosis who are treated with medical therapy should undergo periodic evaluations for disease progression. Studies have found that lesions decrease in size during medical therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/44,46,47,54\">",
"     44,46,47,54",
"    </a>",
"    ], but rare reports of disease progression raise concern for the risk of the development of ureteral involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/23\">",
"     23",
"    </a>",
"    ]. Progressive disease resulting in bowel obstruction has not been reported.",
"   </p>",
"   <p>",
"    In our practice, we follow patients on medical therapy with physical examination and imaging. At each visit, we perform a bimanual examination, with rectovaginal examination if appropriate, and a transvaginal ultrasound, according to the following schedule:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Every three to four months for the first year",
"     </li>",
"     <li>",
"      Every six to eight months for the next two years",
"     </li>",
"     <li>",
"      Followed by yearly evaluation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    We also obtain a urinary tract ultrasound to exclude hydronephrosis every six months for two years, then yearly.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H602138\">",
"    <span class=\"h1\">",
"     SURGICAL TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical treatment of rectovaginal or bowel endometriosis is guided by the location, size, and depth of infiltration of the endometriotic lesions.",
"   </p>",
"   <p>",
"    The surgical approach to endometriosis may be either conservative or definitive. Conservative surgical treatment consists of excising the symptomatic endometriotic lesions, while leaving surrounding structures intact. For endometriosis in general, the definitive therapy for endometriosis is hysterectomy and bilateral salpingo-oophorectomy with removal of symptomatic lesions at other sites (eg, peritoneum, bowel). Definitive surgery is typically reserved for women who have failed medical and conservative surgical treatment.",
"   </p>",
"   <p>",
"    Rectovaginal and bowel endometriosis are typically coexistent with other disease sites. If the decision is to surgically remove bowel disease, we also treat endometriosis at other sites during the procedure.",
"   </p>",
"   <p>",
"    The surgical approach is usually laparoscopy, but may be laparotomy depending upon the anatomic site of disease, the complexity of the procedure, and the surgeon's laparoscopic skills. These procedures require a surgeon or team of surgeons with experience in both advanced pelvic surgery and bowel surgery. Successful treatment of symptoms may depend upon surgical experience [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/55,56\">",
"     55,56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3389830\">",
"    <span class=\"h2\">",
"     Rectovaginal endometriosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conservative surgery for rectovaginal endometriosis involves dissection of the rectovaginal space and removal of the endometriotic nodule(s). If infiltration of the rectal or vaginal walls is present, resection and repair of these structures may also be required.",
"   </p>",
"   <p>",
"    In addition, rectovaginal disease is often associated with obliteration of the posterior cul-de-sac or lesions of the uterosacral ligaments. Involvement of these sites may require posterior cul-de-sac adhesiolysis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    ablation or resection of the uterosacral ligaments [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/57\">",
"     57",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H29779101\">",
"     'Anatomy of rectovaginal disease'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2499524\">",
"    <span class=\"h3\">",
"     Procedure",
"    </span>",
"    &nbsp;&mdash;&nbsp;The surgical procedure may be carried out at laparotomy or laparoscopy. In our practice, in recent years, laparoscopy is by far the most frequent approach. The basic steps for conservative surgical treatment of rectovaginal disease are as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Explore and delineate the posterior pelvic anatomy - The surgeon explores the accessible portion of the pelvic posterior cul-de-sac, identifies the ureters bilaterally, and develops the pararectal spaces.",
"     </li>",
"     <li>",
"      Dissect the rectum off the posterior vaginal fornix - To identify the vaginal apex, the surgeon inserts examining fingers into the vagina to elevate the posterior vaginal fornix (",
"      <a class=\"graphic graphic_figure graphicRef50155 \" href=\"UTD.htm?19/14/19683\">",
"       figure 1",
"      </a>",
"      ). The surgeon's other hand or an instrument is used from within the pelvis to dissect the rectum from the posterior aspect of the uterus and posterior vaginal wall. This technique allows the surgeon to use both visual and tactile information to ensure a precise plane of dissection, thereby minimizing the risk of bowel injury. This technique is used mainly during laparotomy but can also be employed during laparoscopy.",
"     </li>",
"     <li>",
"      Open the vaginal fornix - The posterior vaginal wall is then grasped at each corner with delicate grasping forceps. This allows direct inspection of the endometriotic lesion and a precise estimate of the need for further rectal detachment.",
"     </li>",
"     <li>",
"      Excise the endometriotic lesions - Once free margins around the lesion are reached both laterally and caudally, the endometriotic plaque is excised. This is usually performed using a V-shaped incision that follows the original shape of the lower posterior cul-de-sac. When the posterior vaginal fornix is infiltrated by the lesion, we excise the lesion. If the lesion is not excised, symptoms are likely to persist.",
"     </li>",
"     <li>",
"      Assess the anterior rectal wall - In the presence of kinking, stenosis or infiltration of the rectal wall by the endometriotic nodule, an intraoperative consultation from a bowel surgeon is required to determine the treatment approach.",
"     </li>",
"     <li>",
"      Reattach the vagina to the cervix &ndash; In our practice, we use a&nbsp;T-shaped suture (ie, a short vertical suture of the caudal portion of the vaginal incision), followed by a transverse suture of the posterior vaginal wall to the cervix, using 3-0 polyglactin (Vicryl&trade;) sutures. During a laparoscopic procedure, this step is performed vaginally.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    We administer antibiotic prophylaxis appropriate for bowel surgery since there is a high likelihood of entry into the bowel lumen. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/23/18806?source=see_link\">",
"     \"Control measures to prevent surgical site infection following gastrointestinal procedures\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some surgeons perform a low anterior rectal resection, but it appears that excision of the endometriotic nodule is preferable to bowel resection. In our practice, we limit colorectal resection in women with rectovaginal disease to two clinical situations: (1) those with nodules requiring extensive opening of the rectum, for which suturing may result in iatrogenic stenosis and (2) those with fibrotic and unhealthy tissue margins at increased risk of suture dehiscence.",
"   </p>",
"   <p>",
"    This practice is supported by findings that rectal segmental resection does not appear to offer better pain control than nodule excision and may result in adverse gastrointestinal symptoms. As an example, a retrospective study (n = 41) compared these two surgical approaches [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/58\">",
"     58",
"    </a>",
"    ]. At 26-month follow-up, women treated with either approach had similar improvement in pain symptoms, but women who underwent rectal segmental resection compared with nodule excision were significantly more likely to develop frequent stools, defined as &ge;3 per day (52 versus 19 percent).",
"   </p>",
"   <p>",
"    In addition, rectal resection is complicated by rectovaginal fistula in up to 10 percent of women [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/55\">",
"     55",
"    </a>",
"    ]. If rectal wall infiltration is suspected, the surgeon should discuss the potential for this complication with the patient. Many women prefer to live with residual dyschezia than to risk a vaginal passage of feces or a colostomy. In order to reduce the risk of rectovaginal fistula formation, several surgeons perform a temporary preventive ileostomy at first-line surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/58,59\">",
"     58,59",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2499718\">",
"     'Complications'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8429892\">",
"    <span class=\"h3\">",
"     Follow-up",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following resection of rectovaginal endometriosis, we advise patients to avoid sexual intercourse for eight weeks. We see patients for a routine follow-up visit approximately six weeks postoperatively.",
"   </p>",
"   <p>",
"    Instructions for patients following gynecologic surgery can be found separately. (See",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?27/27/28083?source=see_link\">",
"     \"Patient information: Care after gynecologic surgery (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3389837\">",
"    <span class=\"h2\">",
"     Bowel endometriosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bowel endometriosis at sites other than the rectosigmoid is treated surgically by excising the lesion. The extent of this resection depends upon the lesion's depth of infiltration and size, as well as the surgeon's preference. Surgical options include [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/11\">",
"     11",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Shaving or superficial excision &ndash; This may be performed",
"      <strong>",
"       only",
"      </strong>",
"      for lesions that do not invade beyond the serosa. Electrosurgical or laser techniques are typically used for this type of procedure [",
"      <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/60\">",
"       60",
"      </a>",
"      ]. The integrity of the bowel must be assessed after",
"      <span class=\"nowrap\">",
"       shaving/superficial",
"      </span>",
"      excision is performed. Damage to the bowel muscularis requires repair or resection of the damaged area.",
"     </li>",
"     <li>",
"      Discoid full thickness bowel excision and repair &ndash; The lesion and full thickness of the surrounding bowel wall are excised. The bowel wall is then closed with manual suture in two layers.",
"     </li>",
"     <li>",
"      Segmental bowel resection and anastomosis &ndash; The lesion and bowel segment are resected, followed by bowel anastomosis. Consistent with the anatomic distribution of the disease, over 90 percent of segmental bowel resections performed in women with endometriosis are of the rectosigmoid [",
"      <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/17\">",
"       17",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H5266309\">",
"       'Distribution of disease'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A systematic review of surgical treatment of deep colorectal endometriosis included 49 studies with 3894 women [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/11\">",
"     11",
"    </a>",
"    ]. The majority of patients underwent segmental bowel resection and anastomosis (71 percent), followed by",
"    <span class=\"nowrap\">",
"     shaving/superficial",
"    </span>",
"    procedures (17 percent) and discoid excision (10 percent).",
"   </p>",
"   <p>",
"    There are no high quality data regarding the choice of the type of resection. Retrospective studies suggest that complete pain relief is more likely in women who undergo segmental or discoid resection compared with shaving (92 versus 80 percent in one study [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/61\">",
"     61",
"    </a>",
"    ]). On the other hand, complication rates appear to increase with the extent of resection. An example of this was reported in a retrospective study of 187 women with bowel endometriosis, which found the following rates of complications for different procedures: segmental resection (38 percent); disc excision (23 percent); and shaving (6 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Given the available data, the smallest resection required to excise the lesion should be utilized. Unfortunately, complete excision may be difficult to determine with gross visualization. In a systematic review of women who underwent bowel resection for colorectal endometriosis, six studies reported that 20 percent of specimens had margins that were positive for endometriosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2750185\">",
"    <span class=\"h2\">",
"     Management of incidental bowel lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rectovaginal disease is more commonly diagnosed preoperatively than disease of other bowel sites. This is because rectovaginal disease is often suggested by characteristic symptoms (eg, dyschezia), and a likely diagnosis can be made preoperatively with physical examination and imaging. In contrast, bowel lesions beyond the rectosigmoid junction are associated with nonspecific symptoms. These lesions are typically found incidentally during diagnostic laparoscopy for pelvic pain or infertility and can be confirmed with biopsy. (See",
"    <a class=\"local\" href=\"#H1090993\">",
"     'Diagnostic laparoscopy'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In our practice, we do not biopsy all bowel lesions that are discovered incidentally. For such lesions, we remove only those that are small in diameter (&lt;2 cm) and that can be removed without entering the bowel muscularis or lumen.",
"   </p>",
"   <p>",
"    Removal of lesions that require bowel wall excision or bowel resection should be performed only in patients who have been counseled about the procedure and have given informed consent and have undergone a proper preoperative bowel preparation. For this reason, some women with bowel endometriosis have a two-stage procedure, one surgery for diagnosis and another for treatment. A systematic review of surgical treatment for colorectal endometriosis reported that 56 to 59 percent of women had undergone a previous surgery for endometriosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/11\">",
"     11",
"    </a>",
"    ]. However, a careful preoperative evaluation should limit the necessity for this two-procedure approach.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2499718\">",
"    <span class=\"h2\">",
"     Complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications vary by whether the procedure was rectovaginal dissection or bowel resection. The complications of these procedures are the same as for other pelvic dissection or bowel resection procedures.",
"   </p>",
"   <p>",
"    Surgical treatment of rectovaginal endometriosis is associated with major complications in 3 to 10 percent of patients, according to a literature review of 36 mostly retrospective studies [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/55\">",
"     55",
"    </a>",
"    ]. Urinary retention was the most frequently reported complication, possibly due to denervation of the bladder. Bladder dysfunction was found mostly, but not exclusively, in women who underwent colorectal resection. Rectovaginal fistula was reported in up to 10 percent of women. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/4/35912?source=see_link\">",
"     \"Acute urinary retention\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/11/32951?source=see_link\">",
"     \"Rectovaginal, anovaginal, and colovesical fistulas\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The complications associated with bowel resection and anastomosis were reported in a systematic review of 49 studies of surgical treatment of colorectal endometriosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/11\">",
"     11",
"    </a>",
"    ]. In studies of bowel resection only, the complication rates were: rectovaginal fistula (2.7 percent); anastomotic leakage (1.5 percent); and abscess (0.3 percent). Summary data were not given for less extensive resection of bowel lesions. An example of complication rates for such procedures was reported in a retrospective study: segmental resection (38 percent); disc excision (23 percent); and shaving (6 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23892106\">",
"    <span class=\"h2\">",
"     Outcome",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4930795\">",
"    <span class=\"h3\">",
"     Pain symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical treatment results in improvement of pain symptoms, based upon consistent results from retrospective case series [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/62-76\">",
"     62-76",
"    </a>",
"    ]. It is difficult to quantify the extent and duration of pain relief, since outcome measures used by studies have been heterogeneous [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The degree of improvement in pain associated with surgical treatment of rectovaginal endometriosis was best illustrated in the only study that compared surgery with expectant management. The study was a prospective cohort study, in which 105 infertile women were treated either with rectovaginal dissection and excision of the endometriotic nodule (with low anterior rectal resection in some women) via laparotomy or expectant management [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/67\">",
"     67",
"    </a>",
"    ]. At two-year follow-up, women in the surgery group had significantly lower rates of moderate to severe pain symptoms than those in the expectant management group: dysmenorrhea (61 versus 75 percent); deep dyspareunia (27 versus 52 percent); and dyschezia (22 and 43 percent); no significant difference between groups was found for non-menstrual pelvic pain.",
"   </p>",
"   <p>",
"    Overall, for all sites of rectovaginal or bowel endometriosis, substantial postoperative short-term pain relief is reported by approximately 70 to 90 percent of the patients [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/17\">",
"     17",
"    </a>",
"    ]. However, at one-year follow-up, approximately 50 percent of the women needed analgesics or hormonal treatments [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/37,70,75\">",
"     37,70,75",
"    </a>",
"    ]. The reported recurrence of symptoms at two to five years after surgery varies from 4 to 54 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/17,73,76,77\">",
"     17,73,76,77",
"    </a>",
"    ]. Approximately 20 percent of women require additional conservative or definitive surgery because of pain relapse [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/61,68,78,79\">",
"     61,68,78,79",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4930802\">",
"    <span class=\"h3\">",
"     Infertility",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical treatment of rectovaginal endometriosis does not appear to improve fertility. This was best illustrated in a prospective cohort study (n = 105), which found no difference in pregnancy rates at two-year follow-up for women treated either with rectovaginal dissection and excision of the endometriotic nodule (with low anterior rectal resection in some women) via laparotomy or expectant management (45 and 47 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/67\">",
"     67",
"    </a>",
"    ]. The conception rate observed in the surgery group was similar to that previously reported by others [",
"    <a class=\"abstract\" href=\"UTD.htm?24/17/24858/abstract/77,80,81\">",
"     77,80,81",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Given these data, in our practice we counsel our patients that surgical treatment of rectovaginal or bowel endometriosis would most likely reduce pain symptoms but would not greatly modify reproductive prognosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4930858\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Rectovaginal or bowel involvement is estimated to be present in 5 to 12 percent of women with endometriosis. The rectosigmoid colon is the most common site of bowel endometriosis. Bowel involvement typically coexists with disease at other sites. (See",
"      <a class=\"local\" href=\"#H23891569\">",
"       'Prevalence'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5266309\">",
"       'Distribution of disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bowel endometriosis can be thought of as two different entities, depending upon anatomic location: (1) rectovaginal endometriosis and (2) involvement of the bowel wall proximal to the rectosigmoid colon. Presenting symptoms, evaluation, and management differ somewhat for these two locations. (See",
"      <a class=\"local\" href=\"#H23891856\">",
"       'Diagnosis and evaluation'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2750080\">",
"       'Approach to treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Women with rectovaginal or bowel endometriosis may present with the classic symptoms of endometriosis (dysmenorrhea, dyspareunia, and infertility)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      with gastrointestinal symptoms (eg, dyschezia, diarrhea, constipation, bloating). Rectal bleeding is an uncommon presentation, but if bleeding is present and consistently coincides with menstrual bleeding, it is highly suggestive of rectovaginal endometriosis with infiltration into the rectal wall. In rare cases, bowel obstruction occurs. (See",
"      <a class=\"local\" href=\"#H23891848\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The presence of rectovaginal or bowel endometriosis is typically suggested by a physical examination finding of a painful rectovaginal nodule or by findings on pelvic ultrasonography. Alternatively, rectovaginal or bowel endometriosis may be discovered during laparoscopy performed to evaluate pelvic pain or infertility. (See",
"      <a class=\"local\" href=\"#H23891856\">",
"       'Diagnosis and evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Transvaginal ultrasound followed by rectal endoscopic ultrasound is the imaging sequence of choice for evaluation of women with suspected rectovaginal endometriosis. Rectal endoscopic ultrasonography is not typically used as a first-line study for evaluating rectovaginal endometriosis. This is because the information it yields is similar to transvaginal ultrasound, but rectal ultrasound is more uncomfortable and requires sedation in some patients. If a rectovaginal lesion is found on transvaginal ultrasonography, rectal endoscopic ultrasonography is used as a follow-up study to determine the depth of infiltration and the distance from the anal junction. We suggest that MRI be reserved for women in whom a rectovaginal nodule is suspected, but is not found on both physical examination and transvaginal sonography. An imaging approach to assess for disease proximal to the rectosigmoid colon has not been established. These lesions are typically discovered at the time of diagnostic laparoscopy. (See",
"      <a class=\"local\" href=\"#H1461141\">",
"       'Imaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For most women with symptomatic rectovaginal or bowel endometriosis, we suggest medical rather than surgical treatment as first-line therapy. Surgery is a reasonable choice for women who are willing to accept the risks of surgery and who prefer to avoid chronic medical therapy. Urgent surgical treatment is required for women with bowel or ureteral stenosis. If medical treatment fails to adequately relieve symptoms, we suggest surgical therapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1091088\">",
"       'Medical versus surgical treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Estrogen-progestin contraceptives or progestins alone are usually the initial choices of medical therapy for women with rectovaginal or bowel endometriosis. (See",
"      <a class=\"local\" href=\"#H23176626\">",
"       'Medical treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Conservative surgery for rectovaginal endometriosis involves dissection of the rectovaginal space and removal of the endometriotic nodule(s). If infiltration of the rectal or vaginal walls is present, resection and repair of these structures may also be required. (See",
"      <a class=\"local\" href=\"#H3389830\">",
"       'Rectovaginal endometriosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bowel endometriosis at sites other than the rectosigmoid is treated surgically by excising the lesion. The extent of this resection depends upon the lesion's depth of infiltration and size, as well as the surgeon's preference. (See",
"      <a class=\"local\" href=\"#H3389837\">",
"       'Bowel endometriosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Surgical treatment of rectovaginal endometriosis is associated with major complications in 3 to 10 percent of patients. (See",
"      <a class=\"local\" href=\"#H2499718\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/1\">",
"      Howard FM. The role of laparoscopy in the evaluation of chronic pelvic pain: pitfalls with a negative laparoscopy. J Am Assoc Gynecol Laparosc 1996; 4:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/2\">",
"      Weed JC, Ray JE. Endometriosis of the bowel. Obstet Gynecol 1987; 69:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/3\">",
"      Redwine DB. Ovarian endometriosis: a marker for more extensive pelvic and intestinal disease. Fertil Steril 1999; 72:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/4\">",
"      Bailey HR, Ott MT, Hartendorp P. Aggressive surgical management for advanced colorectal endometriosis. Dis Colon Rectum 1994; 37:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/5\">",
"      Pereira RM, Zanatta A, Preti CD, et al. Should the gynecologist perform laparoscopic bowel resection to treat endometriosis? Results over 7 years in 168 patients. J Minim Invasive Gynecol 2009; 16:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/6\">",
"      Nisolle M, Donnez J. Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril 1997; 68:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/7\">",
"      Hartmann D, Schilling D, Roth SU, et al. [Endometriosis of the transverse colon--a rare localization]. Dtsch Med Wochenschr 2002; 127:2317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/8\">",
"      COLLIER HA, GONZALES LL, BOSSERT LJ. Cyclic ascites as a manifestation of endometriosis. Report of a case. Obstet Gynecol 1962; 19:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/9\">",
"      Meyers WC, Kelvin FM, Jones RS. Diagnosis and surgical treatment of colonic endometriosis. Arch Surg 1979; 114:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/10\">",
"      Iaroshenko VI, Salokhina MB. [Endometriosis of the stomach]. Vestn Khir Im I I Grek 1979; 123:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/11\">",
"      Meuleman C, Tomassetti C, D'Hoore A, et al. Surgical treatment of deeply infiltrating endometriosis with colorectal involvement. Hum Reprod Update 2011; 17:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/12\">",
"      Remorgida V, Ferrero S, Fulcheri E, et al. Bowel endometriosis: presentation, diagnosis, and treatment. Obstet Gynecol Surv 2007; 62:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/13\">",
"      Somigliana E, Infantino M, Candiani M, et al. Association rate between deep peritoneal endometriosis and other forms of the disease: pathogenetic implications. Hum Reprod 2004; 19:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/14\">",
"      Martin DC, Batt RE. Retrocervical, retrovaginal pouch, and rectovaginal septum endometriosis. J Am Assoc Gynecol Laparosc 2001; 8:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/15\">",
"      Vercellini P, Carmignani L, Rubino T, et al. Surgery for deep endometriosis: a pathogenesis-oriented approach. Gynecol Obstet Invest 2009; 68:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/16\">",
"      Khong SY, Bignardi T, Luscombe G, Lam A. Is pouch of Douglas obliteration a marker of bowel endometriosis? J Minim Invasive Gynecol 2011; 18:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/17\">",
"      De Cicco C, Corona R, Schonman R, et al. Bowel resection for deep endometriosis: a systematic review. BJOG 2011; 118:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/18\">",
"      Chapron C, Dubuisson JB, Chopin N, et al. [Deep pelvic endometriosis: management and proposal for a \"surgical classification\"]. Gynecol Obstet Fertil 2003; 31:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/19\">",
"      Sangi-Haghpeykar H, Poindexter AN 3rd. Epidemiology of endometriosis among parous women. Obstet Gynecol 1995; 85:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/20\">",
"      Chatman DL, Ward AB. Endometriosis in adolescents. J Reprod Med 1982; 27:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/21\">",
"      Missmer SA, Hankinson SE, Spiegelman D, et al. Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am J Epidemiol 2004; 160:784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/22\">",
"      Wills HJ, Reid GD, Cooper MJ, Morgan M. Fertility and pain outcomes following laparoscopic segmental bowel resection for colorectal endometriosis: a review. Aust N Z J Obstet Gynaecol 2008; 48:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/23\">",
"      Fedele L, Bianchi S, Zanconato G, et al. Is rectovaginal endometriosis a progressive disease? Am J Obstet Gynecol 2004; 191:1539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/24\">",
"      Vercellini P. Endometriosis: what a pain it is. Semin Reprod Endocrinol 1997; 15:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/25\">",
"      Vercellini P, Frontino G, Pietropaolo G, et al. Deep endometriosis: definition, pathogenesis, and clinical management. J Am Assoc Gynecol Laparosc 2004; 11:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/26\">",
"      Vercellini P, Trespidi L, De Giorgi O, et al. Endometriosis and pelvic pain: relation to disease stage and localization. Fertil Steril 1996; 65:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/27\">",
"      Fauconnier A, Chapron C, Dubuisson JB, et al. Relation between pain symptoms and the anatomic location of deep infiltrating endometriosis. Fertil Steril 2002; 78:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/28\">",
"      Yantiss RK, Clement PB, Young RH. Endometriosis of the intestinal tract: a study of 44 cases of a disease that may cause diverse challenges in clinical and pathologic evaluation. Am J Surg Pathol 2001; 25:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/29\">",
"      De Ceglie A, Bilardi C, Blanchi S, et al. Acute small bowel obstruction caused by endometriosis: a case report and review of the literature. World J Gastroenterol 2008; 14:3430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/30\">",
"      Varras M, Kostopanagiotou E, Katis K, et al. Endometriosis causing extensive intestinal obstruction simulating carcinoma of the sigmoid colon: a case report and review of the literature. Eur J Gynaecol Oncol 2002; 23:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/31\">",
"      Vercellini P, Aimi G, Panazza S, et al. Deep endometriosis conundrum: evidence in favor of a peritoneal origin. Fertil Steril 2000; 73:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/32\">",
"      Propst AM, Storti K, Barbieri RL. Lateral cervical displacement is associated with endometriosis. Fertil Steril 1998; 70:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/33\">",
"      Hudelist G, English J, Thomas AE, et al. Diagnostic accuracy of transvaginal ultrasound for non-invasive diagnosis of bowel endometriosis: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2011; 37:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/34\">",
"      Bazot M, Lafont C, Rouzier R, et al. Diagnostic accuracy of physical examination, transvaginal sonography, rectal endoscopic sonography, and magnetic resonance imaging to diagnose deep infiltrating endometriosis. Fertil Steril 2009; 92:1825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/35\">",
"      Bazot M, Detchev R, Cortez A, et al. Transvaginal sonography and rectal endoscopic sonography for the assessment of pelvic endometriosis: a preliminary comparison. Hum Reprod 2003; 18:1686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/36\">",
"      Piketty M, Chopin N, Dousset B, et al. Preoperative work-up for patients with deeply infiltrating endometriosis: transvaginal ultrasonography must definitely be the first-line imaging examination. Hum Reprod 2009; 24:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/37\">",
"      Thomassin I, Bazot M, Detchev R, et al. Symptoms before and after surgical removal of colorectal endometriosis that are assessed by magnetic resonance imaging and rectal endoscopic sonography. Am J Obstet Gynecol 2004; 190:1264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/38\">",
"      Bazot M, Bornier C, Dubernard G, et al. Accuracy of magnetic resonance imaging and rectal endoscopic sonography for the prediction of location of deep pelvic endometriosis. Hum Reprod 2007; 22:1457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/39\">",
"      Chapron C, Vieira M, Chopin N, et al. Accuracy of rectal endoscopic ultrasonography and magnetic resonance imaging in the diagnosis of rectal involvement for patients presenting with deeply infiltrating endometriosis. Ultrasound Obstet Gynecol 2004; 24:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/40\">",
"      Biscaldi E, Ferrero S, Remorgida V, Rollandi GA. Bowel endometriosis: CT-enteroclysis. Abdom Imaging 2007; 32:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/41\">",
"      Zwas FR, Lyon DT. Endometriosis. An important condition in clinical gastroenterology. Dig Dis Sci 1991; 36:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/42\">",
"      Vercellini P, Barbara G, Abbiati A, et al. Repetitive surgery for recurrent symptomatic endometriosis: what to do? Eur J Obstet Gynecol Reprod Biol 2009; 146:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/43\">",
"      Vercellini P, Crosignani PG, Somigliana E, et al. Medical treatment for rectovaginal endometriosis: what is the evidence? Hum Reprod 2009; 24:2504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/44\">",
"      Vercellini P, Pietropaolo G, De Giorgi O, et al. Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate. Fertil Steril 2005; 84:1375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/45\">",
"      Ferrero S, Camerini G, Ragni N, et al. Norethisterone acetate in the treatment of colorectal endometriosis: a pilot study. Hum Reprod 2010; 25:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/46\">",
"      Fedele L, Bianchi S, Zanconato G, et al. Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis. Fertil Steril 2001; 75:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/47\">",
"      Razzi S, Luisi S, Calonaci F, et al. Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis. Fertil Steril 2007; 88:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/48\">",
"      Ferrero S, Camerini G, Seracchioli R, et al. Letrozole combined with norethisterone acetate compared with norethisterone acetate alone in the treatment of pain symptoms caused by endometriosis. Hum Reprod 2009; 24:3033.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/49\">",
"      Practice Committee of American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis. Fertil Steril 2008; 90:S260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/50\">",
"      Vercellini P, Barbara G, Somigliana E, et al. Comparison of contraceptive ring and patch for the treatment of symptomatic endometriosis. Fertil Steril 2010; 93:2150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/51\">",
"      Vercellini P, Crosignani P, Somigliana E, et al. 'Waiting for Godot': a commonsense approach to the medical treatment of endometriosis. Hum Reprod 2011; 26:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/52\">",
"      Roman H. Oral contraceptives and endometriosis. Hum Reprod 2011; 26:1600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/53\">",
"      Vercellini P, Crosignani PG, Somigliana E, et al. Reply: Oral contraceptives and the endometriosis domino effect. Hum Reprod 2011; [Epub ahead of print]:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/54\">",
"      Fedele L, Bianchi S, Zanconato G, et al. Gonadotropin-releasing hormone agonist treatment for endometriosis of the rectovaginal septum. Am J Obstet Gynecol 2000; 183:1462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/55\">",
"      Vercellini P, Crosignani PG, Abbiati A, et al. The effect of surgery for symptomatic endometriosis: the other side of the story. Hum Reprod Update 2009; 15:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/56\">",
"      Carmona F, Mart&iacute;nez-Zamora A, Gonz&aacute;lez X, et al. Does the learning curve of conservative laparoscopic surgery in women with rectovaginal endometriosis impair the recurrence rate? Fertil Steril 2009; 92:868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/57\">",
"      Vercellini P, Aimi G, Busacca M, et al. Laparoscopic uterosacral ligament resection for dysmenorrhea associated with endometriosis: results of a randomized, controlled trial. Fertil Steril 2003; 80:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/58\">",
"      Roman H, Loisel C, Resch B, et al. Delayed functional outcomes associated with surgical management of deep rectovaginal endometriosis with rectal involvement: giving patients an informed choice. Hum Reprod 2010; 25:890.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/59\">",
"      Ruffo G, Scopelliti F, Scioscia M, et al. Laparoscopic colorectal resection for deep infiltrating endometriosis: analysis of 436 cases. Surg Endosc 2010; 24:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/60\">",
"      Donnez J, Squifflet J. Complications, pregnancy and recurrence in a prospective series of 500 patients operated on by the shaving technique for deep rectovaginal endometriotic nodules. Hum Reprod 2010; 25:1949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/61\">",
"      Mohr C, Nezhat FR, Nezhat CH, et al. Fertility considerations in laparoscopic treatment of infiltrative bowel endometriosis. JSLS 2005; 9:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/62\">",
"      Duepree HJ, Senagore AJ, Delaney CP, et al. Laparoscopic resection of deep pelvic endometriosis with rectosigmoid involvement. J Am Coll Surg 2002; 195:754.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/63\">",
"      Darai E, Thomassin I, Barranger E, et al. Feasibility and clinical outcome of laparoscopic colorectal resection for endometriosis. Am J Obstet Gynecol 2005; 192:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/64\">",
"      Dubernard G, Piketty M, Rouzier R, et al. Quality of life after laparoscopic colorectal resection for endometriosis. Hum Reprod 2006; 21:1243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/65\">",
"      Donnez J, Nisolle M, Casanas-Roux F, et al. Rectovaginal septum, endometriosis or adenomyosis: laparoscopic management in a series of 231 patients. Hum Reprod 1995; 10:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/66\">",
"      Donnez J, Nisolle M, Gillerot S, et al. Rectovaginal septum adenomyotic nodules: a series of 500 cases. Br J Obstet Gynaecol 1997; 104:1014.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/67\">",
"      Vercellini P, Pietropaolo G, De Giorgi O, et al. Reproductive performance in infertile women with rectovaginal endometriosis: is surgery worthwhile? Am J Obstet Gynecol 2006; 195:1303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/68\">",
"      Reich H, McGlynn F, Salvat J. Laparoscopic treatment of cul-de-sac obliteration secondary to retrocervical deep fibrotic endometriosis. J Reprod Med 1991; 36:516.",
"     </a>",
"    </li>",
"    <li>",
"     Candiani GB, Vercellini P, Fedele L, et al. Conservative surgical treatment of rectovaginal septum endometriosis. J Gynecol Surg 1992; 8:177.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/70\">",
"      Anaf V, Simon P, El Nakadi I, et al. Impact of surgical resection of rectovaginal pouch of douglas endometriotic nodules on pelvic pain and some elements of patients' sex life. J Am Assoc Gynecol Laparosc 2001; 8:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/71\">",
"      Chapron C, Jacob S, Dubuisson JB, et al. Laparoscopically assisted vaginal management of deep endometriosis infiltrating the rectovaginal septum. Acta Obstet Gynecol Scand 2001; 80:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/72\">",
"      Angioni S, Peiretti M, Zirone M, et al. Laparoscopic excision of posterior vaginal fornix in the treatment of patients with deep endometriosis without rectum involvement: surgical treatment and long-term follow-up. Hum Reprod 2006; 21:1629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/73\">",
"      Kristensen J, Kjer JJ. Laparoscopic laser resection of rectovaginal pouch and rectovaginal septum endometriosis: the impact on pelvic pain and quality of life. Acta Obstet Gynecol Scand 2007; 86:1467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/74\">",
"      Campagnacci R, Perretta S, Guerrieri M, et al. Laparoscopic colorectal resection for endometriosis. Surg Endosc 2005; 19:662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/75\">",
"      Fleisch MC, Xafis D, De Bruyne F, et al. Radical resection of invasive endometriosis with bowel or bladder involvement--long-term results. Eur J Obstet Gynecol Reprod Biol 2005; 123:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/76\">",
"      Brouwer R, Woods RJ. Rectal endometriosis: results of radical excision and review of published work. ANZ J Surg 2007; 77:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/77\">",
"      Fedele L, Bianchi S, Zanconato G, et al. Long-term follow-up after conservative surgery for rectovaginal endometriosis. Am J Obstet Gynecol 2004; 190:1020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/78\">",
"      Nezhat C, Nezhat F, Pennington E. Laparoscopic treatment of infiltrative rectosigmoid colon and rectovaginal septum endometriosis by the technique of videolaparoscopy and the CO2 laser. Br J Obstet Gynaecol 1992; 99:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/79\">",
"      Mereu L, Ruffo G, Landi S, et al. Laparoscopic treatment of deep endometriosis with segmental colorectal resection: short-term morbidity. J Minim Invasive Gynecol 2007; 14:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/80\">",
"      Possover M, Diebolder H, Plaul K, Schneider A. Laparascopically assisted vaginal resection of rectovaginal endometriosis. Obstet Gynecol 2000; 96:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/17/24858/abstract/81\">",
"      Redwine DB, Wright JT. Laparoscopic treatment of complete obliteration of the cul-de-sac associated with endometriosis: long-term follow-up of en bloc resection. Fertil Steril 2001; 76:358.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14189 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-183.166.191.243-84F2B57B49-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_17_24858=[""].join("\n");
var outline_f24_17_24858=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H4930858\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4930774\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29778980\">",
"      OVERVIEW OF DISEASE CHARACTERISTICS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5266609\">",
"      Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5266309\">",
"      Distribution of disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29779101\">",
"      Anatomy of rectovaginal disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1460574\">",
"      Depth of infiltration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23891569\">",
"      PREVALENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23891848\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3390061\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23891856\">",
"      DIAGNOSIS AND EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1461059\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1461149\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H600841\">",
"      Biopsy of visible lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1461141\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1220610\">",
"      - Ultrasound",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H1892424\">",
"      Transvaginal ultrasound",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H1892431\">",
"      Rectal endoscopic ultrasound",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1892632\">",
"      - Magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1220625\">",
"      - Other imaging studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9832995\">",
"      - Urinary tract imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H960154\">",
"      Bowel endoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1090993\">",
"      Diagnostic laparoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2750080\">",
"      APPROACH TO TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1090893\">",
"      Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1091088\">",
"      Medical versus surgical treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H960221\">",
"      Counseling patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23176626\">",
"      MEDICAL TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23176687\">",
"      Estrogens and progestins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23176694\">",
"      Other medical therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23176701\">",
"      Following patients during treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H602138\">",
"      SURGICAL TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3389830\">",
"      Rectovaginal endometriosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2499524\">",
"      - Procedure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8429892\">",
"      - Follow-up",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3389837\">",
"      Bowel endometriosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2750185\">",
"      Management of incidental bowel lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2499718\">",
"      Complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23892106\">",
"      Outcome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4930795\">",
"      - Pain symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4930802\">",
"      - Infertility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4930858\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/14189\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/14189|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?19/14/19683\" title=\"figure 1\">",
"      Rectovaginal exam during laparoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/14189|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/56/35712\" title=\"picture 1\">",
"      Endometriosis posterior vaginal fornix",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/4/35912?source=related_link\">",
"      Acute urinary retention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/55/43897?source=related_link\">",
"      Approach to the adult with chronic diarrhea in developed countries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/1/43032?source=related_link\">",
"      Approach to the woman with sexual pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/26/41384?source=related_link\">",
"      Causes of chronic pelvic pain in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/18/3367?source=related_link\">",
"      Causes of female infertility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/23/18806?source=related_link\">",
"      Control measures to prevent surgical site infection following gastrointestinal procedures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/30/16874?source=related_link\">",
"      Differential diagnosis of abdominal pain in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/22/13673?source=related_link\">",
"      Etiology and evaluation of chronic constipation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/6/7272?source=related_link\">",
"      Etiology of lower gastrointestinal bleeding in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/18/24872?source=related_link\">",
"      Intestinal gas and bloating",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14810?source=related_link\">",
"      Overview of the treatment of endometriosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/15/38136?source=related_link\">",
"      Pathogenesis and treatment of infertility in women with endometriosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/48/19210?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of endometriosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/27/28083?source=related_link\">",
"      Patient information: Care after gynecologic surgery (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/40/26246?source=related_link\">",
"      Perianal abscess: Clinical manifestations, diagnosis, treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/60/39879?source=related_link\">",
"      Primary dysmenorrhea in adult women: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/11/32951?source=related_link\">",
"      Rectovaginal, anovaginal, and colovesical fistulas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/46/14058?source=related_link\">",
"      Small bowel obstruction: Causes and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/42/25254?source=related_link\">",
"      Thoracic endometriosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/60/1993?source=related_link\">",
"      Urinary tract endometriosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/35/27191?source=related_link\">",
"      Uterine adenomyosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/27/5560?source=related_link\">",
"      Vaginal intraepithelial neoplasia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_17_24859="Classification of secondary esophageal motility abnormalities";
var content_f24_17_24859=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F75807&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F75807&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Classification of secondary esophageal motility abnormalities",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Diagnosis",
"       </td>",
"       <td class=\"subtitle1\">",
"        Conventional manometry",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        Systemic sclerosis",
"       </td>",
"       <td>",
"        Loss of distal (smooth muscle) peristalsis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Weak lower esophageal sphincter pressure (&lt;10 mmHg)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Normal proximal esophagus and UES (striated muscle)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Chagas' disease",
"       </td>",
"       <td>",
"        Identical to idiopathic achalasia",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Diabetes mellitus",
"       </td>",
"       <td>",
"        A variety of motility abnormalities of the esophageal body",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Chronic idiopathic intestinal pseudo-obstruction",
"       </td>",
"       <td>",
"        Loss of distal esophageal motility",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Chronic gastroesophageal reflux disease",
"       </td>",
"       <td>",
"        Ineffective esophageal motility (IEM)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypotensive lower esophageal sphincter",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     UES: upper esophageal sphincter.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_17_24859=[""].join("\n");
var outline_f24_17_24859=null;
var title_f24_17_24860="Diagnostic criteria ADEM";
var content_f24_17_24860=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F74896&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F74896&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diagnostic criteria of acute disseminated encephalomyelitis (ADEM)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Clinical features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        First clinical attack of inflammatory or demyelinating disease in the CNS",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute or subacute onset",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Affects multifocal areas of the CNS",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Polysymptomatic presentation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Must include encephalopathy:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Acute behavioral change such as confusion or irritability",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        <strong>",
"         and/or",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Alteration in consciousness ranging from somnolence or coma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Attack should be followed by improvement on clinical and/or neuroradiologic (MRI) measures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sequelae may include residual deficits",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No other etiologies can explain the event",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        ADEM relapses (with new or fluctuating symptoms, signs or MRI findings) occurring within three months of the inciting ADEM episode are considered part of the same acute event. In addition, ADEM relapses that occur during a steroid taper or within four weeks of completing a steroid taper are considered part of the initial inciting ADEM episode.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Lesion Characteristics on MRI FLAIR and T2 weighted images",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Large (&gt;1 to 2 cm in size) multifocal, hyperintense, bilateral, asymmetric lesions in the supratentorial or infratentorial white matter. Rarely, brain MRI shows a single large (&ge;1 to 2 cm) lesion predominantly affecting white matter.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gray matter, especially basal ganglia and thalamus, may be involved",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Spinal cord MRI may show confluent intramedullary lesion(s) with variable enhancement, in addition to the abnormalities on brain MRI",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No radiologic evidence of previous destructive white matter changes",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Encephalopathy is a required feature for the diagnosis of ADEM, but is not a typical feature of multiple sclerosis. In addition, a cerebrospinal fluid pleocytosis &ge;50 white blood cells/mm can be observed in ADEM, whereas this finding is highly atypical for multiple sclerosis.",
"    <div class=\"footnotes\">",
"     CNS: central nervous system.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Krupp, LB, Banwell, B, Tenembaum, S. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007; 68:S7.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_17_24860=[""].join("\n");
var outline_f24_17_24860=null;
var title_f24_17_24861="TIPS high risk varic bleed";
var content_f24_17_24861=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F64881&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F64881&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Survival after TIPS in high-risk variceal bleeding",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 403px; height: 281px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Probability of survival after TIPS placement in patients with active variceal hemorrhage despite emergent endoscopic sclerotherapy who were considered to be at high risk of dying after surgery. Hemostasis was achieved in 90 percent and the 30-day survival was 63 percent; in those without pulmonary compromise (nonaspirators), 30-day survival was above 90 percent. This difference in outcome persisted with long-term follow-up.",
"    <div class=\"footnotes\">",
"     TIPS: transjugular intrahepatic portosystemic shunt.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Sanyal AJ, Freedman AM, Luketic VA, et al. Gastroenterology 1996; 111:138.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_17_24861=[""].join("\n");
var outline_f24_17_24861=null;
var title_f24_17_24862="Trocar positions for robotic pelvic surgery";
var content_f24_17_24862=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F87621&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F87621&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Trocar positions for robotic pelvic surgery",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 421px; height: 373px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Robotic &nbsp;trocar positions. A: umbilical incision for the robotic camera; B, C and D: lateral 8 mm ports for robotic trocars; E: 10 mm accessory port for the bedside assistant.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_17_24862=[""].join("\n");
var outline_f24_17_24862=null;
var title_f24_17_24863="Normal adult scaphoid radiograph";
var content_f24_17_24863=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F58484&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F58484&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Scaphoid view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 332px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This posterior anterior (PA) radiograph of the wrist taken with ulnar deviation of the hand serves to isolate the scaphoid (arrow) from overlaping shadows.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kevin E. Burroughs, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_17_24863=[""].join("\n");
var outline_f24_17_24863=null;
